Detecting differences in volatile organic compounds produced by Leishmania infantum infected and uninfected dogs by Staniek, Monica
 Detecting Differences in 
Volatile Organic 
Compounds Produced by 
Leishmania infantum 









In Biomedical and Life Sciences 
 
Lancaster University 
Faculty of Health and Medicine 








I declare that the content of this thesis is my own work and has not been submitted 
by myself in substantially the same form for the award of a higher degree elsewhere. 










First and foremost, my thanks go to my supervisors, Prof Gordon Hamilton and Dr 
Rod Dillon for their mentorship, supervision and endless supply of coffee over the 
years. I will always be grateful for your continued support, friendship and faith in me. 
Many thanks also to Dr Luigi Sedda for his support in the statistical analysis of the 
data in addition to his personal support and becoming a true friend.  
I also render my thanks to Raquel Vionette and Fraser Mitchell for their technical 
support in the labs at Lancaster University and Tim Gibson of RoboScientific for his 
supply of the VOC Analyser and support in the sample analysis. Special thanks also go 
to the Central Control of Zoonosis (CCZ) in Governador Valadares for their practical 
support and permission to carry out the field work. I would also like to thank Ricardo 
Alves Miranda (CCZ phlebotomist) and Erika M. Costa (Veterinarian, FioCruz, Rio) for 
collecting the dog blood samples and initial clinical assessment of the dogs, as well as 
Melissa Bell (Lancaster University) and Cristian F. de Souza (FioCruz, Rio) for 
providing in-field technical support. Furthermore, I would also like to thank Prof P. 
Bates (Division of Biomedical and Life Sciences, Lancaster University) for supplying 
the cultured Leishmania promastigotes and Viv Dillon for helping with initial thesis 
corrections. 
I would also like to extend my gratitude to the staff in the Division of Biomedical and 
Life Sciences at Lancaster University as well as the friends I have made during my 
PhD, special mention to Natalie Jones, James Tollitt, Alex Hardgrave, Marine Aublette 




I am profoundly grateful to the dog owners of Altinópolos, Governador Valadares for 
allowing me to carry out this research on their cherished companions.  
This work received financial support from the Lancaster University studentship. 
v 
 





Table of Contents v 
Contents Pages 1 - 5 
List of Figures vi 








List of Figures 
Figure 1.1: The life cycle of Leishmania species 10 
Figure 1.2: Living female Lu. longipalpis, the most common vector of 
Leishmania infantum in Brazil                                                                                                          20
Figure 1.3: Dead Lutzomyia sandflies viewed under a microscope 20 
Figure 1.4: Leishmania amastigotes in skin lesion biopsy 29 
Figure 1.5: Flow diagram representation of human and artificial (VOC 
Analyser) olfactory systems 41 
Figure 2.1: Location of the municipality of Governador Valadares on a 
map of Brazil 48 
Figure 2.2: Altinopolis, Governador Valadares - State of Minas Gerais, 
Brazil 49 
Figure 2.3: A clinical questionnaire used during samples collection 53 
Figure 2.4: Portable entrainment system 54 
Figure 3.1: Clinical symptoms observed during sample collection 59 
Figure 3.2: Distribution of Canine Visceral Leishmaniasis 63 
Figure 3.3: Leishmania infantum kDNA minicircle DNA partial sequence 
and primer location 69 
Figure 3.4: Gels showing sensitivity of two sets of primer pairs for the 
detection of Le. infantum. 73 
Figure 3.5: MaryF/MaryR specificity PCR. 74 
Figure 3.6: Standard curve constructed using serial dilutions of Leish-
mania infantum DNA. 76 
Figure 3.7: Melting curve analyses of PCR products. 76 
Figure 3.8: Agarose gels of genomic DNA of 24 random samples ex-
tracted from canine buffy coat in A; August 2017 and B; April 2018 77 
Figure 3.9: Agarose gels showing the amplification of the constitutive 
canine -  globin gene for 24 random samples from A; August 2017 and 




Figure 3.10: SYBR safe-stained 2% agarose gels showing the results of 
electrophoresis of 24 random PCR products from A; April 2017 dogs 
and B; August 2018 dogs 
 
80 
Figure 3.11: kDNA qPCR assay of all positive samples from A; in the field 
(August 2017) n=185, B; CCZ (April 2018) n=16 and C; in the field (April 
2018) n=133. 83 
Figure 4.1: Positive result obtained by K26/K39-specific antibody Dual-
Path Platform rapid diagnostic test (DPP®) for Dog #201. 96 
Figure 4.2: VOC Analyser (Model 307 VOC analyser, RoboScientific Ltd, 
Leeds, United Kingdom) employing 12 semi-conducting polymer sen-
sors. 107 
Figure 4.3: VOC Analyser data response for each sensor. 112 
Figure 4.4: Discriminant Function Analysis (DFA) (XLstat version 3.4), 
using sensor array 1, of dog hair from a Border Collie (BC) and Cavalier 
King Charles (CKC). 120 
Figure 4.5: DFA with multiple variables using sensor array 1 (A) and 
sensor array 3 (B) of VOC’s released from the buffy coat of dogs natu-
rally infected with Leishmania infantum (Triangles) or from negative 
controls (Circles). 134 
Figure 5.1: Basic Y-tube olfactometer design. 166 
Figure 5.2: Dog #138 bioassay to determine optimal dilution. 168 
Figure 5.3: Dogs #138, #128 and #027 bioassay to confirm optimal dilu-
tion 170 
Figure 5.4: Female sandfly behavioural bioassay using an unblinded 
protocol of 2018 infected vs uninfected dogs.  173 
Figure 5.5: Female sandfly behavioural bioassay performed using a 
blinded protocol of 2018 infected vs uninfected dogs 176 
Figure 5.6: Male sandfly behavioural bioassay performed using an un-
blinded experimental protocol of 2018 infected vs uninfected dogs.  179 
Figure 5.7: Male sandfly behavioural bioassay following a blinded ex-
perimental protocol of 2018 infected vs uninfected dogs.  182 
Figure 6.1: Schematic diagram of a GC/MS system 199 
Figure 6.2: Types of capillary columns. 199 
viii 
 
Figure 6.3: Principal component analysis score plots of dog hair volatile 
samples from the gas chromatography / mass spectrometry analyses of 
2017 dogs on A) DB-Wax column and B) HP5-MS column 216 
Figure 6.4: Principal component analysis score plots of dog hair volatile 
samples from the GC/MS analyses of 2018 dogs on A) DB-Wax column 





List of Tables 
Table 1.1:  The reported cases per year and estimated annual incidence of 
both visceral and cutaneous leishmaniasis. 16 
Table 1.2: Studies describing the odours emitted from the skin in response 
to different diseases and metabolic disorders. 40 
Table 3.1: Current diagnostic methods used for cVL diagnosis 57 
Table 3.2: Summary of PCR results for Leishmania infantum detection in 
dogs from Governador Valadares, Minas Gerais, Brazil. 81 
Table 3.3: Percentage infection rates and clinical symptoms of positive 
dogs 81 
Table 4.1: List of 2017 dogs selected for volatile organic compound (VOC) 
Analyser analysis. 115 
Table 4.2: Outcome of the mixture model analysis showing the top three 
models for the 2017 uninfected and infected dog data. 121 
Table 4.3: Outcome of the mixture model analysis showing the top three 
models for the 2018 uninfected and infected dog data. 121 
Table 4.4: Confusion matrix for Gaussian mixture model Eigen 
Decomposition Discriminant Analysis (EDDA) classification for uninfected 
and infected dogs in 2017 without subclasses. 123 
Table 4.5: Confusion matrix for Gaussian mixture model Eigen 
Decomposition Discriminant Analysis (EDDA) classification for 1 uninfected 
dog class and 3 infected dog classes in 2017. 123 
Table 4.6: Confusion matrix for Gaussian mixture model Eigen 
Decomposition Discriminant Analysis (EDDA) classification for uninfected 
and infected dogs in 2018 without subclasses 124 
Table 4.7: Confusion matrix for Gaussian mixture model Eigen 
Decomposition Discriminant Analysis (EDDA) classification for 2 uninfected 
dog classes and 6 infected dog classes in 2018.   124 
Table 4.8: Cross Validation and Confounder Cross Validation analysis of 
2017 data 2 groups vs 4 groups. 126 
Table 4.9: Cross Validation and Confounder Cross Validation analysis of 
2018 data 2 groups vs 8 groups. 126 




Table 4.11: Discriminant analysis for the means of uninfected and infected 
dogs in 2017 (n=55). 128 
Table 4.12: Discriminant analysis for uninfected and infected dogs in 2018 
(n=446). 129 
Table 4.13: Discriminant analysis for the means of uninfected and infected 
dogs in 2018 (n=149). 129 
Table 4.14: Relative Importance of the first 5 different sensor variables in 
the contribution to the clustering by R-cran, observed in the 2017 data; A 
and 2018 data; B 130 
Table 4.15: Confusion matrix for Gaussian mixture model Eigen 
Decomposition Discriminant Analysis (EDDA) classification for uninfected 
dogs in 2017 and 2018. 131 
Table 4.16: Parasite load and clinical signs of high and low VOC Analyser 
discriminated dogs 132 
Table 5.1: Samples compared during the female sandfly unblinded 
bioassay 161 
Table 5.2: Samples compared during the female sandfly blinded bioassay. 162 
Table 5.3: Samples compared during the male sandfly unblinded bioassay 163 
Table 5.4: Samples compared during the male sandfly blinded bioassay 163 
Table 5.5: Number of female sandflies which responded to Dog #138. 167 
Table 5.6: Number of female sandflies which responded to Dogs #138, 
#128 and #027. 169 
Table 5.7: Number of female sandflies which responded to infected and 
uninfected dog odour; Unblinded protocol 172 
Table 5.8: Number of female sandflies which responded to infected and 
uninfected dog odour. Blinded protocol 175 
Table 5.9: Number of male sandflies which responded to infected and 
uninfected dog odour; Unblinded protocol 178 
Table 5.10: Number of male sandflies which responded to infected and 
uninfected dog odour. Blinded protocol 181 
Table 6.1: Significantly important volatiles identified in the hair samples 




Table 6.2: 2017 Confusion matrixes for the Principle Component Analyses 




Table 6.3:  2018 Confusion matrixes for the Principle Component Analyses 
(PCA’s) using Agilent Mass Professional Profiler software (MPP) v15.0. 219 
Table 6.4: VOC’s identified as potential biomarkers for Leishmania 





0C  Degrees Celsius 
AD  Alzheimer’s disease  
amu  Atomic mass unit 
ASSURED Affordable, Sensitive, Specific, User-friendly, Rapid and Robust, 
Equipment free and Deliverable to end users 
BC  Border Collie (Rover) 
BIC  Bayesian Information Criterion  
CCV  Confounder Cross Validation 
CCZ  Centre for the Control of Zoonosis  
CD  Crohn’s Disease  
CKC  Cavalier King Charles (Bonnie) 
CL  Cutaneous leishmaniasis  
Ct  Cycle threshold 
CV  Cross Validation 
cVL  Canine visceral leishmaniasis 
DA  Discriminant Analysis 
DAT  Direct Agglutination Test  
DDT  Dichlorodiphenyltrichloroethane 
DFA  Discriminant Function Analysis  
dH2O  Distilled water  
DHT  Dihydrotestosterone 
dNTP  Deoxynucleotide  
DPP  Dual-path platform 
EDDA  Eigen decomposition discriminant analysis  
EDTA  Ethylenediaminetetraacetic acid 
xiii 
 
EIC  Extracted ion chromatograms  
ELISA  Enzyme-linked immunosorbent assay 
FBS  Fetal bovin serum 
GC  Gas chromatography  
GC/MS Gas chromatography coupled mass spectrometry 
GV  Governador Valadares  
H2  Hydrogen 
HIV  Human immunodeficiency virus 
HOMEM Hemoflagellate-modified minimum essential medium 
IC  Immunochromatographic 
IFAT  Indirect fluorescent-antibody test  
IRS  Indoor residual spraying  
ITC  Insecticide treated curtains 
ITN  Insecticide treated bed nets  
kDNA  Kinetoplast deoxyribonucleic acid 
LAT  Latex agglutination test 
Le.  Leishmania 
LLITN  Long lasting insecticide treated nets 
Lu.  Lutzomyia 
M.  Mycobacterium 
m/z  Mass to charge ratio 
M199  Medium199 
MCL  Mucocutaneous leishmaniasis  
MHC  Major histocompatibility complex  
MPP  Mass professional profiler 
MRSA  Methicillin-resistant Staphylococcus aureus  
xiv 
 
MS  Mass spectrometry  
MSSA  Methicillin-sensitive Staphylococcus Aureus  
NIST14  National Institute of Standards and Technology library  
P.  Phlebotomus  
PC  Principle component  
PCA  Principle component analysis 
PCR  Polymerase chain reaction  
PCR-RFLP Polymerase chain reaction - restriction fragment length polymorphism 
PD  Parkinson’s Disease 
PLS-DA Partial least squares discriminant analysis  
POC  Point of care  
RDT  Rapid diagnostic test 
Rel Freq Relative frequency  
RK26  Recombinant kinase 26  
Rk39  Recombinant kinase 39 
ROS  Reactive oxygen species 
rRNA  Ribosomal ribonucleic acid 
Rt-qPCR Real time quantitative polymerase chain reaction  
SCOT  Support-coated open tubular  
SPME  Solid-phase microextraction 
T.  Toxoplasma 
TB  Tuberculosis 
UTI  Urinary tract infections  
V.  Viannia 
VL  Visceral leishmaniasis  
VOC  Volatile organic compound 
xv 
 
WCOT  Wall-coated open tubular  




Detecting Differences in Volatile Organic 
Compounds Produced by Leishmania 








In Biomedical and Life Sciences 
 
Lancaster University 
Faculty of Health and Medicine 






The leishmaniases are a complex of parasitic diseases which cause 
approximately 30,000 deaths annually. In Brazil, leishmaniasis is a significant burden 
(Bezerra et al., 2018). Dogs are the main reservoir host for Leishmania (Le.) infantum 
parasites and are the source of infection for the human population. Le. infantum is 
transmitted to people via the bite of an infected Lutzomyia (Lu.) longipalpis sandfly. 
To disrupt this transmission cycle, it is important to identify Leishmania infected dogs 
and remove them from the population. However, current diagnostic methods are 
complex, can be inaccurate and therefore limit effective reservoir control. 
The aim of this study was to determine whether Leishmania infantum 
infected dogs could be discriminated from uninfected dogs using three different 
xvii 
 
methodologies; a VOC Analyser, behavioural bioassay and gas chromatography mass 
spectrometry (GC/MS). Previous studies have shown that animals (e.g. dogs, 
hamsters) infected with Leishmania parasites produce odours that are different to 
those produced by uninfected animals (De Oliveira et al., 2008; Magalhães-Júnior et 
al., 2014b). In this study the VOC analyser demonstrated the ability to reliably 
discriminate between Leishmania infected and uninfected dogs, with high sensitivity 
(97-100%) and specificity (95-100%). The accuracy demonstrated of this diagnostic is 
an improvement on the current in-field DPP test used for cVL diagnosis, with a 
sensitivity of 75-89% and specificity of 56-70% having been recently reported 
(Figueiredo et al., 2018). This result suggests the potential for this approach for the 
rapid, non-invasive POC diagnosis of dogs infected with leishmaniasis. Studies on the 
behavioural response of male and female to the odour of infected and uninfected 
dogs showed that female Lu. longipalpis were significantly more attracted to infected 
odour whereas males were not. This result may suggest that Leishmania could be 
manipulating canine host odour in order to aid its own transmission. Increased 
attractiveness of infected dog odour suggests the potential of whole dog odour 
baited traps as a novel vector control methodology. Further GC/MS analysis 
confirmed the differences observed between the odour profiles of infected and 
uninfected dogs through both the VOC Analyser and behavioural bioassays. This 
analysis also allowed for the identification of the chemical structure and composition 
of compounds present in infected dogs which have the potential to not only enhance 
the VOC Analyser as a cVL specific diagnostic, but also could be investigated as 
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Chapter One - Introduction 
 
1.1 Introduction to leishmaniasis  
Leishmaniasis is a neglected vector-borne tropical disease caused by protist 
parasites from the genus Leishmania (Kinetoplastida: Trypanosomatidae) (Ross, 1903). 
Leishmania affects both humans and animals, with over 20 different species of the 
parasite having been named (World Health Organisation, 2016). Leishmaniases are 
devastating diseases that have negative effects on both economic productivity as well 
as socioeconomic development; recurrent epidemics have caused high morbidity and 
mortality in affected communities (Camargo and Langoni, 2006). The World Health 
Organisation considers leishmaniasis as one of the most important zoonotic diseases, 
particularly in Brazil, where approximately 85,000 cases of visceral leishmaniasis were 
reported from 1990 to 2016, with the fatality rate reaching 20% (Luz et al., 2018). 
Female Phlebotomine sandflies (Psychodidae: Phelebotominae) provide the primary 
route of Leishmania transmission (Bates and Rogers, 2004). Over 800 species of 
Phlebotomine sandflies have been recorded, with 98 having proven or suspected 
vectorial capacity for human leishmaniasis (Maroli et al., 2013). Females of two genera 
(Phlebotomus and Lutzomyia) have been proven to be successful Leishmania vectors 
for human pathogenic species and are therefore of medical importance (Killick-
Kendrick, 1999). These include, 56 Lutzomyia species (Diptera: Psychodidae) found 
throughout the New World, and 42 Phlebotomus species (Diptera: Psychodidae) found 
throughout the Old World (Maroli et al., 2013). Female sandflies are only able to 
transmit the species of the Leishmania that attach to the midgut (Lewis, 1971). 
Although the recognition of leishmaniases as a public health problem is growing, the 
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disease still remains one of the world’s most neglected tropical diseases. A lack of easy 
diagnostics, safe and effective drugs and vector control tools are currently hampering 
the successful control of Leishmania (Hailu et al., 2016). 
 
1.1.1 Clinical Manifestations 
The clinical outcome of Leishmania infection depends on a complex association 
between three main factors; the parasite, the host and the vector and is manifested in 
three different forms, all of which vary in symptoms and severity (MacMorris-Adix, 
2009). 
Cutaneous Leishmaniasis (CL) is the most common and widespread of the three 
diseases. It is characterised by painful skin ulcers that are located at the site of or close 
to the location of the sandfly bite (Hide et al., 2007). The morphology of the ulcerative 
skin lesions can vary; they can become large and destructive ulcers which remain for 
many months before healing, or they can be relatively small with little effect on the 
patient (Oliveira et al., 2004). Although these skin ulcers are largely self-healing with 
no need for any specific treatment, the scars that remain can often be socially 
debilitating (Hotez, 2008). Various etiological agents cause Old World and New World 
CL, including Leishmania major, Le. tropica and some zymodemes of Le. infantum in 
the Old World (Masmoudi et al., 2013) and Le. mexicana or species of the Le. Viannia 
subgenus in the New World (Pace, 2014).  
Mucocutaneous leishmaniasis (MCL) is a severe form of cutaneous 
leishmaniasis, mainly characterised by skin ulcers which develop around mucosal 
regions. These lesions often lead to disfiguring and extensive destruction of the 
mucous tissues of the mouth, nose and face. Arms and legs can also be affected which 
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can ultimately lead to serious disability (Hide et al., 2007). Around 35,000 cases of MCL 
occur annually with 90% of all cases occurring within three countries; Brazil, Bolivia 
and Peru (Pace, 2014). 
Visceral leishmaniasis (VL) is arguably the most severe form of Leishmaniasis 
with fatalities occurring approximately 95% of the time if left untreated (Ready, 2004). 
Visceral leishmaniasis is normally characterized by splenomegaly and hepatomegaly 
as well as severe weight loss, fever, pancytopenia and hypergammaglobulinemia 
(Sundar and Rai, 2002). Various etiological agents are known to cause VL with studies 
confirming Le. donovani as the main etiological agent in India, whereas Le. infantum is 
the primary etiological agent in Europe and South America. Phlebotomus (P.) 
perniciosus is the primary vector for Le. infantum in Europe, P. argentipes for Le. 
donavani in the Indian subcontinent and in South America, particularly Brazil, the 
primary vector for Le. infantum is Lu. longipalpis (Miró et al., 2012). The risk factors 
involved in the transmission of VL including canine infection, socioeconomic factors 
and environmental features, are still very poorly understood (Miranda de Araújo et al., 
2013). 
 
1.1.2 Transmission and Life Cycle 
Leishmania has a digenetic life cycle, alternating between phlebotomine 
sandfly vectors and competent mammalian hosts (Figure 1.1). Mammalian hosts range 
from desert rats to canines and humans, who are often considered as accidental hosts. 
Outside of the mammalian host, the parasite life cycle is confined to the digestive tract 
of female sandflies. The precise location of the parasite differs between Leishmania 
subgenera. Species in the New World subgenus Viannia (e.g. Le. braziliensis) are 
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known as peripylarian parasites as they enter the hindgut before migrating to the 
midgut. Species in the Leishmania subgenus (e.g. Le. mexicana), however, are 
suprapylarian parasites as they develop in and are restricted to the midgut (Lainson et 
al., 1977). Leishmania colonisation of the midgut is vital for parasite transmission. 
Promastigotes undergo specific development in the sandfly midgut which culminates 
in their differentiation into metacyclic promastigotes which are infective to and 





Figure 1.1 Life cycle of Leishmania species. When a sandfly takes a blood meal, infective 
promastigotes are injected into a susceptible host mammal. These promastigotes are 
then phagocytosed and transform into amastigotes, multiplying by simple division within 
these cells. The parasites continue to infect phagocytic cells either at the site of the bite 
(CL) or in secondary lymphoid organs (VL). When sandflies feed on an infected host, they 
become infected with amastigotes. These amastigotes transform into promastigotes in 
the midgut of the sandfly and migrate from the midgut to the stomodeal valve 






Parasite development in the vector begins following the bite of a female 
sandfly and ingestion of a blood meal containing macrophages that are infected with 
amastigotes; the immotile form of the parasite. Once ingested, a morphological 
change and development of the parasite occurs due to a notable difference in 
conditions in the sandfly, such as an increase in pH and a decrease in body 
temperature. The ingested amastigotes develop into procyclic promastigotes that are 
weakly motile and possess a short flagellum which beats at the anterior end of the cell. 
This form of the parasite is the first replicative form. The promastigotes proliferate in 
the ingested blood meal, being separated from the sandfly midgut by a type I 
peritrophic matrix. Approximately 48–72 hours after the blood meal, the parasites 
slow their replication and differentiate into motile, long nectomonad promastigotes. 
This parasite form is able to escape from the blood meal encased in the peritrophic 
matrix, migrate to the lumen of the midgut, and from there to the midgut anterior 
where they develop into short nectomonad promastigotes (or leptomonads) and, 
enter another proliferative cycle (Rogers et al., 2002). Following detachment, 
migration and colonisation of the stomodeal valve, effective transmission of the 
parasite can occur. Leishmania ultimately transform into infective metacyclic 
promastigotes which, during a blood meal, are delivered to the mammalian host 
through regurgitation into the blood pool formed during feeding (Sacks and Perkins, 
1985).  
After the sandfly blood feeds on the mammalian host, the metacyclic 
promastigotes can infiltrate the host. In mammals, macrophages are the main cellular 
host for these parasites. These promastigotes can attach to the macrophages via 
receptor mediated mechanisms, being engulfed by phagocytosis forming a 
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phagolysosome within the macrophage. Promastigotes undergo various metabolic 
and biochemical changes within the macrophage which result in the formation of 
intracellular amastigotes (Rodriguez et al., 2017). The infected macrophage bursts, 
releasing amastigotes which migrate to various areas of the host circulatory system 
i.e. dendritic cells, fibroblasts, new macrophages in the skin and the visceral system 
(Rittig and Bogdan, 2000). Due to macrophages being immune effector cells, the 
interaction of Leishmania parasites with these immune cells causes a distinctive 
response of the immune system. The observed parasite interaction with the 
mammalian host immune system cause distinct morphological changes, some of which 
have been linked to an increase in parasite transmission. Ulcerative lesions that are 
developed during cutaneous infection have been identified as areas that poses a high 
parasite load, which has been directly correlated with disease transmission due to the 
efficacy of sandflies to acquire parasites while feeding there (Aslan et al., 2016). 
Furthermore, previous research has also demonstrated that the immune response to 
parasitic infections causes the production of disease biomarkers and volatile 
compounds which have been shown to increase vector attractiveness (De Moraes et 
al., 2014). However, this phenomenon has currently not been demonstrated during 
Leishmania infection. 
Various mammals have been implicated in the transmission of Leishmania with 
dogs and rats known to be among the major reservoirs in the New and Old World 
respectfully. Other mammals, including opossums (Didelphis spp.) and the crab-eating 
fox (Cerdocyon thous) have shown evidence of playing an epidemiological role in 
parasite transmission, however, these hosts have never been confirmed as reservoirs 
and the impact they have on the transmission cycle is unclear (Courtenay et al., 2002; 
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Dantas-Torres, 2007). Bush dogs (Speothos venaticus) and maned wolves (Chrysocyon 
brachyurus) have also been proven to be infectious to sandfly vectors, however the 
relevance of these findings from an epidemiological standpoint is unknown (Luppi et 
al., 2008; Mol et al., 2015). Recent findings have demonstrated the potential of sheep 
as a host for Leishmania infantum in China, however, successful transmission of the 
parasite is unknown (Han et al., 2018). Possibly more epidemiologically important 
results have identified rabbits that were infected with Leishmania infantum in Spain 
(Gracia et al., 2014). The variety of different host animals that have been identified is 
an important factor to consider when understanding the mechanisms behind the 
successful transmission of Leishmania. 
Although Leishmania transmission predominantly occurs via a sandfly vector, 
other insects could also be implicated as potential vectors. Leishmania DNA has been 
detected in ticks which were collected from naturally infected dogs in Brazil. The 
presence of parasite DNA suggests the participation of ticks in the zoonotic cycle of 
cVL (Campos and Costa, 2014). Additionally, research has also shown that Leishmania 
enriettii can develop a late stage infection the biting midge C. sonorensis (Seblova et 
al., 2015). Leishmania amazonensis and Le. braziliensis have also been detected in 
biting midges in Brazil (Rebelo et al., 2016). Additionally, research has also detected 
Leishmania infantum DNA in fleas that were collected from naturally infected dogs in 
Brazil (Colombo et al., 2011). These studies support the theory that other biting and 
or blood feeding insects could be potential natural vectors for Leishmania. Other 
modes of transmission have also been reported that do not require an insect vector. 
The parasite has shown successful transmission venereally, vertically and through 
infected blood transfusions. Transmission of VL either directly or due to the production 
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of an artificial leishmaniasis cycle through blood transfusions, has been shown in both 
infected dogs and humans. In 2001, Owens et al documented the first transmission of 
Le. infantum by blood transfusion through foxhounds used as blood donors. 
Furthermore, Leishmania parasites have been detected in shared syringes collected in 
Spain, suggesting that needle sharing could promote the spread of Leishmania 
amongst intravenous drug users (Cruz et al., 2002). There is further evidence to 
support this artificial means of transmission. In southern Europe approximately 70% 
of all adult VL cases are associated with HIV, with IV drug users accounting for 50-90% 
of all cases of HIV-leishmaniasis co-infection (Burton, 2001). Venereal transmission of 
cVL has also been reported, with Le. infantum having been shown to be transmitted 
between naturally infected male dogs who copulated with uninfected bitches, due to 
the shedding of Leishmania parasites into the semen (Silva et al., 2009). Magno da 
Silva et al., (2009), reported the first vertical transmission of Le. infantum from 
naturally infected female Brazilian dogs, with parasites found in the liver and spleen 
of two pups which were stillborn from a naturally infected mother. Interestingly, 
further direct dog to dog transmission has been recently reported, with the 
transmission of Le. infantum being demonstrated through the bite of a naturally 
infected dog that attacked another dog living in the same household causing multiple 
wounds (Naucke et al., 2016).  
The identification of other potential routes of transmission, other than via the 
bite of the sandfly vector, suggests the possible need for further research into 
Leishmania transmission as well as the current methods utilised for Leishmania 
disease control. This is particularly essential in areas without biological vectors, with 
vertical and sexual routes highlighted as being particularly important (Oliveira et al., 
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2015). Despite this, health authorities still only consider the transmission of 
Leishmania by sandflies as being of epidemiological importance. Although other 
insects have demonstrated their potential as natural vectors for leishmaniasis, 
particularly ectoparasites in dogs, transmission capability and vector competence are 
yet to be confirmed. Although these insects may participate in the transmission cycle 
of Leishmania it is, however, unclear as to whether this is a terminal or incidental link, 
or whether these insects are epidemiologically important vectors (Rebelo et al., 2016).  
 
1.1.3 Epidemiology  
Leishmaniases are distributed worldwide and are present in both tropical and 
subtropical regions, affecting both urban and rural communities (Akhoundi et al., 
2016). Leishmaniasis is endemic in 88 countries on five main continents; Africa, Asia, 
Europe and North and South America. Leishmaniases are predominantly found in 
poverty-stricken countries with an estimated 350 million people at risk of infection. In 
2014, there were approximately 300,000 reported cases of leishmaniasis with an 
annual reported incidence of 900,000 to 1.6 million (Table 1.1) (Alvar et al., 2012). The 
prevalence of leishmaniasis has, however, decreased over the past few years with new 
reports suggesting and estimated 700,000 to 1 million new cases each year with 
25,000 to 65,000 deaths (World Health Organisation, 2019). Over 90% of global VL 
cases occur in six countries: Bangladesh, Brazil, Ethiopia, India, Sudan and South 
Sudan. In contrast, CL is more widely distributed, with cases occurring in four main 
epidemiological regions; the Mediterranean, the Americas, Central Asia and the 
Middle East. Despite the presence of CL in Southern Europe and the Middle East, 95% 
17 
 
of CL incidences occur in seven countries; Afghanistan, Algeria, Brazil, Colombia, Iraq, 
Iran, and Syria (Alvar et al., 2012). 
 
1.2 Leishmania (Le.) infantum  
Leishmania infantum is an intracellular protozoan parasite that is part of the 
Le. donovani complex. This species of Leishmania is the only member of the complex 
that is present in South America, found over a wide area from northern Argentina to 
Southern USA (Ready 2014). Various wild and domestic vertebrates have been 
demonstrated as being reservoirs for Le. infantum in the New World, with infection 
recorded in carnivores, rodents and lagomorphs. Infection has recently been identified 
in red foxes in Argentina (Millán et al., 2016) as well as domestic cats in Brazil 
(Medonca et al., 2017). Despite these findings, canines are the main reservoir host of 
Le. infantum in endemic areas both in the Old and New Worlds. This has led to the 
Table 1.1:  The reported cases per year and estimated annual incidence of both 
Visceral and Cutaneous Leishmaniasis. CL and VL has been recorded in 6 regions 
worldwide; Americas, Sub-Saharan Africa, East Africa, Mediterranean, Middle East to 
Central Asia and South Asia (Table adapted from Alvar et al., 2012). 
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development of canine visceral leishmaniasis and an increase in the transmission of 
leishmaniasis to human hosts (Marcondes et al., 2019). Although some VL infections 
by Le. infantum can be clinically characterised, many are asymptomatic with 
approximately 13 times more asymptomatic cases of leishmaniasis being reported in 
Brazil (Costa et al., 2002). Although predominantly transmitted by the sandfly vector 
Lutzomyia longipalpis throughout the Americas (Figures 1.2 and 1.3), research has also 
demonstrated that Le. infantum can also transmitted by Lutzomyia evansi in Venezuela 
and Colombia (Feliciangeli et al., 1999; Bejarano et al., 2001) and Lutzomyia cruzi in 
Brazil (Dos Santos et al., 2003) 
 
1.3 Lutzomyia (Lu.) longipalpis  
The genus Lutzomyia consists of approximately 400 species, 33 of which have 
a medical importance as vectors of Leishmania (Beati et al., 2004). The first description 
of Lutzomyia longipalpis was by Lutz and Neiva in 1912. Lutzomyia longipalpis is well 
adapted to live in a variety of different ecological environments and habitats and has 
the ability to adjust to various climate conditions (Costa et al., 2013). In Brazil, the 
geographical range of Lu. longipalpis is expanding.  Although previously found in 
forest/rural sites, Lu. longipalpis is now adapting to urban areas throughout the 
country. This adaptation has been demonstrated and research has suggested that the 
increase in the number of Lu. Longipalpis found in urban areas of Brazilian cities is 
potentially due to soil transfer from the natural environment (Brazil, 2013) as well as 
deforestation in order to build powerlines and other man-made constructions 
(Marzochi et al., 2009; Almeida et al., 2013). Additionally, the movement of 
Leishmania infected dogs to urban areas has also been shown to have a negative 
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impact on sanitary conditions in domestic environments allowing Lu. longipalpis 
to successfully establish and spread (Salomon et al., 2015). The increased presence Lu. 
longipalpis in urban areas is a contributing factor to the observed increase in reported 
cases of human and canine VL throughout Brazil (Desjeux, 2004).  
 
1.3.1 Taxonomy of Lutzomyia longipalpis  
Sandflies are recognised by their slender legs, humped thorax and small hairy 
wings that are held in either an arched like manner or erect at roughly 40 degrees 
when at rest or blood feeding (Figures 1.2 and 1.3) (Sharma and Singh, 2008). They 
rarely exceed 5mm in length with females having a total body length that is generally 
larger than males (Azevedo et al., 2000). Males are easily recognisable due to their 
prominent external structures known as coxites, which extend past the tip of the 
abdomen (Rutledge and Gupta 2009). Members of the subfamily Phlebotominae have 
relatively long mouth parts which possess cutting mandibles (Schmidt and Roberts, 
1996). This results in sandflies being pool feeders with their mouth parts being well 
adapted to make an incision in the host skin and sucking up the blood that collects 
around the wound.  
Lutzomyia longipalpis is recognized as being a complex of several sibling 
species that are found in different regions throughout the Americas (Araki et al., 2009). 
Not only has morphological variation been identified, but biochemical, behavioural 
and physiological differences have also been reported (Souza et al., 2017). The 
differences observed between the epidemiology as well as the variation in behavioural 
and physiological features have been shown to influence the vectorial capacity of Lu. 
longipalpis. It has been suggested that transmission dynamics differ among the Lu. 
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longipalpis sibling species with different species able to transmit specific Leishmania 
to different animal hosts (Maingon et al., 2008). This observed variability in Lu. 
longipalpis could have a major effect on disease transmission. However, in order to 
gain a better understanding of the association between this species and VL incidence, 
further work needs to be undertaken on the geographical distribution of the Lu. 







Figure 1.3: Dead Lutzomyia sandflies viewed under a microscope. A female (left) and 
male (right) sandfly of the genus Lutzomyia (Dantas-Torres, 2009). Not only are male 
sandflies smaller than females, but also the external genitalia of the male sandfly 
consists of paired structures which grip the female during copulation (Singh and 
Phillips-Singh, 2010). 
Figure 1.2: Living female Lu. longipalpis, the most common vector of Leishmania 
infantum in Brazil. Sandflies are approximately 1.5‒5 mm in length, with a hairy 
appearance, and wings which extended over the body at 40 degrees (Lerner et al., 
2007).   
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1.4 Current Leishmania Prevention and Control Methods in Brazil 
1.4.1 Reservoir Control 
Methods that are employed to control the reservoir host of zoonotic 
leishmaniasis are influenced by which animals act as reservoirs. In Brazil, dogs are the 
primary reservoirs for leishmaniasis and it is therefore necessary to develop 
appropriate control measures (Ribeiro et al., 2018) The use of reservoir control 
strategies as a possible intervention against visceral leishmaniasis is based on previous 
studies which have proven that the incidence rate of human infection is directly 
associated with the number of infected canines as well as the high observed efficiency 
of dogs able to transmit the parasite to sandflies (Dye, 1996; Courtenay et al., 2017).  
Canine Leishmaniasis (cVL) is notoriously difficult to control. This is due to the 
intricate transmission cycle between humans, sandflies and dogs as well as the 
complex ecology and biology of sandflies (Alexander and Maroli, 2003). Dog culling is 
officially recommended for the control of cVL throughout Brazil, where each year 
hundreds of thousands of canines with suspected infection are euthanized (Dantas-
Torres et al., 2012). This control method, which aims to break the parasite’s 
transmission cycle, is in theory, an effective strategy (Costa et al., 2013). The removal 
of the source of infection through euthanizing infected dogs not only removes the 
reservoir host from the environment, but also reduces the average duration of the 
infectious period (Werneck, 2014). This control programme has, however, been 
considered as ineffective with a high occurrence rate of cVL being observed in endemic 
areas throughout Brazil (Dantas-Torres et al., 2012). Furthermore, studies have shown 
that not only is there is no significant reduction in human VL cases in Brazil but also a 
high occurrence of false positive results in the confirmatory test are still observed 
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(Silva et al., 2019). Despite the identified problems with the current methodology, the 
culling protocol is still being maintained throughout Brazil.   
The lack of specificity of the current diagnostic tests that are used for 
identifying infected dogs in the field is a major factor contributing to the 
ineffectiveness of the current control programme. If the canine culling strategy is to 
be successful, then a more effective and accurate method of in-field diagnosis is 
required. 
 
1.4.2 Vector Control 
Due to the transmission of Leishmania parasites occurring between animal 
reservoirs and humans via the bite of infected phlebotomine sandflies, current control 
methods have adopted protocols which aim to reduce human contact with infected 
sandflies. Current sandfly vector control measures that are employed throughout 
Brazil include the residual spraying of the internal walls of houses and animal shelters 
with insecticides, also known as indoor residual spraying (IRS), the use of insecticide-
impregnated dog collars and the use of insecticide-treated bed nets (ITNs), curtains 
(ITCs) and clothing (Pinart et al., 2015).  
Despite the widespread use of these control methods, numerous problems and 
impracticalities have been identified through research. Although IRS is the most 
commonly-used sandfly control method, spraying needs to be repeated regularly, with 
research demonstrating a decrease in IRS efficacy after 1 month (Banjara 2019). This 
therefore decreases the long‐term sustainability of this methodology. Furthermore, 
conventional ITCs and ITNs need to be retreated or replaced on a regular basis, 
approximately every 6 to 12 months (Pulkki-Brännström et al., 2012). Although there 
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have been recent developments in long-lasting ITNs (LLITNs) which provide effective 
protection for 3 years, most sandfly activity tends to occur around sunset, thereby 
limiting the effects of LLITNs (Roberts 2006). Additionally, the use of insect repellents 
and protective clothing is not affordable or practical for poorer populations who live 
in highly endemic regions. Although it has been reported that sandflies are very 
sensitive to insecticides, some Dichlorodiphenyltrichloroethane (DDT) resistance has 
been reported (Dhiman and Yadav, 2016). This resistance is also a common 
phenomenon in malaria control programs with mosquito resistance representing a 
significant problem. Although IRS and ITNs have been demonstrated to generally 
reduce malaria incidence, it has been shown that they have little impact on the 
prevalence of malaria (Loha et al., 2019). Due to the current limitations in vector 
control methodologies, new techniques and protocols need to be developed in order 
to reduce the number of female sandflies in endemic areas in Brazil. This will 
subsequently lead to a reduction in the transmission of Leishmania. 
 
1.5 Canine visceral leishmaniasis (cVL) 
CVL is a zoonotic vector-borne disease caused by the Leishmania infantum 
parasite. In Brazil, canines as the main reservoir hosts of Le. infantum, play a key role 
in the transmission of the parasite to humans. In terms of the incidence of cVL 
throughout Brazil, studies undertaken in endemic areas have shown a prevalence of 
up to 70% (Quinnell et al., 2013). CVL has previously been regarded as a rural disease, 
however, studies have now demonstrated that it is firmly established in large 
urbanised areas therefore being a major risk to human health (Guimarães et al., 2016). 
It has been suggested that the control of human VL is dependent on the effective 
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control of cVL. This has stimulated an increase in research into leishmaniasis infection 
in canines, and effective control methods (Pessoa-e-Silva et al., 2019). Current 
methodologies employed for decreasing VL transmission in Brazil are based on vector 
and reservoir control programs (Werneck, 2014). However, trials from Brazil, which 
have evaluated the effect of infected dog culling on the incidence of leishmaniasis, 
report a relatively low effectiveness. Although a reduction in seroconversion was 
reported, the studies suggest an urgent need to revise the use of culling in the Brazilian 
VL control program (Costa et al., 2007; Werneck et al., 2014b). 
 
1.5.1 Epidemiology and Clinical Manifestations  
CVL is widespread throughout both rural and urban areas of South America 
having been implicated in human CL epidemiology (Dantas-Torres, 2009). Research 
has demonstrated that dogs from rural areas of Brazil are 3.4 times more likely to be 
infected than those in urban environments (Oliveira et al., 2016). CVL also presents 
with a complex epidemiology in South America. This can be demonstrated through 
various factors. These include the multiple causative agents and culpable sandfly 
species that have been identified (Coelho et al., 2009).  
An extensive range of clinical manifestations and immune responses have been 
demonstrated in dogs infected with cVL. The infection in canines can range from being 
a subclinical or a self-limiting disease, to a very severe and often fatal illness (Solano-
Gallego et al., 2009). CVL can manifest itself asymptomatically or through nonspecific 
clinical signs with loss of body weight, splenomegaly, renal disease and fever being 
common, nonspecific clinical manifestations (Ciaramella et al., 1997). The disease can 
range in severity from mild proteinuria to chronic renal failure; the main cause of 
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fatality due to cVL (Solano-Gallego et al., 2011). Due to the asymptomatic nature and 
nonspecific clinical manifestations of cVL, diagnosis through the observation of clinical 
signs is unreliable and ineffective yet it is often used as an initial assessment of 
infection (Coura-Vital et al., 2011). The current unreliability of cVL diagnosis is a major 
concern particularly as current control methods rely on an accurate diagnosis. 
 
1.5.2 Canines as a Reservoir Host of Leishmania infantum  
A natural reservoir host can be defined as an animal or species that is infected 
by a parasite, and subsequently serves as a source of the infection for humans and/or 
another species (Medical Dictionary, 2007). This basic description has been redefined 
numerous times with Ashford, (2003) describing a reservoir host as being an ecological 
system in which an infectious agent can survive indefinitely. It has been suggested that 
a good reservoir host is one that is in close contact with humans, is susceptible to 
Leishmania infection and available to the sandfly vector in high enough quantities to 
cause infection. A good reservoir should rest and breed within the same habitat as the 
sandfly, being the primary blood meal source, with the disease progressing at such an 
extent so that the animal can survive until, at least, the next transmission season. 
These suggested qualities therefore implicate the dog as a good reservoir for 
Leishmania particularly in the urban environment in Brazil (Bray, 1982). 
In Brazil, canines have been found to be naturally infected by various species 
of Leishmania including Le. amazonensis, Le. infantum and Le. braziliensis among 
others (Monteiro de Andrade et al., 2006). Leishmania infantum is the etiological 
agent of zoonotic visceral leishmaniasis, a vector borne disease that is potentially fatal 
to humans and canines, posing a significant risk to public health in Brazil (Buckingham-
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Jeffery et al., 2019). The domestic dog has long been identified as the main reservoir 
host of Leishmania infantum infection throughout Brazil (Moreno and Alvar, 2002). 
Research has shown that canines are highly susceptible to Le. infantum infection, being 
exposed to infected sandflies that readily feed on animals (Rogers and Bates, 2007). A 
consequence of the ability of canines to act as a reservoir host is a steady increase in 
the number of human VL cases reported throughout Brazil over the past 30 years 
(Conti et al., 2016). It is very common for canines to become infected by Le. infantum 
and not display any apparent clinical manifestations whilst maintaining a high 
transmission rate for long periods of time (Moreno and Alvar, 2002). It is therefore 
important to develop further diagnostic techniques other than the observation of 
clinical signs as many infected dogs are asymptomatic. Lutzomyia longipalpis sandflies 
can adapt easily to the peridomestic and domestic environment (Salomón et al., 2015) 
with studies including Macedo-Silva et al., (2014) observing the presence of dog blood 
within fed Lu. longipalpis sandflies collected from domestic areas. There is sufficient 
experimental and epidemiological evidence to support the contention that canines are 
the main reservoir host of Le. infantum for human infection. It is therefore reasonable 
to conclude that domestic dogs play a significant role in the epidemiology of visceral 
leishmaniasis particularly in Brazil (Petersen, 2009). 
 
 
1.5.3 Current Diagnosis of Canine Leishmaniasis 
The anthroponotic transmission of Leishmania, where humans are the major 
reservoir for the parasite, occurs predominantly in India and East Africa. In the 
Americas however, zoonotic transmission of Leishmania occurs with dogs in Brazil 
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consisting of the main source of transmission (Werneck, 2014). CVL is notoriously 
difficult to control. This is due to the intricate transmission cycle between humans, 
sandflies and dogs as well as the complex ecology and biology of sandflies (Alexander 
and Maroli, 2003). Although it is suggested that a prompt diagnosis and treatment of 
human cases could be employed to reduce zoonotic VL, this methodology is not an 
effective solution as humans do not play an important role in Leishmania transmission 
in Brazil (Quinnell and Courtenay, 2009).  
CVL diagnosis in Brazil is based on serological, parasitological and molecular 
methods. Parasitological diagnosis by microscopy of bone marrow and splenic 
aspirates is a common diagnostic used for cVL in endemic regions (Ribeiro et al., 2018). 
Although these techniques offer reliable evidence of the presence of the parasite in 
samples (Figure 1.4), there are many associated drawbacks. These include a lack of 
sensitivity when the parasite number is small and the requirement of a trained 
individual to analyse samples (Ertabaklar et al., 2015). Additionally, Leishmania growth 
capacity varies from one species to another, a further disadvantage (Rasti et al., 2016). 
Due to the current limitations of direct examination, new approaches have been 
developed for diagnosis of cVL in the laboratory.  
Polymerase chain reaction (PCR) based diagnostics provide the greatest 
diagnostic sensitivity in canines compared with other laboratory-based techniques. 
These molecular techniques involve a delayed sample processing time, generate a 
species-specific diagnosis, and have a high sensitivity all of which are essential for the 
accurate diagnosis of cVL (da Silva Solcà et al., 2014). PCR and RT-qPCR are currently 
part of common veterinary diagnostic routines, which have proven useful for follow-
ups as well as allowing for diagnosis to be performed on various biological samples 
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such as blood, skin fragments or bone marrow aspirates (Silva et al., 2017). Serological 
based methodologies are also commonly-used in Brazil for cVL diagnosis. These 
techniques involve the detection of specific anti-Leishmania antibodies using 
quantitative serological techniques such as the enzyme-linked immunosorbent assay 
(ELISA) and indirect fluorescent-antibody test (IFAT). Although the IFAT is considered 
the reference technique by the World Organization for Animal Health (OIE, 2016), 
various studies have reported ELISA as being more sensitive than IFAT for cVL diagnosis 
(Figueiredo et al., 2009; da Silveira et al., 2011;; Sobrinho et al., 2012). However, the 
diagnosis of cVL through serological methods has a variety of limitations. These include 
cross-reactions with cutaneous Leishmania species, Trypanosoma parasites and other 
haemoparasites. In addition, false positive and negative results are common due to 
low antibody titres and the presence of antibodies in dogs that were previously treated 
(Lopes et al., 2017). Despite these limitations, immunochromatographic assays are 
currently employed as routine serological laboratory diagnostic tests for the diagnosis 




In addition to laboratory tests, the diagnosis of cVL also occurs in a field-based 
environment. Over the last 10 years, field diagnosis has involved the use of the 
recombinant K39 (rK39) antigen; a 39‐aminoacid repeat recombinant leishmanial 
antigen. Rapid diagnostic tests (RDTs) such as the immunochromatographic (IC) rK39 
test and DPP (Dual-Path Platform) diagnostic have been developed which detect rK39-
reactive antibodies in sera. The rK39 antigen has been used widely to detect cVL as it 
was found that anti-rK39 antibodies are more prevalent in positive dogs than in 
humans (Scalone et al., 2002). However, research has reported varying sensitivities for 
these RDTs with a range of sensitivities from 46% - 100% being reported in the 
diagnosis of cVL (de Lima et al., 2010; Quinnell et al., 2013; Mendonça et al., 2017). 
Research has also demonstrated varying test specificities, ranging from 33% to 100% 
Figure 1.4: Leishmania amastigotes in skin lesion biopsy. Parasites are stained with 
either Giemsa or hematoxylin and eosin. Amastigotes appear as oval or round bodies 
that are 2-4ul in diameter with characteristic kinetoplasts and nuclei and are indicated 
by arrows (Hadjipetrou et al., 2014). 
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among the literature. Therefore, additional laboratory based parasitological or 
serological tests are currently necessary in order to confirm in-field positive results.  
In Brazil, the primary in-field diagnostic approach used is the dual-path 
platform (DPP) diagnostic test. This tool was recently developed by Chembio 
Diagnostic Systems, Inc (Medford, NY, USA) and is currently manufactured by Bio-
Manguinhos/Fiocruz in Brazil. The DPP is a colloidal gold-based 
immunochromatography assay designed to detect antibodies that are present in dog 
blood against rK26/rK39. This rapid, disposable device has, in theory, great potential 
for the diagnosis of cVL especially when considering mass screening exercises. This is 
due to its proven technological advantages over other rapid diagnostic assays which, 
until recently, had been used as common practice in Brazil (Figueiredo et al., 2018). 
The sensitivity and specificity of the DPP test is, however, under debate with few 
studies having been carried out to determine test accuracy. While some studies are 
reporting a sensitivity of 98% (Mendonça et al., 2017), others have determined a 
sensitivity of 47% (Solcà et al., 2014) with other results inbetween. Research from 2008 
in Brazil also highlights the inaccuracy of this diagnostic test. It was reported that from 
August 2002 to July 2004, 61% of the canine population from an endemic area in Brazil 
were culled following a positive diagnosis using the current in-field DPP test, with only 
27% of those confirmed as positive for the presence of anti-Leishmania antibodies 
following subsequent tests (Nunes et al., 2008). Inconsistency in this diagnostic can be 
shown when analysing test specificity with results between 60% – 100% being 
reported across the literature. Further to the dispute about test sensitivity/specificity, 
additional disagreement on the capability of the DPP test to diagnose symptomatic 
and/or asymptomatic dogs can also been seen with some research suggesting the test 
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is able to detect both asymptomatic and symptomatic dogs equally (Laurenti et al., 
2014), while others suggesting the opposite, with a relatively low sensitivity being 
demonstrated when identifying asymptomatic dogs that are positive (Grimaldi et al., 
2012). 
Despite the uncertainty surrounding the current diagnostics, in 2012 the 
Brazilian Ministry of Health established a standard protocol for the diagnosis of cVL. 
This currently involves a laboratory-based ELISA as a confirmatory test following a 
screening test using the Dual-Path Platform (DPP) rapid in-field diagnostic (Fraga et al., 
2016). In areas affected by cVL, a positive result from these tests is used as the main 
criteria indicating the need to euthanize suspected positive dogs. Even though the 
current diagnostic protocol for cVL has enhanced disease diagnosis, the ELISA 
technique used still requires a laboratory infrastructure and experienced staff. This 
restricts the ability to perform this diagnostic protocol to specialised laboratories only 
(Persichetti et al., 2017). Furthermore, several challenges must be confronted by 
researchers when applying laboratory-based techniques directly in the field. These 
include the storing of reagents at room temperature, performing DNA isolation 
without a centrifuge, or performing a diagnostic analysis of the sample without 
sophisticated laboratory technology (Pessoa-e-Silva et al., 2019). Additionally, the 
suggested inaccuracy of the DPP diagnostic also leads the ineffectiveness of this 
protocol. Although shown to be non-invasive, easy to use and rapid, the routine use 
of the current DPP tests in Brazil is somewhat to blame for the ineffectiveness of the 
current control programme (de Carvalho et al., 2018). It therefore stands to reason 
that the currently used in-field diagnostics need to be reviewed in order to improve 
disease control. Research suggests that the DPP test is unlikely to be sensitive enough 
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for detecting canine carriers of Leishmania infantum (Fraga et al., 2016). Therefore, in 
addition to a highly sensitive laboratory-based diagnosis, an accurate diagnostic test 
which could be implemented primarily in the field would prove advantageous for the 
ongoing control of cVL. Point of care (POC) diagnostics for cVL would achieve a rapid 
turnaround of results and therefore the efficient and prompt removal of infected dogs 
(Travi et al., 2018). 
 
1.5.4 Canine Leishmaniasis in Study Area; Governador Valadares (GV) 
In the 1960s cases of human VL were first reported in Governador Valadares 
(GV), with the area being determined as highly endemic for leishmaniasis (Coelho and 
Falcão, 1966). Following this, VL control and surveillance activities were implemented 
throughout the region to control disease transmission (Barata et al., 2013). However, 
an interruption in the control programme at the beginning of the 1990s has resulted 
in the re-emergence of human VL with cases of cVL also becoming more common and 
widespread throughout GV (Malaquias et al., 2007). The high rate of cVL observed in 
the area is important as research suggests that an increase in cVL in endemic areas is 
correlated with an increase in cases of human VL and a high transmission rate (Lima et 
al., 2018). Transmission of the parasite occurs intensely in GV, with research from 2008 
to 2011 demonstrating a 30.2% infection prevalence in domestic dogs from 35 districts 
following in-field diagnosis (Barata et al., 2013). The high transmission rate could also 
be attributed to the poor quality housing with only basic sanitation in the area, with 
many residents living with or near domestic dogs (Coura-Vital et al., 2011). 
Although epidemiological studies in the area have suggested that Le. infantum 
is the sole etiological agent of cVL, recent research has reported canine infection with 
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Le. amazonensis in GV (Valdivia et al., 2017). Additionally, other studies have also 
demonstrated the possible emergence of Le. braziliensis in canines in the area 
(Malaquias et al., 2007). In parallel with multiple Leishmania species being detected in 
dogs in GV, research in the area has also identified multiple Leishmania species in the 
insect vector Lu. longipalpis, the most abundant sandfly species in the region (Cardoso 
et al., 2019). The high transmission rate of leishmaniasis in GV can therefore be 
attributed not only to the high incidence rate of cVL, but also the presence of multiple 
Leishmania species in infected dogs in the area and the ability of the local sandfly 
vector to transmit the parasite.  
 
1.6 Parasite manipulation 
The transmission of parasites has been shown to involve both passive transfer via 
ingestion of one host by another or active host-seeking by the parasite. Previous 
studies have shown that parasites are able to manipulate aspects of their host's 
behaviour. This manipulation has been shown to enhance the interactions between 
vectors and suitable hosts thereby increasing the rate of parasitic transmission 
(Holmes and Bethel, 1972). Parasites are thought to alter the behaviour of their hosts 
in a variety of different ways, all which aid in the survival and transmission of the 
parasite. Those parasites that are trophically transmitted (i.e. when one host is eaten 
by the next), can manipulate the behaviour of their intermediate host by increasing 
the predation by the definitive host on the intermediate host thereby aiding 
transmission (Lafferty, 1999). Parasites which thrive in a habitat different to the one 
in which the host lives can manipulate the host resulting in the movement of hosts to 
a different habitat. For example, hairworms (Paragordius tricuspidatus) induce crickets 
35 
 
to drown in water, which enables the parasite to exit into an aquatic environment 
which favours its reproduction (Biron et al., 2006). Many studies have also reported 
that parasites are able to manipulate their vector in order to aid transmission (Moore, 
1993). The most common report of this transmission aid is the behavioural 
manipulation of rats by the parasite Toxoplasma (T.) gondii. Studies have shown that 
T. gondii is able to cause permanent behavioural changes altering the rat's perception 
of cat predation risk (Webster et al., 2007). Evidence suggests that these behavioural 
alterations are a product of selective pressures on the parasite to enhance its 
transmission from the rat intermediate host to the cat definitive host. The mechanism 
of action used by T. gondii to alter the intermediate host behaviour is however 
unknown (Berdoy et al., 2000). Perhaps more relevant is research which has 
demonstrated Leishmania manipulation of sandfly feeding behaviour. Leishmania 
infection within sandflies has been shown to increase vector biting persistence on mice 
following feeding interruption as well as promoting feeding on multiple hosts. This 
suggests that Leishmania can enhancing their transmission efficiency through sandfly 
manipulation, increasing biting persistence (Rogers and Bates, 2007). 
It would prove advantageous for the transmission of the parasite if its vector was 
more responsive to infected host odours, as this is the predominant cue that is used 
by vectors to find a blood meal. This parasite manipulation has been observed in 
research relating to both malaria and leishmaniasis. Recent research has 
demonstrated that malaria infection alters the odour of naturally infected human 
patients in Africa (de Boer et al., 2017). Further it has also been demonstrated that 
Plasmodium associated changes in human odour increases the attractiveness to 
mosquitoes (Robinson et al., 2018). Although this study did not confirm direct parasite 
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manipulation causing an increase in infection associated compounds, the increase in 
mosquito attraction which was demonstrated could lead to a higher number of 
vector–host interactions and increased transmission. Additional research by Rossignol 
et al., (1986) demonstrated that a higher number of Aedes aegypti mosquitoes were 
attracted to the odour of guinea pigs infected with Plasmodium gallinaceum. Both 
O’Shea et al., (2002) and more recently Nevatte et al., (2017) demonstrated that the 
odour of golden hamsters infected with Leishmania infantum was significantly more 
attractive to sand flies compared to before infection when the same hamsters were 
uninfected. This increased attraction could result in enhanced transmission of the 
Leishmania parasite with more sandflies becoming infected when feeding on a positive 
host. Furthermore, the identification of individual volatiles and whole odour profiles 
that are attractive to sandflies could be used in the practical application of 
attractiveness experiments in the field. 
 
1.6.1 Host Odours for Vector Control 
Effective sand fly vector control remains a key goal in order to reduce the 
world’s burden of leishmaniasis. Although the development of new vaccines and drugs 
may eventually lead to a long-term solution for leishmaniasis control, the 
implementation of vector control strategies may lead to a reduction in the incidence 
of disease over a shorter timeframe (Bray et al., 2014). However, the limitations 
observed for the current vector control methodologies used in Brazil, suggest that new 
protocols need to be established in order to reduce the female sandfly number and 
disease transmission. There are two primary limitations observed; insecticide 
resistance due to the negative impact of insecticide exposure, and the current control 
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measures only targeting those vectors that rest and feed indoors primarily during the 
night (Barreaux et al., 2017). Targeting female sand flies specifically would be an 
effective strategy to decrease Leishmania transmission risk. Not only would specific 
targeting provide a short-term benefit by killing the vector-competent individuals but 
would also have benefits in the future by reducing the number of offspring and 
therefore enhance the control of sand fly population growth (Claborn, 2010). 
The use of odours for vector control is not a new concept. An increase in the 
attraction of different insect vectors to human, animal and synthetic odour has long 
been established. Research has shown that the release of carbon dioxide in the vicinity 
of commonly-used mosquito traps enhances the capture of host‐seeking mosquitoes 
(McPhatter and Gerry et al., 2017). Research has also shown that mosquito traps 
baited with human odours, significantly attracts more mosquitoes than un-baited 
traps, with a 3.6-fold increase in attraction shown (Matowo et al., 2013). This research 
suggests that human odour could be utilised as an affordable source of attractants 
which would supplement odour baited mosquito traps. The use of odours for sandfly 
vector control has also been shown. Not only have sandflies demonstrated an 
increased attraction to the volatile components which were identified through the 
analysis of infected dog odour (Magalhães‐Junior et al., 2019), but an attraction to 
synthetic male sandfly pheromone has also been observed (Bray et al., 2014). These 
observations suggest the use of natural odours and VOCs in the development of 
volatile baited traps. The use of such traps could increase the number of female 
sandflies caught, thereby reducing disease burden. In fact, the use of male pheromone 
for vector control has already been demonstrated in the field, with greater numbers 
of Lutzomyia longipalpis being caught and killed by pheromone baited light traps 
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placed in chicken sheds sprayed with insecticide (Bray et al., 2010). Furthermore, a 
decline in the use of Insecticide-treated bed nets and insecticide spraying of houses 
would also reduce the current risk of sandfly insecticide resistance, all of which would 
contribute to effective sandfly vector control. 
 
1.6.2 Odours as Diagnostic Markers and Potential cVL Diagnostic  
Detecting disease at an early stage increases the chance of successful 
treatment. There is therefore a need for non-invasive, inexpensive and early diagnostic 
techniques. The odour emitted by an individual infected with disease may be one of 
the first and most important clues that could lead to an early diagnosis. It has long 
been reported that all diseases, including those parasitic in both humans and animals, 
are associated with a change in the body odour profile of the infected individual with 
different volatile organic compounds (VOCs) being released (Table 1.2) (Liddell, 1976). 
Further gas chromatography experiments have identified many different VOCs in 
human clinical specimens could potentially serve as disease markers (Mitruka, 1975; 
Sethi et al., 2013).  Volatiles often present themselves as endogenous products of 
metabolic and physiological body processes in response to infection. During the 
pathogenesis of an infectious disease, the pathogen interacts actively with cells of the 
infected host, resulting in the production of a variety of different chemical 
metabolites. VOCs are also produced by the host’s immune system in response to any 
microbial infections for example through the inflammatory response (Sethi et al., 
2013).  
The VOCs produced in response to disease are emitted through various means 
such as in exhaled breath and through sweat. The analysis of the breath volatiles of 
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infected individuals for disease diagnosis is not a new concept. During both healthy 
and pathological states, exhaled air contains many VOCs produced during metabolic 
processes due to metabolites moving to from the blood to the lungs (Cazzola et al., 
2015). The analysis of breath of individuals in various diseases states, has allowed for 
the study of any modifications observed in exhaled VOC profiles. Most notably has 
been the diagnosis of lung cancer through the analysis of exhaled breath with the 
breath of patients suffering from lung cancer being detected with a sensitivity of 79% 
and a specificity of 72 % using VOC analysis when distinguishing between patients with 
lung cancer and healthy individuals (Chang et al., 2018). In addition to the analysis of 
breath, VOCs are also detectable in sweat, however there is very limited research in 
this area. The skin emits a variety of different volatile metabolites, many of them being 
odorous, with sweat containing various biomarkers of different diseases including 
diabetes and cystic fibrosis (Jadoon et al., 2015). As it is known that infected individuals 
produce different VOCs compared to those that are healthy, it can be suggested that 
detecting a change in those VOCs through the analysis of skin and sweat could be 
achieved. In fact, many studies have noted a change in the odour of an infected 
individual in various disease states (Table 1.2). The identification of volatile biomarkers 
in clinical specimens offers a potential option for development of inexpensive, non-
invasive and rapid diagnostic tools which can allow for the monitoring of several 
disease states. 
The current ineffectiveness of VL control in Brazil has led to the expansion of 
leishmaniases cases creating a significant public health problem (Werneck et al., 
2014). Due to the role dogs play as a reservoir host for leishmaniasis in Brazil, research 
has been undertaken in order to identify new potential diagnostics for cVL. Research 
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has identified that the odour on the hair of dogs infected with Le. infantum consists of 
Leishmania specific volatiles, with distinct differences also being observed in the VOC 
profiles of symptomatic and asymptomatic dogs (De Oliveira et al., 2008, Magalhães‐
Junior et al., 2014b). This distinct difference in volatiles following Leishmania infection 
suggests the diagnostic potential of a technique which could differentiate between 




1.7 Volatile Organic Compound (VOC) Analyser 
A volatile organic compound (VOC) Analyser, also known as an “electronic nose”, 
is a device intended to detect and differentiate between odours (Stitzel et al., 2011). 
The introduction of this device has allowed volatiles and odours to be used for many 
diagnostic situations. VOC Analysers can detect and differentiate between the volatile 
Table 1.2: Studies describing the odours emitted from the skin in response to 
different diseases and metabolic disorders. Studies have associated these diseases 
with different odours that are released from affected human tissues, primarily the skin 
(Table adapted from Wilson and Baietto, 2011). 
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organic compounds released as a result of various infections (Pavlou and Turner, 
2000). The VOC Analyser was developed in order to emulate the mammalian olfactory 
system (Figure 1.5). Essentially, the procedure behind VOC Analyser analysis consists 
of headspace sampling using a sample delivery system, an array of sensors which 
respond to families of molecules, and a pattern recognition module which generates 
a signal pattern used to characterise odours. The odour molecules are drawn into the 
VOC Analyser using headspace sampling in which the air surrounding a sample which 
contains released volatiles is injected into the VOC Analyser (Pearce et al., 2003). The 
VOCs within the odour sample are exposed to the array of sensors. The sensor array 
reacts to the individual volatile compounds upon contact, with the adsorption of each 
volatile on the sensor surface causing a specific physical change to the sensor. This 
physical change causes a subsequent change in electrical properties with each sensor 
responding to different VOCs at varying degrees (Harsányi, 2000). The specific 
response observed for each sensor is recorded by an electronic interface which 
Figure 1.5: Flow diagram representation of human and artificial (VOC Analyser) 
olfactory systems. VOC Analysers are described as having three main components; the 
vapour delivery system, the electronic sensor array and the pattern recognition 





transforms the signal into a digital value. This value is recorded and subsequently 
analysed by pattern recognition algorithm systems (Arshak et al., 2004). The VOC 
Analyser system has been designed so that the sensor array produces an overall 
response pattern for each individual odour, therefore allowing for identification. 
 
1.7.1 Diagnostic Potential of VOC Analysers 
The sense of smell has been used for centuries by medical doctors to determine 
the general health and physical state of their patients (Wilson, 2011). The basic 
principle behind VOC Analysers has been the development of a painless, simple and 
non-invasive screening method for the early medical diagnosis of various diseases. 
Studies have demonstrated that specific diseases and bacteria produce characteristic 
smells, all of which can be recognised and identified by VOC analysers (Shirasu and 
Touhara, 2011). Currently, the diagnosis of infection using traditional culture methods 
can take a minimum of 24 hours for the bacteria to be colonised and detected for 
diagnostic means (Bursle and Robson, 2016). Furthermore, the use of molecular and 
serological techniques for disease diagnosis using various biological samples (e.g. 
blood and urine) not only require sophisticated laboratory environments, but also 
have a slow turnaround time for results (Caliendo et al., 2013). The slow turnaround 
time of these methodologies is a significant limitation of current diagnostic methods. 
The prevention and early treatment of disease which is essential in biomedicine, 
requires an early and accurate diagnosis. For both to be implemented, it is important 
that relevant rapid results are obtained using sensitive technologies. Currently, VOC 
Analyser technology has proven effective in numerous areas of medical diagnosis 
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including the detection of tuberculosis (TB) (Bruins et al, 2013), urinary tract infections 
(UTI’s) (Pavlou et al., 2002) and cancers (Thriumani et al., 2014). 
Various studies have demonstrated that VOC Analysers have a great ability to 
not only detect but also distinguish between a wide variety of fungi and bacteria from 
the human body, with specific biomarkers being identified (Chen et al., 2013). In vitro 
studies have demonstrated that it is possible to distinguish between different species 
of aerobic bacteria based on differences in the quantity of ketones, terpenes and 
trimethylamines produced. For example, Mycobacterium tuberculosis; the causative 
agent of tuberculosis, has been identified in cultured sputum samples using enzymes 
which enhance M. tuberculosis growth and volatile production (Pavlou et al., 2004). 
Subsequently, recent research demonstrated the ability of point of care VOC Analysers 
to distinguish between patients with confirmed tuberculosis cases and healthy 
individuals with 91% sensitivity and 93% specificity (Teixeira et al., 2017).  Further to 
this, six different bacterial species that are responsible for eye infections; Haemophilus 
influenza, Escherichia coli, Moraxella catarrhalis, Streptococcus pneumoniae, 
Pseudomonas aeruginosa and Staphylococcus aureus were successfully differentiated 
into six different classes using data which was obtained using a VOC Analyser (Dutta 
et al., 2002). Additionally, recent research utilised VOC Analyser technology to 
different between methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-
sensitive Staphylococcus aureus (MSSA) as well as Escherichia coli, Streptococcus 
pyogenes, Clostridium perfringens and Pseudomonas aeruginosa with 78% sensitivity. 
This research supports the concept of using VOC Analyser technology to not only 
identify the relevant bacteria causing wound infections, but also promptly administer 
the appropriate antibiotics (Saviauk et al., 2018). 
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In addition to the differentiation between bacterial pathogens, VOC Analysers 
have demonstrated the ability to detect various disease biomarkers produced by the 
human body during infection. A study by Di Natale et al., (1999) demonstrated that 
patients suffering from kidney disorders produce distinguishable volatile organic 
compounds, which can be useful in the diagnosis as well as the control of renal dialysis. 
Further studies by the same group have also demonstrated that lung cancer can be 
identified through the analysis of patient’s breath using a VOC Analyser (Di Natale et 
al., 2003).  This work showed promising results, with all lung cancer patients being 
successfully identified through the detection of aromatic compounds and alkanes. 
Additional recent research has also demonstrated that VOC Analyser technology can 
discriminate between the exhaled breath of patients with lung cancer and health 
individuals with 96% sensitivity and 91.5% specificity (Tirzïte et al., 2018). Further 
research has also shown the potential use of VOC Analysers to identify Parkinson’s 
disease (PD) and Alzheimer’s disease (AD) sufferers. The technology was able to 
differentiate between patients with PD and AD from healthy controls with 94% 
accuracy. Patients with PD were also identified independently with 100% sensitivity 
and specificity (Bach et al., 2015). 
The use of VOC biomarkers in the diagnosis of parasitic diseases is expected to 
become increasingly important as more information on specific VOCs relating to 
various diseases becomes more available and as biomarker detection with VOC 
Analysers becomes a routine clinical. Numerous studies have already identified 
distinct odour profiles and associated biomarker VOCs for several different parasites 
and their associated diseases. In some cases, including cVL (de Oliveira et al., 2008; 
Magalhães-Junior et al., 2014) and malaria (Kelly et al., 2015; Berna et al., 2015), 
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unique chemicals and/or chemical groups have been identified. A recent study by 
Gikunoo et al., (2014) demonstrated that the parasitic protozoon Plasmodium 
falciparum, the predominant causative agent of malaria, could be detected using 
experimental carbon nanofibers grown on glass microballoons. This model system 
could detect Plasmodium falciparum histidine-rich protein-2 antigen concentrations 
as low as 0.025ng/ml. As previous research has demonstrated that VOCs bind readily 
to carbon nanofibers (Cuervo et al., 2008), it could be suggested that carbon 
nanofibers could be utilised in the development of VOC Analysers for parasitic disease 
diagnosis. 
Despite the promising diagnostic potential and non-invasive ease of use, there are 
still limitations to the VOC Analyser and improvements that need to be made. For the 
diagnosis of disease, VOC analysers still have a relatively low sensitivity and specificity 
when compared to current molecular and microbiological techniques (Cellini et al., 
2017). Furthermore, their routine use in a clinical application is yet to be fully 
evaluated, with studies identifying a proof of concept rather than real world 
application (Wilson, 2018). Due to the current technology being independently 
developed, each individual VOC Analyser possesses a custom-built sensor array. 
Therefore, the technology will perform differently during routine clinical diagnosis of 
disease, even with a standardised protocol for sampling and analysis (Baietto et al., 
2010). Additionally, the device is reported to be affected by environmental factors 
such as humidity and temperature. These factors in addition to sensor degradation 
have been shown to cause sensor drift which produces poor batch-to-batch 
reproducibility (Sujatha et al., 2012). However, despite these disadvantages, the use 
of VOC Analyser technology for disease analysis cannot be understated. The device 
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can assist with other laboratory based diagnostic techniques such as PCR, providing a 
rapid screening of samples which would optimise resource and time commitment 
during routine clinical practice. The use of VOC Analysers as a new possibility for real 
time assays as well as the fast and accurate diagnosis of disease, can ultimately allow 
for an earlier diagnosis as well as an evaluation of patient condition before clinical 
signs occur. 
 
1.8 Aims of Project 
The first aim of this work, was to determine whether Leishmania can manipulate 
canine host odour in order to aid its own transmission. The second aim of the research 
was to demonstrate whether a VOC analyser could identify and therefore diagnose 
dogs that are infected with leishmaniasis. If successful, this work could demonstrate 
the use of a VOC Analyser as a novel, rapid and non-invasive diagnostic test for cVL. 
Finally, GC/MS technology was utilised to confirm any discrimination observed 
between Leishmania infected and uninfected dogs, both previously (de Oliveira et al., 
2008; Magalhães-Junior et al., 2014) and following VOC Analyser analysis. GC/MS 
analysis also enabled the chemical structure and composition of potential Leishmania 
specific compounds to be preliminarily identified. These could, therefore, be used in 
the future development of both the VOC Analyser as a cVL diagnostic tool and odour 
baited vector traps.  
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Chapter Two - General Methods 
 
2.1 Study Area 
The municipality of Governador Valadares (18°51′S–41°56′W) is a city located 
in the eastern region of the state of Minas Gerais. It covers part of the Rio Doce basin, 
which is in the south east of Brazil (Figure 2.1). The city has an estimated population 
of 280,901 (Population Estimate 01.07.2017) distributed across 150 districts 
(citypopulation.de, 2017). The region experiences a hot and humid climate with 
temperatures that vary little throughout the year with an annual average of 32.6°C. 
Governador Valadares is an area of re-emerging focus for visceral leishmaniasis. From 
2008 to 2017, 191 human cases of VL were reported mainly affecting children from 0 
to 9 years of age and adult males, with a lethality rate of ~16% (DATASUS, 2019). 
Leishmania transmission occurs intensely in this region, with a high incidence rate of 
Canine Visceral leishmaniasis (cVL) (33.8%) being identified as an area of concern with 
many control programes focused on reducing cVL cases (Cardoso et al., 2019). 
Collection of canine blood and hair samples was carried out in the Altinopolos 
neighborhood of Governador Valadares (Figure 2.2). This area was chosen because of 
the high prevalence of cVL observed there (Barata et al., 2013) and the large number 




Figure 2.1: Location of the municipality of Governador Valadares on a map of Brazil. 
Coordinates: 18°51′12″S - 41°56′42″W. State of Minas Gerais. Mesoregion of Vale do 
Rio Doce. Image provided by Dr Luigi Sedda. 
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Collection of canine blood and 
hair samples was carried out in the Altinopof Governador Valadares. This area 
was chosen bec 
Figure 2.2: Altinopolis, Governador Valadares - State of Minas Gerais, Brazil.  Map of 
Altinopolis displays the main streets and avenues that interconnect this 
neighbourhood with other parts of Governador Valadares. The location of all dogs 
sampled is highlighted in red (bottom right). A wide distribution of dogs sampled for 




2.2 Dog recruitment 
Recruitment of domestic dogs in 2017 (n=185) and initial sampling was carried 
out during August in Altinopolis. The dogs were chosen randomly following owners 
consent obtained by signing a consent form and were microchipped to aid their 
identification in the 2018 follow up study. Inclusion criteria: dogs aged ≥ 3 months; 
dogs without previous clinical assessment or laboratory diagnosis for cVL. Exclusion 
criteria: pregnant/lactating bitches; aggressive dogs; stray dogs.  
In April 2018 149 dogs were sampled, this number included 133 dogs that were 
resampled from the available 2017 cohort and an additional 16 “infected” dogs that 
were recruited from the CCZ facility, to compensate for loss of dogs between 2017 and 
2018. The main reasons for dog loss included death, the owner having moved and the 
owners unwilling to give consent for sample collection. Inclusion and exclusion criteria 
were the same as previously stated. 
 
2.3 Blood Samples 
2.3.1 Collection of Blood Samples in 2017 
Between 5ml and 10ml of peripheral dog blood was collected in 10ml K2 EDTA-
coated tubes via venepuncture of the leg and neck. Blood samples taken in the field 







2.3.2 Collection of Blood Samples in 2018 
10ml of peripheral dog blood was collected in 10ml K2 EDTA-coated tubes via 
venepuncture of the neck. Blood samples taken in the field were stored in a cool box 
with a freezer pack before being transferred to a 4oC fridge until processing. 
 
2.3.3 Buffy Coat Extraction 
200 ml of buffy-coat was obtained following centrifugation of collected blood 
samples at 2500 x g for 10 minutes at room temperature. Buffy coat samples were 
extracted using Pasteir pipettes and placed in 1.5ml Eppendorf tubes. The tubes were 
sealed and stored at -20oC until DNA extraction. 
 
2.3.4 DNA Extraction 
The DNA was extracted from the buffy coat samples using the QIAamp DNA 
Blood Mini Kit (Qiagen) following the manufacturer’s instructions using 200μl of buffy-
coat. The lysis was based on protein kinase with a final elution volume of 50μl. 
 
2.4 Collection of Hair Samples 
Canine hair samples in both 2017 and 2018 were obtained by cutting the hair 
next to the skin of the dogs using surgical scissors that were sterilized using hexane 
prior to the collection of each sample. The sampling was performed in the dorsal area 
on all dogs, with a minimum of 2g of hair being collected. All samples were placed in 





2.5 Clinical Questionnaire 
A clinical questionnaire was completed by either CCZ cVL control specialists, or 
veterinarians for each dog sampled (Figure 2.3). This questionnaire allowed for a 
record of clinical signs, dog body score and presence and severity of ectoparasites to 
be kept for all dogs. This information was subsequently used following PCR, VOC 
Analyser and GC/MS analysis to determine any correlation between changes in odour, 
infection status and the symptoms observed. All dogs were assessed for clinical signs 
of Leishmania infection with information of all clinical signs observed recorded for 
each individual dog.  
Animals were classified according to the presence of clinical signs suggestive of cVL. 
The main signs of cVL considered were onychogryphosis, ophthalmologic 
abnormalities, adenitis, cachexia, hepatosplenomegaly, alopecia, and crusted ulcers 
and lesions; dogs were classified as asymptomatic (the absence of clinical signs), 
oligosymptomatic (the presence of one to three clinical signs), or symptomatic (the 
presence of more than three clinical signs according to the criterion adapted from 





2.6 Entrainment of Volatile Organic Compounds (VOC’s)  
Approximately 1g of collected hair from samples collected in both 2017 and 
2018 were introduced into a portable entrainment system in order to collect volatiles 
present. The portable entrainment set up is made up of a pump and rotameter 
confined in a 16 inch x 12 inch x 6 inch case (Figure 2.4).  
Charcoal-filtered air supplied by the portable entrainment system (flow rate, 
15ml sec-1) was introduced into the top of a 50ml round-bottom glass flask which 
contained individual hair samples. The supplied air was extracted from the top of the 
glass flask and the VOCs collected in a 3.5-inch glass vial containing Tenax as the 
absorbent. Air entrainments of each hair sample were run for 2.5hours. Collected 
Figure 2.3: A clinical questionnaire used during samples collection during sample 
collection. Owners address and personal information in addition to clinical signs, dog 
body score and presence and severity of ectoparasites were recorded for all dogs. 
Dogs were classified as either oligosymptomatic or symptomatic depending on the 




VOCs were recovered through elution of each Tenax tube with 2ml Hexane to provide 
1ml - 1.5ml of extract. A fresh Tenax tube was used for each entrainment. All eluted 
samples were concentrated to a final volume of approximately 500l using nitrogen 
and stored at -20oC until further analysis. A caryophyllene internal standard was added 
to each sample following elution with hexane. 10l of 50ng/l caryophyllene was 
added to the 500l of each sample which therefore contained 500ng of caryophyllene. 
Figure 2.4: Portable entrainment system. The portable entrainment system is 
composed of a pump which supplies filtered air to a rotameter. Individual hair 
samples are placed in 50ml round bottom flasks and volatiles collected in Tenax 
vials. For the purpose of this experiment the flow rate was set at 15ml/sec.  
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Canine visceral leishmaniasis (cVL) is a zoonotic disease found in the Old and 
New Worlds. It is caused predominantly by Leishmania infantum and has been directly 
associated with human cases of visceral leishmaniasis (VL) (Nunes et al., 2010). In 
urban areas, the domestic dog (Canis familiaris) is the main reservoir host for the 
disease which is transmitted through the bite of an infected phlebotomine sand fly. It 
is because these dogs live within close proximity to the human population that many 
cases of human VL have been reported (Alvar et al., 2012). Accurate diagnosis in order 
to implement successful removal of these dogs from the environment is therefore 
essential in order to control the transmission of the parasite and reduce disease 
burden. 
Traditional diagnosis was based on the direct identification of Leishmania in 
bone marrow aspirates by lab-based microscopy. However, the use of invasive 
procedures in order to obtain bone marrow samples, combined with a low sensitivity 
for the microscopic diagnosis of Leishmania (between 53% and 85%) demonstrate the 
limitations of this technique (Schallig et al., 2019; Chappuis et al., 2007). Serological 
testing was also a traditional methodology adopted for VL diagnosis (Varani et al., 
2017). Immunodiagnostic techniques, particularly IFAT and ELISA which detect 
antigens/antibodies in biological samples are still used widely for the diagnosis of both 
human VL and cVL. However, limitations have been identified (Table 3.1). Recent 
research has demonstrated a low sensitivity and specificity for these methods when 
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diagnosing VL. The IFAT demonstrated an inadequacy with sensitivities ranging from 
18% to 93% for the diagnosis of human VL being reported (Mendonça et al., 2017). 
Furthermore, studies have reported a low sensitivity of these methods for the 
diagnosis of Leishmania in immunosuppressed patients. The IFAT sensitivities ranged 
from 11% to 82% (Cota et al., 2012). Molecular tests for the diagnosis of VL have also 
been developed over the past 10 years. Studies have demonstrated that PCR which 
targets the Leishmania kinetoplast DNA within clinical samples is a highly sensitive 
technique for VL diagnosis. Sensitivities as high as 98% have recently been reported 
(Khatun et al., 2017). The analytical sensitivity of PCR has also shown the ability to 
detect between 0.1 and 0.001 parasites per ml of sample, with this methodology able 
to correctly diagnose vaccinated dogs; a limitation of serological methods (Travi et al., 
2018). However, there is still a lack of standardisation for PCR tests, with each 
individual laboratory differing in the setup of assays, DNA preparation, the PCR target 
and the reaction optimisation (Cota et al., 2012). 
Due to the limitations of the currently used diagnostic techniques, there are 
still challenges associated with the control of VL. The accurate identification of 
infected dogs is of importance, as a reduction in the number of positive dogs would in 
turn reduce the incidence of human VL. However, many countries currently rely on 
serological diagnostic methods rather than molecular ones. The resulted misdiagnosis 
of negative and positive dogs has led to controversy which surrounds the culling of 
seropositive, but clinically healthy dogs as well as allowing false negative dogs to 
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remain in the domestic environment. Therefore, the use of molecular methods should 
be considered as an alternative to alleviate the misdiagnosis which currently occurs.   
Table 3.1: Current diagnostic methods used for cVL diagnosis. The sensitivities, 
specificities, advantages and disadvantages of the different methods used for the 
diagnosis of leishmaniasis are shown in the table above. Table adapted from 
Sundar and Rai, (2002). 
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3.1.1 Current Laboratory Based cVL Diagnosis  
CVL is a widespread disease, found throughout both the Old and New Worlds. 
The incidence rate and distribution of cVL depends not only on human behaviour and 
location of the transmission sites, but also on the local ecological features and the 
characteristics of the Leishmania species present (Franco et al., 2011). The diagnosis 
of infected dogs should be established as soon as possible in order to improve disease 
prognosis as well as avoid both dog and human transmission from false negative cases 
and preventable euthanasia from false positive ones (Gharbi et al., 2015).  
The current diagnosis of infected dogs considers not only the clinical signs 
observed, but also the epidemiological origin of the dog (Figure 3.1) (Solano-Gallego 
et al., 2011). However, due to the nonspecific nature of some clinical signs, with other 
diseases found in areas of endemicity, such as mange (demodicosis), an inflammatory 
disease caused by the Demodex mite in dogs, presenting with very similar clinical signs 
(Mozos et al., 1999), cVL diagnosis relies heavily on laboratory support. The origin of 
the infected dogs is an important factor considered when determining which 
laboratory test will be utilised; different serological, molecular and parasitological 
techniques are performed in different regions (Ribeiro et al., 2018). Furthermore, 
although cVL is predominantly caused by Le. infantum, other Leishmania species have 
also been identified in infected dogs. These include Le. tropica in Europe (Ntais et al., 
2013) and Le. amazonensis (Valdivia et al., 2017) and Le. braziliensis (de Lima Cunha 
et al., 2006) in the Americas. Therefore, a diagnostic technique that is considered 
successful allows for the correct identification of Leishmania species. This in turn leads 
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to a greater accuracy in diagnostic tests resulting in a smaller percentage of false 
negatives and positives, that are a major hurdle facing cVL control.  
 
3.1.1.1 Europe (Old world)  
Old world cVL was originally thought to be a disease found around the 
Mediterranean basin (Figure 3.2), where it was believed to have originated, as well as 
parts of Asia and Africa (Ready, 2014). In Europe, the main proven vectors for cVL are 
species from the Phlebotomus genus including predominantly P. ariasi and perniciosus 
(Ready, 2014). Cases of cVL have also been reported in countries in the western parts 
of Europe as well as the Balkan region (Franco et al., 2011). Research has provided 
Figure 3.1: Clinical signs observed during sample collection: The main signs of cVL 
which were observed were crusted ulcers and lesions, dermatitis, onychogryphosis, 
cachexia, ophthalmologic abnormalities, and hepatosplenomegaly. 
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evidence to show that cVL is expanding throughout Europe where dogs have been 
diagnosed as positive in areas such as north western Italy (Muccio et al., 2015), 
Portugal (Maia et al., 2016) and a recent case of leishmaniasis being reported in a UK 
dog with no travel history (McKenna et al., 2019). The expansion of cVL northwards is 
in part due to territorial contiguity. This is often associated with global warming that 
is favouring vectorial transmission, but also by the importation of infected dogs to 
these areas (Maia and Cardoso, 2015). It has been estimated that CVL affects about 
2.5 million dogs in the Mediterranean area each year (Moreno and Alvar, 2002). In 
2011, it was reported that the seroprevalence rate of visceral leishmaniasis in 
domestic dogs in countries throughout Europe was 25%, with an estimated 700 new 
cases of visceral leishmaniasis in humans being reported (Franco et al., 2011). 
Currently, laboratory diagnosis of cVL in Europe is based on a combination of 
different criteria which include the presence of clinical signs. These include 
adenopathy, squamosis, onychogryphosis, localised alopecia and loss of weight 
(Solano-Gallego et al., 2011). Microscopic identification of Leishmania parasites in 
lymph node aspirates and bone marrow is used extensively in Europe (Travi et al., 
2018). However, the low sensitivity of this technique makes diagnosis unreliable. 
Therefore, positive cases of cVL are confirmed by serological techniques, particularly 
ELISAs (Travi et al., 2018). ELISAs have previously demonstrated 100% sensitivity for 
the detection of Leishmania infantum antigens in dogs in different states of infection 
in Italy (Solano-Gallego et al., 2014) and 100% when diagnosing canine leishmaniasis 
using a dot-ELISA in Spain when a 1/800 cut off titre was established (Fisa et al., 1997). 
Diagnostic PCR is also undertaken to identify infected dogs in Europe due to its high 
sensitivity and specificity as well as European countries being able to afford the 
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equipment required. A recent study demonstrated the accuracy of PCR protocols for 
the diagnosis of canine leishmaniasis in Portugal, with the higher overall percentage 
(37.6%) of infected dogs being detected using this technique (Albuquerque et al., 
2017). Prior studies also demonstrated a sensitivity of 100% when using PCR to 
diagnose cVL using lymph node aspirates in Italy (Reale et al., 1999). Furthermore, PCR 
can also be utilised as a species-specific technique due to the availability of Leishmania 
species specific primers. Therefore, this methodology is currently being utilised more 
frequently due to other Leishmania species which have been identified as causing cVL 
in some regions of southern Europe (Ntais et al., 2013). 
Despite the apparent accuracy of the methodologies used throughout Europe, the 
diagnostic procedures used are very different from the cVL diagnostics that are 
undertaken in countries throughout South America. There are many reasons for this; 
the cost of veterinary diagnostic services which many cannot afford, the lack of 
guideline for CVL management and the lack of availability of molecular diagnostic tools 
(Dantas-Torres et al., 2012). 
 
3.1.1.2 The Americas (New World) 
New World cVL is found primarily in Southern and Central America (Figure 3.2). 
However, several cases of cVL have also been reported in 21 U.S. states and 2 Canadian 
provinces predominantly in foxhound kennels (Petersen and Barr, 2009). Although 
primarily thought of as an imported disease in North America, the sporadic 
appearance of leishmaniasis not only in foxhounds but also in other species of dogs 
with no travel history outside North America indicates the potential of the disease to 
spread to new regions (Duprey et al., 2006). The Leishmania infantum parasite is 
63 
 
believed to have been introduced to the Americas through domestic dogs brought 
over from Spain and Portugal during the last 500 years (Lukes et al., 2007). Throughout 
the Americas, Leishmania infantum is primarily transmitted by Lutzomyia longipalpis 
sand-flies, however, other Lutzomyia species including Lutzomyia migonei have also 
been shown to be potential vector for this parasite (Guimarães et al., 2016). 
In South America, Brazil is of importance with a reported 90% of the total annual 
cVL cases. Until 2012, the IFAT was the primary laboratory diagnostic test adopted by 
the Brazilian Ministry of Health for dog screening and culling campaigns. However, this 
technique has shown limitations. Not only is the IFAT restricted to a laboratory setting 
(Solano-Gallego et al., 2011) but varying specificities and sensitivities have also been 
reported. The sensitivity of the IFAT has been shown to range from 68% to 100% with 
the specificity ranging from 52% to 100% when diagnosing cVL in Brazil (da Silva et al., 
2006; Ferreira et al., 2007). Further notable limitations include potential cross-
reactivity with other pathogens including trypanosomes (Paltrinieri et al., 2016) and a 
significantly lower sensitivity for the diagnosis of asymptomatic dogs when compared 
with ELISA (Coura-Vital et al., 2014). The relatively low sensitivity of this test for 
asymptomatic diagnosis, the complicated execution of the technique and the long 
turnaround time between sample collection and culling of the infected dogs are 
possible reasons for the poor effectiveness of culling campaigns (Romero and Boelaert 
et al., 2010). ELISA is currently the most utilised methodology throughout Brazil, 
generally demonstrating a higher sensitivity for the diagnosis of cVL. ELISA sensitivity 
has been shown to range from 91% to 97% with the specificity ranging from 83% to 
98% when diagnosing cVL in Brazil (da Silva et al., 2006; Ferreira et al., 2007). It is due 
to the higher sensitivity of the technique that in 2012 the Brazilian Ministry of Health 
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adopted the ELISA as the recommended laboratory-based protocol for cVL diagnosis. 
Research has shown that the modification of this protocol should have a significant 
impact of cVL diagnosis. When analysing the plasma samples of 1,226 dogs using the 
old protocol a prevalence rate of 6% was reported. However, when analysing the same 
samples using the new adopted methodology, a prevalent prevalence of 8% was 
demonstrated (Coura-Vital et al., 2014). 
 
3.1.2 Molecular diagnosis of cVL 
3.1.2.1 PCR as a Diagnostic Technique for cVL 
An accurate diagnosis of cVL is essential for the control of visceral 
leishmaniasis. A variety of molecular techniques have proven to be highly effective in 
the diagnosis of canine leishmaniasis, none more so than several PCR methods. Over 
the past decade, many PCR based methodologies have been developed for the 
detection, quantification and identification of Leishmania species using specific 
Figure 3.2: Distribution of Canine Visceral Leishmaniasis. Distribution of Canine 
Visceral Leishmaniasis in the Americas (left) and Europe (right) Pictures adapted from 
University of East London. 
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primers to target DNA sequences. These include Leishmania rRNA genes and 
kinetoplast minicircle constant regions. Many studies have reported the use of PCR for 
the diagnosis of cVL using a variety of biological samples including blood, tissue 
fragments and aspirates (Lachaud et al., 2002; Almeida et al., 2013). PCR has proven 
more effective and accurate in cVL cases which had not been resolved by classical 
diagnostic methods demonstrating a gain in sensitivity and specificity (Moreira et al., 
2007). Gomes et al (2007) demonstrated the effectiveness of PCR compared to 
traditional microscopy and culture parasitological methods. PCR showed a positive 
result for 100% of the parasitological confirmed positive cases, also demonstrating a 
high specificity when identifying negative dogs, detecting all 61 dogs (100%) which 
were negative for cVL. The parasitological test however, only identified 56 negative 
dogs (92%), with 5 of the dogs generating a false positive result. Furthermore, when 
compared to serological methods, PCR not only showed a similar sensitivity to an 
ELISA, but also demonstrated a much greater homogeneity for the diagnosis of 
asymptomatic and symptomatic dogs when compared to the ELISA and DPP protocol 
currently used in Brazil (de Carvalho et al., 2018). 
Due to different Leishmania species having been identified as causative agents 
for cVL, the identification of the Leishmania species involved in infection is extremely 
important. This is also essential in endemic areas which have both the cutaneous and 
visceral forms of the disease (Quaresma et al., 2009). With respect to cVL, serological 
methods have shown an inadequacy when differentiating between different species 
of Leishmania. This is a major limiting factor given the presence of Le. braziliensis, Le. 
infantum and Le. amazonensis in canines particularly in the area studied (Dantas-
Torres, 2007, Valdivia et al., 2017). The use of species-specific primers in PCR diagnosis, 
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which amplify conserved sequences found in the Kinetoplast Deoxyribonucleic acid 
(kDNA) minicircles of different strains of Leishmania, has allowed for species specific 
diagnosis. This has proven highly advantageous in the development of new 
treatments, with many endemic regions having multiple Leishmania species all of 
which require different therapy (Schriefer et al., 2009). Studies have reported that PCR 
based techniques including conventional PCR, PCR-RFLP (restriction fragment length 
polymorphism) and real-time quantitative PCR (RT-qPCR), have the ability to 
differentiate between various Leishmania species (Andrade et al., 2006; Marcussi et 
al., 2008, de Morais et al., 2016). Primers are being continuously designed for the 
identification of different Leishmania species using PCR. Primers are currently 
developed in order to identify genus, subgenus and species of Leishmania, therefore 
making them highly specific (Marcussi et al., 2013). The adoption of specific primers 
for the diagnosis of infected dogs allows for PCR protocols to become standardised, a 
current limitation of molecular methods for cVL diagnosis. 
The substantial advantages of PCR including Leishmania species specificity and 
ability to diagnose symptomatic, asymptomatic and vaccinated dogs suggest this 
methodology should be adopted throughout Brazil as a means to diagnose cVL. The 
possibility of less invasive sampling using peripheral blood and a better negative 
predictive value, are also influencing factors to be considered when adopting new 
diagnostic protocols. Therefore, the utilisation of PCR for the diagnosis of cVL in this 
study was suggested, with specific primers chosen in order to identify those dogs 
infected with Le. infantum. However, despite the advantages of PCR based Leishmania 
diagnostics, there is still a lack of standardisation for the PCR tests and it has not been 
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clarified as to whether molecular techniques should be considered as the “gold 
standard” for VL diagnosis (Varani et al., 2017). 
 
3.1.2.2 RT-qPCR Quantification of Leishmania infantum Parasitic DNA 
Although highly accurate in the detection of symptomatic and asymptomatic 
dogs, conventional PCR is only, at best, semi-quantitative. An accurate and rapid 
method to detect and quantify Leishmania parasites is vital. This not only allows for an 
early diagnosis of leishmaniasis but also monitoring the effect of anti-Leishmania 
therapy (Verma et al., 2010) and determining transmission capabilities of an infected 
dog. This is due to research showing that animals with a higher parasite load transmit 
a high percentage of the parasite to sand flies (Kimblin et al., 2008).  
Real Time quantitative PCR (RT-qPCR) has become progressively more popular 
over the last few years not only for the detection and quantification of Leishmania, 
but also for species specific identification (Galluzzi et al., 2018). Previous research 
demonstrated the ability of RT-qPCR to diagnose and distinguish between malaria 
species with 97.4% sensitivity (Mangold et al., 2005) as well as demonstrating a 
detection limit of 100 parasites/mL of blood (0.1 genome equivalents) when used to 
diagnose trypanosomiasis (Becker et al., 2004). Recently, research has demonstrated 
a high sensitivity of 100% when using RT-qPCR to detect Le. infantum in the spleen and 
skin of infected dogs (Nunes et al., 2018). Furthermore, studies have also 
demonstrated that RT-qPCR is as equally effective as conventional PCR for the 
detection of Leishmania parasites in blood (Pereira et al., 2014). Although RT-qPCR 
based methodologies have proven effective in the diagnosis of cVL, a standardised 
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method still does not exist, a limiting factor when considering the use of RT-qPCR as a 
routine cVL diagnostic (Galluzzi et al., 2018). 
In addition to the high sensitivity observed, the ability to quantify parasite load 
in infected dogs through RT-qPCR allows for the determination of the status of positive 
dogs. The determination of the parasite load in clinical cases of cVL has become an 
indispensable tool for the diagnosis of leishmaniases. The continuous data generated 
through RT-qPCR could provide a better understanding for clinicians managing cases 
of cVL by differentiating between dogs infected with Leishmania or dogs with the 
active leishmaniasis (Otranto and Dantas-Torres, 2013). Larger studies are, however, 
necessary for the clarification of the dividing line between disease and infection.  
 
3.1.3 Chapter Aims 
PCR has previously been used as an analytical method for the diagnosis of cVL in 
numerous studies, directly revealing the presence of small parasite numbers in 
samples in addition to demonstrating a high sensitivity and specificity (Travi et al., 
2018). In this chapter I aim to use PCR as a diagnostic tool for canine leishmaniasis, 
identifying positive dogs for further VOC Analyser analysis. Furthermore, using RT-
qPCR I aim to determine the parasite load in those dogs which are infected, allowing 
for the diagnostic threshold of the VOC Analyser to be determined and to provide 




3.2.1 Optimization of Parasite Detection 
3.2.1.2 Parasite culture 
Leishmania infantum promastigotes (strain M4192) supplied by Paul Bates at 
Lancaster University, were grown in 20% Foetal Bovine Serum (FBS) hemoflagellate-
modified minimum essential medium (HOMEM) in 25ml plastic culture flasks and 
stored in a 26oC incubator. Multiplication was observed over three days (72 hours) 
when the medium contained flagellate forms of the parasite (promastigotes) that 
were appropriate to perform a passage. Successful 1:100 passages in medium were 
made to a total volume of 10ml. Passages were performed every three days to 
continue the optimal growth of the culture. 
 
3.2.1.2 DNA Extraction of seeded samples 
200 ml of buffy-coat was obtained following centrifugation of 5 ml of beagle 
whole blood (K2 EDTA) supplied by Seralab at 2500 x g for 10 minutes at room 
temperature. Seeded samples were made by adding [105] live pelleted Le. infantum 
promastigotes (M4192) to the canine buffy coat. Serial dilutions (1:10) were 
performed in order to obtain parasite concentrations ranging from [105] to [10-3] 
parasites mL-1 of blood, corresponding to DNA equivalents of 1000, 100, 10, 1, 0.1, 
0.01, 0.001, 0.0001 and 0.00001 parasites per PCR tube. The DNA was extracted from 
these samples using the QIAamp DNA Blood Mini Kit (Qiagen) following the 
manufacturer’s instructions with 200μl of buffy-coat. The lysis was based on protein 
kinase with a final elution volume of 50μl. 
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3.2.1.3 Primer Optimisation 
Two sets of primers were compared for sensitivity when used in conventional 
PCR for detecting low parasite concentrations; MaryF (5’ – CTT TTC TGG TCC TCC GGG 
TAG G – 3’), and MaryR (5’- CCA CCC GGC CCT ATT TTA CAC CAA – 3’) which amplify a 
140bp conserved region of the Leishmania kDNA minicircle (Mary et al., 2004) (Figure 
3.3) and LeF (5’ –TCC GCC CGA AAG TTC ACC GAT A - 3’) and LeR (5’ – CCA AGT CAT 
CCA TCG CGA CAC G - 3’) which amplified a 400bp region of Leishmania rRNA ITS-1 
(Spanakos et al., 2008).  
The reactions were performed in a final volume of 25l with 0.5l DNA 
template (100ng l-1), 12.5l Mastermix (dH2O, Buffer 5x, MyTaq redmix polymerase, 
dNTP’s) and 10µM of each primer (MaryF/R or LeF/R). The PCR amplification was 
performed in a TECHNE® Prime Thermal Cycler (Bibby Scientific) using the following 
conditions: 95oC for 5mins and 30 cycles of 95oC for 30sec, 57oC for 30sec and 72oC for 
60sec, followed by 72oC for 10min. 
 
 
Figure 3.3: Leishmania infantum kDNA minicircle DNA partial sequence and 
primer location. The bold underlined sequences represent the MaryF and MaryR 
primer pair (Mary et al., 2004). 
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3.2.1.4 Primer Specificity 
Due to recent research identifying dogs infected with Le. (L.) amazonensis and 
Le. (V.) braziliensis in Brazil (Souza et al., 2019), MaryF/R primer specificity was 
determined. Canine buffy coat was seeded using live pelleted Le. (L.) infantum (strain 
M4192), Le. (L.) amazonensis (strain M2269) and Le. (V.) braziliensis (strain LTB300) 
promastigotes stabilites. DNA was extracted according to the protocol in Chapter 2 
and conventional PCR performed under the same conditions as mentioned above. 
 
3.2.2 Molecular Diagnosis of Dogs 
3.2.1.1 Real time qualitative PCR detecting Leishmania DNA 
Extracted DNA from canine blood from both sampling occasions (August 2017 
or April 2018) was tested using conventional PCR to diagnose those dogs which were 
positive for Leishmania infantum. Primer pair MaryF and MaryR (Mary et al., 2004) 
was used due to their specificity for Le. infantum and their ability to detect low parasite 
concentrations. Reaction conditions as described above. 
 
3.2.1.2 Agarose gel electrophoresis 
Gel electrophoresis was performed using 2% agarose gels prepared with 1x TAE 
buffer. The gels were run at 90 V for 1hr 30 minutes and visualized under UV light 
following the addition of 1µl of 40x gel red to each sample when loading the gel. 
 
3.2.1.3 RT-qPCR 
Real-time quantitative PCRs (RT-qPCR) for the detection and quantification of 
Le. infantum DNA in positive dog samples from both sampling occasions (August 2017 
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or April 2018) were performed using MaryF/R primers. The RT-qPCR amplifications 
were performed on a Bio-Rad C1000™ Thermal Cycler with each reaction consisting of 
a final volume of 13.0µl; 12.0µL of PCR mix plus 1µL of DNA (approximately 75-100 ng 
l-1 per reaction). The RT-qPCR mix was composed of 6.25 µL 2x QuantiNova SYBR 
Green PCR Master Mix, 0.5 µL of each primer (MaryF/R, corresponding to 10 mmol) 
and 4.75 µL of water as described by Costa Lima Junior et al, (2013).The amplification 
was performed under the following conditions as described by Ceccarelli et al, (2014): 
94oC for 10 min, followed by 40 cycles at 94oC for 30 sec, 60oC for 20 sec and 72oC for 
20 sec. At the end of each run, a melt curve analysis was performed from 55oC to 95oC 
in order to identify the formation of non-specific products as well as primer dimers. 
Each reaction was performed in triplicate. A standard curve was established using 
extracted Le. infantum DNA; 1:10 serial dilutions, ranging from 10,000 to 0.01 
parasites per ml.  
 
3.2.1.4 Internal control 
The genomic DNA extracted from the canine buffy coat underwent agarose gel 
electrophoresis in order to detect its integrity as well as its molecular size and to 
roughly determine the DNA content. Furthermore, in order to determine the 
effectiveness of the DNA extraction and the transport of samples from Brazil to the 
UK, and to verify negative results for both PCR and qPCR, amplification of the 
constitutive canine globin gene was performed using the primers: ‘5 - CAA CTT CAT 
CCA CGT TCA CC – 3’ and ‘5 - ACA CAA CTG TGT TCA CTA GC – 3’ (Greer et al., 1991) 
under the same conditions as the samples. A positive result with the canine 




3.3.1 Optimisation  
3.3.1.1 PCR 
Buffy coat samples extracted from canine blood supplied by Seralab were 
seeded with [10]5 live L. infantum (M4192) promastigotes. In order to determine 
sensitivity of both sets of primers (Mary F/R and LeF/R), 1:10 serial dilutions were 
performed with a minimum concentration of [10]-3 parasites/ml. The sensitivity of 
each PCR reaction was assessed by determining the intensity of each banding pattern 
in the gel red stained agarose gel (Figure 6). At higher concentrations (≥[10]3 
parasites/ml), the bands produced by MaryF/R primers showed a greater intensity. 
However, there was no difference in PCR sensitivity of both sets of primers and both 
were still able to detect Leishmania DNA at high concentrations (Figure 3.4). The 
differences between the primer pairs became significant at low concentrations (≤[10]2 
parasites/ml). LeF/R were able to detect a minimum parasite concentration of [10]0 
whereas MaryF/R were able to detect a minimum concentration of [10]-2, therefore, 





3.3.1.2 Primer specificity 
Due to the high sensitivity of MaryF and R, combined with recent research 
identifying dogs infected with Leishmania amazonensis and braziliensis in Brazil (Souza 
et al., 2019; Valdivia et al., 2017), the specificity of MaryF and MaryR primers for New 
World species was determined. PCR assays were performed using Leishmania species: 
Le. (L.) infantum, Le. (L.) amazonensis and Le. (V.) braziliensis seeded in dog buffy coat. 
                 M                  +                      -                    [10]5   [10]4   [10]3   [10]2   [10]1   [10]0   [10]-1  [10]-2   [10]-3 





Figure 3.4: Gels showing sensitivity of two sets of primer pairs for the detection 
of Le. infantum. Two PCR reactions using A; MaryF/R primers which amplify a 140bp 
conserved region of the Leishmania kDNA minicircle and B; LeF/R primers which 
amplify a 400bp region of Leishmania rRNA, was carried out using template DNA 
extracted from cultured Leishmania infantum promastigotes (M4192). M, 




As represented in Figure 3.5, primers MaryF and MaryR were able to amplify all these 
New World species with varying sensitivity. An additional BLAST search however 
highlighted a lack of sequence homology for MaryF and MaryR primers in Le. (L.) 
amazonensis and Le. (V.) braziliensis kDNA minicircle sequences. 
 
3.3.1.3 SYBR green qPCR 
The sensitivity of the SYBR green RT-qPCR reaction using MaryF/R primers was 
tested by using 1:10 serial dilutions of Leishmania infantum DNA extracted from a 
known quantity of cultured parasites. Figure 3.6 presents the standard curve, efficacy 
and slope generated with concentrations ranging from [10]4 to [10]-2 Le. infantum 
parasites per ml of canine blood. The generated standard curve was subsequently used 
Figure 3.5: MaryF/MaryR specificity PCR. PCR was conducted using MaryF/R primers 
in order to determine primer specificity for Leishmania infantum. 1: Le. infantum 
(140.2ng/l); 2: Le. amazonensis (99.5ng/l); 3: Le. (V.) braziliensis (125.9ng/l). A 
100bp ladder (M) was used as a reference panel. +, positive control; -, negative 
control. 




to detect unknown parasite concentrations in positive canine blood samples collected 
from Brazil during both sampling occasions (August 2017 or April 2018).  
The results show the Le. infantum amplicon having melting temperature of 
approximately 81oC, without the formation of primer dimers or non-specific products 
(Figure 3.7). The RT-qPCR assay showed a sensitivity ranging from 10,000 parasites per 
ml of blood to 0.01 parasites/mL using calibration curves constructed with serial 
dilutions of Le. infantum DNA. The MaryF/R pair of primers was able to amplify the 





Figure 3.6: Standard curve constructed using serial dilutions of Le. infantum DNA. 
A standard curve was obtained using serial dilutions of Le. infantum M4192 DNA 
with primers MaryF and MaryR. The standard curve was obtained with serial 
dilutions ranging from 10,000 to 0.01 parasites equivalent/mL of whole canine 
blood. Slope, −3.053; PCR efficacy, 112.6%; R squared, 0.994. 
y = -3.053x + 33.681 
R2 = 0.994 
Log L. infantum DNA (parasite equivalent) 
C
t 
Figure 3.7: Melting curve analyses of PCR products. Dissociation curve of the 
amplification products of Le. infantum obtained using primers MaryF/MaryR 




3.3.2 DNA degradation and purity 
3.3.2.1 DNA Degradation 
The purity and integrity of the DNA extracted during both sampling occasions 
(August 2017 or April 2018) were analysed using gel electrophoresis in order to 
determine DNA integrity and identify any degradation.  
As shown in Figure 3.8, the molecular weight of the extracted genomic DNA 
was greater than 1 kilo base, indicating that the genomic DNA was not only extracted 
intact, but also that the DNA integrity and purity were high. The brightness of the 
extracted DNA was uniform across all samples, confirming that the extraction 
efficiency was consistent. 
  
Figure 3.8: Agarose gels of genomic DNA of 24 random samples extracted from 
canine buffy coat in A; August 2017 and B; April 2018. Blood samples were 
collected, and genomic DNA extracted from 200l of buffy coat. The whole 
genomic DNA obtained was analysed using agarose gel electrophoresis. M, 
molecular weight marker (100bp DNA ladder); +, positive control; -, negative 
control. 
1kb 
M  +    -  A B 
1kb 1kb 





3.3.2.2 Canine beta-globin 
In order to determine the effectiveness and integrity of each PCR reaction, and 
to check for DNA degradation within the samples due to transport of the DNA from 
Brazil to the UK, the amplification of the constitutive canine beta-globin gene (internal 
control) (Quaresma et al., 2009) within 24 random samples for both August 2017 or 
April 2018 were performed (Figure 3.9). Canine beta-globin, has constant expression 
levels and a relatively conserved gene sequence under various conditions. If there is a 
relatively complete canine genome DNA template, canine beta-globin can be amplified 
in all collected samples. Also, if the purity of the extracted DNA is high, canine beta-
globin can also be easily amplified. Gene amplification confirmed that the extracted 
canine genomic DNA was complete and its purity was high, indicating that it can be 
amplified effectively in vitro.  
Figure 3.9: Agarose gels showing the amplification of the constitutive canine -  
globin gene for 24 random samples from A; August 2017 and B; April 2018. DNA 
integrity gels show that all DNA samples used were intact indicating no DNA 
degradation during sample transport from Brazil to UK. M, molecular weight 
marker (100bp DNA ladder); +, positive control; -, negative. control. 
 M +   -  
118bp 
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3.3.3 Molecular diagnosis 
3.3.3.1 Evaluation of PCR Diagnosis 
Results from the molecular diagnosis of each sample collected in the field in 
both August 2017 and April 2018, identified 11/185 (6%) and 34/133 (26%) dogs as 
being positive for Le. infantum respectively (Table 3.2 and 3.3). As the same dog 
population was revisited in 2018, a 20 percent increase in infection rate can therefore 
be confirmed over this period. This increase in infection rate over the 9-month period 
with 33 dogs becoming infected in this period implicates this area (Altinopolis, 
Governador Valadares) as an endemic area for canine leishmaniasis. 
In 2017, three out of the 11 positive dogs presented with one or more clinical 
signs of cVL, the others being asymptomatic. While in 2018, ten out of 34 positive dogs 
presented with clinical signs. According to the clinical evaluation performed on all the 
dogs, the most frequently observed clinical signs were skin lesions including dermatitis 
(18%; 2017, 27%; 2018) and ulcerative lesions (25%; 2018), long nails (9%; 2017, 25%; 
2018) and some dogs also showed signs of conjunctivitis (18%; 2017, 14%; 2018). 
Following sample collection from 16 dogs which were diagnosed as being 
positive by the Brazilian Central Control of Zoonosis in April 2018, only ten (63%) 
classified as being infected following the DPP and ELISA analysis by the CCZ were 
confirmed as positive following the PCR analysis undertaken in this research. The rest 







Figure 3.10: SYBR safe-stained 2% agarose gels showing the results of 
electrophoresis of 24 random PCR products from A; April 2017 dogs and B; August 
2018 dogs. Positive dogs are represented by a 140bp band visible in line with the 
PCR product for the Leishmania positive control (indicated by white arrows). M, 
molecular weight marker (100bp DNA ladder); +, positive control; -, negative 
control. 
     M     +      -  










Table 3.2 Summary of PCR results for Leishmania infantum detection in dogs from 
Governador Valadares, Minas Gerais, Brazil. 185 and 133 dogs were collected in the 
field in both August 2017 and April 2018 respectfully along with 16 dogs diagnosed as 
‘positive’ by the Central Control of Zoonosis over a period of 2 weeks in April 2018. PCR 
experiments were performed in triplicate with positive and negative dogs identified.  
Samples
Collected
Replicate 1 Replicate 2
Replicate 3 
(confirmatory)
Replicate 1 Replicate 2
Replicate 3
 (confirmatory)





8 10 11 26 30 34 9 9 10
Negative 
dogs
177 175 174 107 103 99 7 7 6
% infection 
rate
5% 6% 6% 20% 23% 26% 56% 56% 63%
Aug-17 Apr-18
In field In field Central Control Zoonosis
185 133 16
Table 3.3 Percentage infection rates and clinical symptoms of positive dogs. Dogs were 
classified as asymptomatic (A) (the absence of clinical signs), oligosymptomatic (O) (the 
presence of one to three clinical signs), or symptomatic (S) (the presence of more than 
three clinical signs) according to the criterion adapted from Mancianti et al., 1988) 
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3.3.3.2 RT-qPCR Evaluation of Parasitic Burden in Dogs with Suspected cVL 
The kDNA RT-qPCR assay allowed for the quantification of the parasite load in 
all positive dogs from August 2017/April 2018 and the CCZ. Parasite loads ranged from 
103 to 0.4 parasites mL-1 in 2017 compared to 2018 (both in the field and from the 
CCZ) where the range was from 850 to 1 parasite/mL (Figure 3.11). 
This large variation in parasitic load over the two years can be observed 
through analysis of the median values which ranged from 5.06 parasites/mL (dog 
#116) in 2017 to 28.32 parasites/mL (dog #178) in 2018. Comparisons of parasitic load 
among the samples revealed that dog #126 in 2018 (853.44 parasites/ml) exhibited 
the highest degree of parasitism with dog #146 in 2017 (0.41 parasites/ml) exhibiting 
the lowest. 
The average value of Ct (ΔCt) obtained for dog #126 in 2018 (highest degree of 
parasitism) and for dog #146 in 2017 (lowest degree of parasitism) were the following: 
dog #126; 20.43 and dog #146; 30.45. A lower Ct value correlates with a higher 

















































































































































































































































































































Figure 3.11: kDNA RT-qPCR assay of all positive samples from A; in the field 
(August 2017) n=185, B; CCZ (April 2018) n=16 and C; in the field (April 2018) 
n=133. Positive samples previously determined by PCR were qualitatively analysed 
by RT-qPCR to determine parasite loads of each positive dog. Range of parasite 
load; 0.41 parasites mL-1 to 853.44 parasites ml-1.  White bars; asymptomatic dogs, 




An ideal diagnostic test for canine visceral leishmaniasis (cVL) would show 
100% sensitivity, identifying all dogs infected as well as those uninfected: a ‘gold 
standard’ for infection. The inaccuracy of the current tests used in Brazil will lead to 
high proportion of false positives and negatives therefore hampering cVL control. In 
fact, recent research has demonstrated that the official recommended diagnostic 
protocol for cVL in Brazilian endemic areas fails to successfully diagnose infected 
animals (Lopes et al., 2017).  Although serological tests are currently employed as the 
recommended diagnosis for cVL in Brazil, there are known limitations to the sensitivity 
of these techniques for the diagnosis of asymptomatic dogs. Furthermore, in 
comparison to molecular methods, serological tests demonstrate a low capacity to 
detect Leishmania infection in vaccinated dogs (Solano-Gallego et al., 2017). 
Therefore, the rate of infection in endemic areas may be currently underestimated 
(Nunes de Carvalho et al., 2018).  
Several studies have also shown the use of PCR for the detection of cVL is a 
more sensitive method for Leishmania detection in blood samples than traditional 
diagnostic methods such as microscopy (Moreira et al., 2007). Another advantage of 
PCR as a diagnostic tool is the ability to perform this technique using various biological 
samples. These include blood and buffy coat, lymph node aspirates, lesion scrapings, 
urine and canine conjunctival scrapings. Therefore, not only is this technique highly 
sensitive, but also has the potential to be relatively non-invasive. The impact of the 
high sensitivity of PCR could have a positive impact on the success of the euthanasia-
based measures currently in place for VL control. However, although a high accuracy 
has been demonstrated, the technique is still not used throughout Brazil. This is 
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primarily due to high cost, requirement of sophisticated laboratory infrastructure and 
lack of standardisation of the technique. Despite these limitations, the development 
of safer and faster molecular diagnoses is more advantageous than the continued use 
of conventional techniques (Gualda et al., 2015). 
 
3.4.1 Optimisation of PCR 
Due to the limitations observed for current conventional methods for cVL 
diagnosis, it is important that new methodologies are standardised in order to 
maximise repeatability and quality of the diagnosis. Research has demonstrated PCR 
as a rapid and sensitive tool for the diagnosis of leishmaniasis identifying parasites in 
different clinical samples from reservoirs, vectors and humans. Despite the high 
sensitivity observed for PCR diagnosis of cVL, the performance and quality of the 
technique is also related to the extraction protocol used, as well as the primers chosen. 
The identification of various Leishmania species in infected dogs in Brazil allows the 
opportunity for this technique to become highly specific for specific parasites if the 
correct primers are chosen (Souza et al., 2019). In endemic areas, such as the study 
area chosen here, it is highly possible that different Leishmania species are found. 
Research has demonstrated the presence of Le. amazonensis and Le. braziliensis in 
addition to Le. infantum in infected dogs in Governador Valadares (Valdivia et al., 
2017). Therefore, the utilisation of specific primers that are not only highly sensitive, 
but also detect the correct Leishmania species in clinical samples is highly important. 
This is not only to allow for correct treatments to be used, but also for later work which 
aims to identify Leishmania species specific volatiles in infected dogs.  
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The results discussed here determine the effectiveness of two sets of primers; 
MaryF/R and LeF/R, for the amplification of varying concentrations of Le. infantum 
ranging from [10]5 to [10]-3 parasites/ml.  The MaryF/R primers (Mary et al., 2004) 
have been widely used for the detection of Le. infantum using qPCR. Good efficiency, 
sensitivity and specificity have been shown throughout research (Ceccarelli et al., 
2014). The LeF/R primers (Spanakos et al., 2002) have been used in various 
conventional PCR experiments for detection of generic Leishmania DNA without the 
possibility of species identification but have shown a high sensitivity (Chargui et al., 
2013; Siriyasatien et al., 2016). Although both sets of primers showed excellent 
performance with both detecting a minimum concentration of [10]0 parasites/mL of 
blood, MaryF/R shows both greater specificity and sensitivity, amplifying at 
concentrations of [10]-2 and generating more intense bands at higher concentrations. 
This will in turn lead to a more accurate diagnosis of Leishmania infection in dogs. 
Despite the high sensitivity of these primers for Le. infantum diagnosis, the 
results here demonstrate that these primers can also amplify Le. amazonensis and Le. 
braziliensis (Figure 3.5). The ability of MaryF and R to amplify New World species has 
already been confirmed. Together with the results presented here, it could be 
suggested that these primers amplify a subclass of minicircles that are conserved 
among different Leishmania subgenera or species (Ceccarelli et al., 2014). However, a 
BLAST search which revealed a lack of homology for these species combined with the 
faint bands observed confirm these primers as being more specific for Le. infantum. 
This in turn will allow for a more species-specific diagnosis.  Despite some amplification 
of other New world species, the PCR method described using the primers MaryF/R is 
very effective at diagnosing seeded blood samples at very low concentrations of 
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parasites. This protocol was therefore used for diagnosis of canine blood samples 
collected from Brazil in both 2017 and 2018.  
 
3.4.2 PCR Diagnosis of cVL  
Currently in Brazil, the use of an ELISA for the confirmation of infected dogs 
following the screening using DPP diagnostics using blood samples is a cause for 
concern (Lopes de Mendonça et al., 2017). Not only has a low sensitivity and specificity 
of the DPP test been demonstrated, particularly among sub-clinically infected dogs 
(Grimaldi et al., 2012), but serological techniques present with a variety of limitations 
as previously mentioned. The low effectiveness of the current diagnostic protocol can 
be demonstrated in the results presented here. In 2018, samples were collected from 
16 dogs confirmed as being cVL positive by the CCZ following the use of the current 
diagnostic protocol. After sample collection, these dogs were subsequently culled. 
However, further diagnosis using PCR in this study identified only 10 dogs (63%) as 
actually being positive for Leishmania. Although the unnecessary culling of negative 
dogs is of concern, more worryingly is the fact that positive dogs are being 
misdiagnosed as negative, leaving positive dogs in the environment to continue 
disease transmission. The lack of accuracy observed with the current tests in Brazil, 
highlights the need for a more accurate diagnostic test to be adopted in order to have 
a positive effect on disease control.  
Further to an improvement in the diagnostic sensitivity of the current protocol, 
a diagnostic technique which remains relatively non-invasive would also be highly 
advantageous. The use of PCR for the detection of cVL in peripheral blood has many 
advantages. First, circulating parasites have been identified in dogs (Reithinger et al., 
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2000). Second, taking blood samples is far less invasive and simple compared to other 
sampling methods such as lymph node biopsies or bone marrow aspiration. And third, 
research has demonstrated that the sensitivity of cVL diagnosis by PCR when using 
blood is in concordance with bone marrow aspirates (Pedrosa et al., 2013). Using 
peripheral blood, however, has limitations which need to be considered when 
performing diagnosis. Research has shown that parasite concentration in peripheral 
blood is lower than that found in the lymph nodes, spleen and bone marrow aspirates. 
Furthermore, inhibitors which affect the sensitivity of PCR have been found in 
peripheral blood (Reithinger et al., 2003). Despite these limitations the less invasive 
nature of blood sampling and similar sensitivity to other biological samples has 
resulted in an increased popularity of performing diagnosis using peripheral blood 
samples (Paiva-Cavalcanti et al., 2015). Research has demonstrated that conventional 
PCR has sensitivities ranging from 89% to 100% when using blood samples from 
potentially infected dogs (Carson et al., 2010). Therefore, the use of PCR as a diagnostic 
for cVL using peripheral blood is a technique that should be considered as a 
replacement for the current Brazilian protocol.  
In order to confirm the sensitivity of PCR for the diagnosis of cVL, a 
conventional PCR protocol using Mary F and Mary R primers was used for the diagnosis 
of leishmaniasis in canine samples collected from Governador Valadares (GV). Analysis 
of the PCR results obtained in this study, not only demonstrated the accuracy of PCR 
based techniques for cVL diagnosis, but also confirmed GV as an endemic area for cVL 
in agreement with Cardoso et al., (2019). An infection rate ranging of 6% in 2017 and 
26% in 2018 was demonstrated. These results are in concordance with previous 
studies showing the prevalence of cVL in GV to be 30.2% (Barata et al., 2013). These 
90 
 
results also coincide with recent research which has demonstrated similarities 
between the accuracy of ELISA and PCR for the diagnosis of cVL (Nunes de Carvalho et 
al., 2018). This is due to previous studies in this area using serological based methods 
for the diagnosis of infected dogs.  
Not only was the high infection rate previously observed in this area confirmed, 
but the use of PCR as an effective diagnosis of cVL was also demonstrated with both 
symptomatic and asymptomatic dogs being diagnosed. Overall, although the PCR 
diagnosis of cVL using peripheral blood presents with some difficulties, numerous 
advantages can be observed. These include the high level of sensitivity observed when 
compared to other conventional methods in addition to the ability to detect 
asymptomatic as well as seronegative dogs. With the current methods used in Brazil 
showing a need for improvement, the development of a more accurate diagnostic 
protocol using PCR can be suggested. Increasing the effectiveness of the current 
protocol would prove advantageous for the ongoing control of leishmaniasis. 
 
3.4.3 PCR Diagnosis of Asymptomatic Dogs 
Recent research has proposed the use of a reliable clinical score based on 
clinical signs as a potential tool for the diagnosis of cVL in endemic areas which have 
limited diagnostic resources (da Silva et al., 2017). In fact, a severity score that is based 
on cVL clinical signs has already been proposed in Italy (Manna et al., 2009). Although 
diagnosis using clinical signs could be used as an initial tentative diagnosis, clinical signs 
are highly variable. Clinical manifestations can depend on the immune response in 
each dog, disease history and other factors such as other diseases presenting with 
similar clinical signs (Ribeiro et al., 2018). Efficient diagnosis of cVL also requires the 
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correct diagnosis of infected dogs that are asymptomatic as these dogs not only have 
a great epidemiological importance, but also represent a large proportion of all dogs 
with infection. Research has also shown that asymptomatic dogs are not only highly 
infective, but also highly competent of establishing Leishmania infection in sandflies. 
In fact, a higher proportion of infected sandflies have been shown to feed more on 
asymptomatic dogs (Laurenti et al., 2013). This research not only indicates the role of 
asymptomatic dogs in maintaining the Le infantum cycle, but also demonstrated the 
involvement of these dogs in the spread of VL in endemic areas. Therefore, a 
diagnostic technique that is able to distinguish between both symptomatic and 
asymptomatic dogs is important (Michalsky et al., 2007).  
Recent research has demonstrated that the sensitivity of some serological tests 
is significantly decreased when there are no clinical signs (Mendonça et al., 2017).  A 
sensitivity of 29% has been demonstrated for the diagnosis of asymptomatic dogs 
using the IFAT diagnostic, with a slightly higher sensitivity of 53% being observed when 
diagnosing asymptomatic cases using the ELISA (Mettler et al., 2005). Previous 
research has demonstrated that PCR could be used as a highly sensitive diagnostic tool 
for cVL diagnosis in asymptomatic dogs (Ferreira et al., 2009) In order to demonstrate 
the ability of this PCR protocol to diagnose asymptomatic dogs, clinical manifestation 
was recorded for each dog sampled in the field. Clinical signs were observed in 3 (27%) 
of the 11 positive dogs sampled in 2017 and 10 (29%) of the 34 positive dogs sampled 
in 2018. The clinical signs observed most included skin lesions, long nails and 
conjunctivitis. However, more dogs were asymptomatic with 73% of positive dogs 
presenting with no clinical signs in 2017 and 71% in 2018. The high proportion of 
asymptomatic dogs identified by this PCR protocol demonstrates the use of PCR as an 
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effective diagnostic tool permitting good sensitivity for cVL diagnosis of asymptomatic 
dogs. 
 
3.4.4 Parasite load in positive samples  
The ability to accurately monitor parasite replication and survival using real-
time quantitative PCR (RT-qPCR) is an important concept. Determining parasite 
quantity is vital in order to understand the biology of parasitic infections by 
distinguishing between parasite and host-mediated pathology as well as to monitor 
the effect of therapeutic interventions (Antonia et al., 2018). In fact, recent research 
has demonstrated that malaria treatment that is based on RT-qPCR diagnosis can not 
only reduce the prepatent period, but also the number of adverse events which occur 
before treatment (Walk et al., 2016). Previous research has also demonstrated the 
accuracy of RT-qPCR not only in the diagnosis but also quantification of various 
parasitic infections including malaria and Chagas disease. A developed RT-qPCR was 
able to simultaneously detect three Plasmodium targets with high sensitivity as well 
as provide absolute quantification of the malaria parasite (Kamau et al., 2013). Results 
have also suggested the use of RT-qPCR for the diagnosis and monitoring of T. cruzi 
infection due to a high sensitivity observed for the detection and quantification of the 
parasite (D’Avila et al., 2018). Regarding leishmaniasis, RT-qPCR is considered one of 
the most reliable diagnostic methods due to its high sensitivity (Travi et al., 2018). 
Previous research has investigated the accuracy of different molecular tests when 
diagnosing cVL in bone marrow samples from dogs. It was shown that RT-qPCR was 
the most sensitive technique having a sensitivity of 91% when compared to other PCR 
based methods which had sensitivities ranging from 54% to 72% (Carson et al., 2010). 
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Furthermore, it has also been shown that RT-qPCR can detect parasite levels as low as 
0.2 parasites/mL, when compared to conventional PCR which only recognised a 
positive result when bone marrow samples contained >30 parasites/mL (Francino et 
al., 2006). Additionally, a rapid and low-cost RT-qPCR assay for leishmaniasis has been 
developed through the reduction of reaction volumes as well as DNA amplification 
time. This diagnostic test was able to amplify Le. infantum and Le. braziliensis in 
infected dogs with good sensitivity (Dantas-Torres et al., 2017). This is highly important 
given that cVL infection can be caused by both species of Leishmania. 
The ability to determine parasite load in Leishmania positive dogs allows for a 
correlation, if any, to be seen between symptomatic/asymptomatic dogs and parasite 
load as well as allowing for a threshold level of detection to be determined for 
innovative diagnostic techniques. This quantification also allows for further 
information on the status of positive dogs diagnosed by conventional PCR. In order to 
quantify Leishmania parasite loads in our positive canine blood samples, a real-time 
RT-qPCR was developed using MaryF and MaryR primers (Mary et al., 2004). To 
achieve the best sensitivity, kinetoplast DNA was the molecular target for these 
primers with Lachaud et al., (2002) finding that kinetoplast DNA based methods show 
a minimum sensitivity of 3 parasites per PCR tube. A wide range of parasite loads were 
observed in this study ranging from 0.41 to 853.44 parasites/mL over the two separate 
sampling occasions. In August 2017, not only were there fewer positive dogs as 
demonstrated by conventional PCR diagnosis, but the parasite burden was also 
relatively low with a maximum parasite load of 103 parasites/mL identified. However, 
in April 2018, not only was there an increase in the number of infected dogs, but the 
parasite burden was also significantly increased with a maximum parasite load of 853 
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parasites/mL determined. Due to the longitudinal nature of this study, and the 
significant increase in number of infected dogs and parasite burden over a 9-month 
period, this particular study area could be considered as an endemic area for 
Leishmania infantum infection in dogs. The high parasite loads observed could have a 
direct impact on the identification of dogs which have a high transmitting ability. This 
is due to recent research which has shown that the parasite load in dogs that are 
naturally infected with Le infantum is directly correlated with their ability to infect 
sand fly vectors (Borja et al., 2016). Through these results it can also be suggested that 
RT-qPCR may be a useful tool in the prediction of the outcome of cVL infection, as high 
parasite loads have previously been correlated with disease severity (Verma et al., 
2010).  
Further results from this study also determined that parasite load could be 
directly correlated to clinical status, with dogs with the largest parasite burdens; 126, 
195 and 194, showing clinical signs upon sample collection. This is an observation that 
can be correlated to the results obtained in recent Leishmania research which has 
demonstrated a positive correlation between parasite load and common clinical signs 
observed in cVL (Torrecilha et al., 2016). This is also reflected in other parasitic 
diseases, with research demonstrating that clinical severity in malaria is correlated 
with a higher parasite load (Dormond et al., 2015). It has also been shown that a high 
parasite load is directly related to a greater inflammatory response that is associated 
with Chagas disease (Wesley et al., 2019). The correlation observed between 
Leishmania parasite load and clinical signs may allow veterinarians to make more 
informative decisions regarding infection prognosis and therapy that is based on 
routine initial examinations of clinical signs in the field (Torrecilha et al., 2016). 
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The results obtained here demonstrate that Governador Valadares, which is an 
endemic region for cVL, has a high prevalence of infected dogs which present with a 
wide range of parasite loads (Penaforte et al., 2013). Despite only a few dogs 
presenting with a high parasite load (>100 parasites/ml) it has previously been 
suggested that a small number of highly infected dogs would have a more significant 
impact on parasite transmission than a larger number of dogs with a low parasite load 
(Courtenay et al., 2017). This reinforces the need for strict Leishmania control actions, 
particularly through the culling of seropositive dogs. The accuracy of RT-qPCR for cVL 
diagnosis has previously been shown. Additionally, the added advantage of being able 
to quantify parasite burden not only allows for the status of positive dogs diagnosed 
by PCR to be confirmed, but also allows for an estimation of the parasite load kinetics 
and provides information on the response to treatment (Francino et al., 2006). 
However, despite RT-qPCR-based methodologies proving to be highly effective in 









4.1.1 Current in Field Leishmaniasis Diagnostics in Brazil 
Currently, in Brazil, the main method adopted for the control of visceral 
leishmaniasis in endemic areas is through the euthanasia of infected dogs to reduce 
the transmission of the parasite. Accurate as well as early detection of infected dogs 
is therefore critical but challenging. In 2012, the Brazilian Ministry of Health replaced 
the exisiting protocol which used an ELISA test as an initial screen followed by Indirect 
Immunofluorescence Test for confirmation, with a new protocol which uses the DPP 
(®) canine visceral leishmaniasis (cVL) rapid test as the initial screening test followed 
by an ELISA cVL as the confirmatory test. 
The Dual-Path Platform (DPP) rapid diagnostic test (Figure 4.1) is a novel, 
immunochromatographic assay which was launched by BioManguinhos/Fiocruz, Rio 
de Janeiro, Brazil. Following confirmation of DPP positive dogs with an ELISA these 
dogs are culled, while DPP negative dogs are considered free of infection. A rapid in-
field diagnostic test such as this is generally preferred due to easy use in the field, and 
thus useful for mass screening of cVL (Figueiredo et al., 2018). These infection control 
programmes however tend to fail, not just due to the long delay between diagnosis 
and culling in highly endemic areas, but also due to a lack of accuracy observed with 




Despite the sensitivity of an ELISA being as high as 94%, suggesting that the current 
Brazilian protocol should be successful, there is still debate as to the accuracy of the 
DPP test. The DPP has been assessed several times since it was introduced with the 
most recent studies carried out in Brazil demonstrating an overall sensitiy of 86%-89% 
a specifcity of 70%-94% (Fraga et al., 2016; Figueiredo et al., 2018). Additional research 
has also reported a sensitivity of 47.1% for the DPP diagnosis of splenic aspirates from 
cVL infected dogs compared to a sensitivity of 66.7% when using an ELISA and 100% 
when using RT-qPCR (Solcà et al., 2014). This low sensitivity coincides with results 
Figure 4.1: Positive result obtained by K26/K39-specific antibody Dual-Path 
Platform rapid diagnostic test (DPP®) for Dog #201: In the test window, the right line 
represents the control band (C). The left line indicated by an arrow represents the 
test band (T). If a sample is negative, the test will only develop a single control line 
(C) which demonstrated that the test has worked. A positive sample, however, 
develops both the control line (C) and test line (T). 
T    C 
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presented earlier in this study showing the DPP to have an accuracy of 63% when 
diagnosing dogs in Governador Valadares (Table 3.2 and 3.3, Chapter 3). Further 
research has also demonstrated a low sensitivity and specificity of this rapid diagnostic 
test when diagnosing asymptomatic dogs. Sensitivities as low as 75% and specificities 
as low as 47% have been observed which is of particular concern, especially as many 
infected dogs never display any clinical signs (Grimaldi et al., 2012; Figueiredo et al., 
2018;). Furthermore, research has demonstrated a low sensitivity of the DPP cVL 
diagnosis when compared to current parasitological methods. The lack of accuracy 
demonstrated for this rapid diagnostic test, highlights the need for better in-field 
diagnostic tests that will allow for more effective canine removal regimes than those 
currently used by public health services in Brazil. 
 
4.1.2 Odour and Infection Status 
Research has revealed a variety of ways in which odour could signal both non-
infectious and infectious disease. First, it has been suggested that infections can 
change the composition of microbes both internally and externally which play 
important roles in the development of an individual's distinctive odour. The bacterial 
population on the skin in particular has been shown to play an important role during 
infection, particularly in the canine population, changing its composition as a response 
to disease (Weese, 2013) with an increase in dysbiotic skin microbiota being observed 
during leishmaniasis infection (Gimblet et al., 2017). 
Second, it has been demonstrated that infection triggers an immunological 
response that can change an individual's odour. For example, genes of the major 
histocompatibility complex (MHC) are not only important in the control of 
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immunological non-self/self-recognition but also have a major influence on body 
odour and mating (Janes et al., 2010). Research has found that changes in the levels 
of MHC have an influence on the number of volatile compounds produced by 
mammals including sulphur-containing compounds, male pheromones and carbonyl 
metabolites (Novotny et al., 2007). As a decrease in the expression of MHC class I and 
II on Leishmania infected cells has been shown (Nyambura et al., 2018) it has been 
suggested that this decrease could be influencing the odour of a Leishmania-infected 
individual however, it is still unclear how the MHC genes alter odour. 
Third, it has been suggested that activation of the immune system during 
infection could alter the metabolic by products that are excreted from the endocrine 
system. For example, individuals who have an infection tend to have a lower 
concentration of androgens and corticosterone; hormones that are suspected to 
regulate the production of sex pheromones and `alarm odours' respectively. 
Interestingly, dihydrotestosterone (DHT), the main androgen produced by males, has 
been found to have a significant role in Leishmania infection. In the presence of DHT, 
Leishmania promastigotes were found to have a significantly enhanced replication 
rate, a higher rate of survival in macrophages and an increased infection rate, as well 
as producing significantly larger lesions in mouse earlobes (Sánchez-García et al., 
2018). These results suggest that DHT plays an important role during Leishmania 
infections. Furthermore, research has also shown that during visceral leishmaniasis 
infection there are abnormalities in the hypothalamus-pituitary-adrenal axis, as well 
as irregular ADH and aldosterone secretions, magnesium depletion and thyroid 




4.1.3 Vector-borne Parasite Manipulation of Host Odour 
The survival of vector-borne parasites is dependent their ability to pass from 
one host to another via an insect vector. Parasites that are predominantly found in the 
circulatory system or superficially in the skin, have been shown to influence the odour 
of infected individuals which subsequently increases vector attraction and aids in 
parasite transmission (Hughes and Libersat, 2019). This phenomenon has been 
demonstrated for both malarial infections (De Moraes et al., 2014) and leishmaniasis 
(Tavares et al., 2018). Although it has been demonstrated that parasitic infection 
induces a change in host odour there is still a significant lack of research examining the 
potential of Leishmania parasites to alter the odour of their host animal in a natural 
environment. Through further understanding of such a manipulation, the potential for 
novel diagnostics based on disease odour detection could be suggested.  
 
4.1.4 Diagnosis of cVL based on VOCs  
Observed changes in the volatile organic compounds (VOCs) emitted by the 
parasitized host provides further evidence linking parasitic infection and host odour. 
In canine visceral leishmaniasis (cVL), studies by De Oliveira et al (2008) and 
Magalhães-Junior et al (2014b) provided evidence which suggested a difference 
between the profiles of the VOCs emitted by dogs infected with Le. infantum and those 
which were uninfected. Furthermore, Magalhães-Junior et al (2014b) reported a 
distinct difference in the odour profiles of infected canines which were presenting 
clinical manifestations compared to those infected canines which were showing no 
clinical manifestations. Although these studies suggest that an early diagnosis of 
infected dogs with and without clinical signs could be achieved, there are a few 
101 
 
limitations surrounding the research. Most notably is the small sample size which was 
used during the investigations; 12 healthy and 24 infected dogs (Magalhães-Junior et 
al., 2014b) and 8 healthy and 16 infected dogs (De Oliveira et al., 2008). The use of 
plastic bags during the study by Magalhães-Junior et al (2014b) may also interfere with 
the analysis. Plastic polymers have been shown to generate interference and chemical 
noise when undertaking metabolomics analyses due to the highly sensitive equipment 
used (Yin et al., 2015). Additionally, solid-phase microextraction (SPME) is an 
equilibrium method and all of the compounds found on the dog hair may not be 
completely extracted or in the same proportions from the sample, another limitation 
of the previous analysis (Lappas and Lappas, 2016).  
The work by Magalhães-Junior et al (2014b) identified six specific VOCs that 
could be determined as potential biomarkers of Leishmania infection; all six showed 
significant variations between infected dogs and healthy dogs. In contrast however, 
de Oliveira et al, 2008 identified 24 VOCs which they reported as being significant 
enough to discriminate between infected and non-infected canines, three of which 
showing the most significant difference; 2-hexanone, benzaldehyde and 2,4-
nonadienal. These studies suggest that the identification of the biomarkers in canines 
that are infected with Leishmania could potentially be used as a painless, non-invasive 
diagnostic tool for the identification of cVL. Despite these results, there is still no 
evidence that demonstrates a threshold level or minimum parasite concentration that 
could be detected by observing the change in the odour profiles of canines. 
Furthermore, the origin of the different odour profiles produced during infection has 
not been determined; the change might be related to an alteration of the animal’s 
behaviour once infected or even the microbial composition of the skin (Salgado et al., 
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2016). In order to further understand the observed differences and origin of the 
infected odour profiles, the link between parasite load and infected odour could be 
identified. By identifying the parasite threshold level at which the observed change in 
the VOC profiles occur, the use of odour as an early stage diagnostic could also be 
determined. 
 
4.1.4.1 Leishmania biomarkers in Hair 
The use of hair as an analytical matrix could potentially be used for the 
diagnosis of cVL. Hair as a skin appendage is important for the secretion and excretion 
of endogenous substances (Grice and Segre, 2011). In fact, studies have analysed the 
components of animal hair for forensic investigations (Vincenti et al., 2013), and as an 
indicator of the internal metabolic processing of medicines (Gratacos-Cubarsi et al., 
2006). Hair samples are not only easily to collect but have also been found to become 
naturally impregnated with secreted and excreted substances produced during 
infection; a reflection of the internal metabolism. Previous research has identified 
breast cancer associated lipids excreted on scalp hair (Mistry et al., 2012). In this 
context, it can be stated that the volatiles that are emitted by hair can be 
representative of the volatiles that are emitted through the skin (Bernier et al., 1999). 
Regarding infected dogs, previous research has demonstrated that the hair samples 
from Le. infantum seropositive and seronegative dogs, identified following ELISA 
showed a clear difference in their volatile emission profiles (Oliveira et al., 2008). More 
recent research has also demonstrated the same phenomenon when diagnosing 
infected dogs using PCR (Magalhães-Junior et al., 2014b). Furthermore, this research 
also identified variations between the volatile profiles of uninfected dogs and infected 
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dogs with and without clinical signs. The observed variations between the groups 
within the infected dogs suggested that the volatile profiles may be related to the type 
of immune response generated during infection.  
The possibility of using hair samples to distinguish between the odour profiles 
of Leishmania infected dogs could provide new perspectives regarding the 
pathophysiology of cVL, as well as the interactions between the parasite, host and 
vector. This previously observed change in odour profile of infected dogs could 
contribute to the study of parasite transmission in endemic areas. As hair samples are 
easy to collect and a non-invasive, this methodology is predominantly acceptable to 
dog owners and therefore suggests a new methodology for sample collection for 
disease diagnosis using dog odour. 
 
4.1.4.2 Leishmania biomarkers in blood 
The chemical analysis of blood as a biological sample is currently the most 
common way of diagnosing most pathological conditions. Pathogenic microbial 
species produce various volatile metabolites with the analysis of secondary 
biomarkers in the blood forming the diagnostic approach (Bos et al., 2013). Biomarkers 
found in blood are widely used in research not only to understand several aspects 
related to infectious and non-infectious diseases, such as susceptibility and exposure 
to infection, but also to identify an infected individual (Bryan, 2016). Blood is also an 
important source of body odours with many metabolically produced biomarkers being 
secreted into blood during infection and subsequently emitted to the external 
environment (Shirasu and Touhara, 2011). As research has demonstrated the ability 
to detect between the external odour profile of infected and uninfected individuals, it 
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could also be suggested that such a difference would also be observed through the 
internal odour analysis of blood 
Due to the vector borne nature of most parasitic diseases, and the common 
ingestion of blood meals by such vectors, many parasites are found predominantly in 
the blood of an infected individual. The complex interaction between parasites with 
host immune cells, in addition to the host immune response has been shown to 
produce biomarkers of infection within the blood (Veras et al., 2018). When focusing 
specifically on cVL, Leishmania specific biomarkers have been identified in the blood 
of Le. infantum infected dogs (Maia and Campino, 2018). Leishmania infantum 
infection has been shown to causes oxidative stress of canine neutrophils leading to 
an increase in  reactive oxygen species and thus reduction of antioxidant compounds 
(Almeida et al., 2017), Alterations in protein levels in the blood have also been 
observed, with an elevation of renal and hepatic biochemical parameters also being 
commonly associated with cVL (Meléndez-Lazo et al., 2018). In addition to protein 
alterations, a reduction in some inflammatory markers such as butyrylcholinesterase 
and adenosine deaminase has also been reported in blood samples of infected dogs 
(Tonin et al., 2016). Therefore that the detection of various biomarkers and volatile 
metabolites during infection could be used as a potential diagnosis for cVL. 
 
4.1.5 VOC Analyser - principles and applications  
4.1.5.1 Technology  
Over the past 20 years, work has been undertaken to understand the principles 
behind odour receptors and the organisation of the olfactory system (Buck, 2005; 
Grabe and Sachse, 2018;). Only one type of odorant receptor is located on each 
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olfactory receptor cell which has the capacity to detect only a limited number of 
different substances. For a more complex odour that is composed of a variety of 
odorant molecules, several different receptors are activated. This resulting receptor 
pattern is what determines our impression of the specific odour (Rock et al., 2008). 
In 1982, Persaud and Dodd presented the first idea of a VOC Analyser as a 
device with the capabilities of mimicking the discrimination shown by the mammalian 
olfactory system when identifying the volatile organic compounds (VOCs) that are 
present in the headspace of a biological sample that is being analysed. It was reported 
that a VOC Analyser has the capability to discriminate between a wide variety of 
different odours, and that this discrimination could be achieved without the use of 
highly specific receptors (Persaud and Dodd, 1982). Technical limitations of VOC 
Analysers have been shown however, with the presence of water vapour of high 
concentrations of single compounds; for example, alcohols, causing a loss of 
sensitivity, sensor drift between replicates and a relatively short lifespan of some 
sensors (Cellini et al., 2017).  
A VOC Analyser is an instrument that is made of an array of chemical sensors 
that are ordinarily combined with a pattern recognition system (Bartlett et al., 1997). 
Currently, the classical VOC Analyser which consists of this array of chemical sensors 
is the adopted approach to this technology. Common types of chemical sensors 
currently used are metal oxide and conducting polymer sensors, with metal oxide 
sensors capable of detecting large numbers of different volatiles (Estakhroyeh et al., 
2017). In order to better understand how a VOC Analyser works, an awareness of the 
mechanisms behind the human olfactory system is essential. When we smell, air 
samples that contain molecules of odours are moved past curved bony structures 
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known as turbinates. These structures create a turbulent airflow that carries the 
mixture of VOCs to the olfactory epithelium, where the ends of the nerve cells that 
sense odours are present. These olfactory receptor cells are then activated, and the 
signal is relayed to the brain. The premise behind the VOC Analyser is similar to the 
mechanism behind the human olfactory system. The technology consists of three 
functional components; a sample handler, an array of sensors and a signal processing 
system, which operate in sequence. The turbulent air flow produced by turbinates in 
the human olfactory system is replicated by an intake of air through a tube by the VOC 
Analysers sample handler (Figure 4.2). The array of sensors is a fundamental part of 
this technology with each sensor array in the array having a different sensitivity to 
individual VOCs. These sensors mimic the distinguishability of the nerve cells in our 
olfactory system. For example, where odour A may produce a low response in one 
sensor, but higher responses to others, odour B might produce a low reading for 
sensors that gave a high response to odour A. This variation in sensitivities between 
different sensors generates different patterns of response to different odours 
meaning every sample has a unique ‘smell’. This distinguishability allows the VOC 
Analyser to identify unknown odours from the patterns generated by the sensors. Each 
sensor in the array is designed to have a unique response to the spectrum of different 
odours that are being tested. The generated pattern of response from all the sensors 
in the array is what is used to identify/characterise the odour. 
Other types of VOC Analysers have been developed which utilise mass 
spectrometry (Fenaille et al., 2003) or gas chromatography (Wiśniewska et al., 2017) 
as the detection system. However, the VOC Analyser developed by RoboScientific and 
used for this project employs the same mechanisms as conventional VOC Analysers 
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using a chemical sensor array. The chemical sensors used were thin films of semi-
conducting polymers deposited onto interdigitated gold structures on a silicon 
substrate. An air sample is pulled by a vacuum pump through a plastic or stainless-
steel tube into a small chamber which houses this electronic sensor array. The odour 
is then exposed to the sensors by the sample-handling unit. The exposure of each 
volatile to each sensor produces a change in electrical properties due to the volatile’s 
interaction with the semi-conducting polymer surface. After a few seconds to a few 
minutes depending on the sensor type, a steady-state condition is reached. During this 
period, the response of the sensor to the volatiles exposed to it are recorded and 
delivered to the signal-processing unit. It is the response generated by the sensors that 
creates data which can be analysed and used to determine whether a difference can 




4.1.5.2 CVL Diagnosis using VOC Analysers 
Physicians have valued odour for centuries for diagnostic purposes with a 
variety of research proving the use of odour in the diagnosis of disease. The VOC 
Analyser has shown great potential when used in in vitro experiments, having the 
ability to detect a variety of bacteria and fungi and, in some cases, distinguishing 
between them (Magan et al., 2001). Furthermore, in clinical research, VOC Analyser 
technology has been shown to be a useful potential diagnostic device for the diagnosis 
of a variety of different diseases. Electronic noses have been used to analyse sweat, 
Figure 4.2: VOC Analyser (Model 307 VOC analyser, RoboScientific Ltd, Leeds, 
United Kingdom) employing 12 semi-conducting polymer sensors. Hair samples 
sealed in individual foil bags were analysed using this device. Each bag was pierced 
by a needle connected to tubing leading into the instrument. An intake of air through 
a tube by the VOC Analysers sample handler allows for the headspace of the sample 
to be passed over the sensor array. Each individual VOC present in the sample reacts 
with individual sensors.  The response for each sample was then displayed on a 
computer screen in real time as the sample was analysed. The specific response 
pattern was used to identify and characterise the sample’s odour. 
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breath, urine, and stools, with research having shown the ability of the VOC Analyser 
to distinguish between common bacterial pathogens of the upper respiratory tract 
(Lewis et al., 2017) as well as proving able to detect mycobacterium tuberculosis in 
human sputum samples (Teixeira, et al., 2017) and using urine to diagnose urinary 
tract infections and type 2 diabetes (Roine et al., 2014; Esfahani et al., 2018). Despite 
the extensive amount of research already undertaken into the use of VOC Analysers, 
there remain other domains that are relatively unexplored. Many of these involve the 
potential detection of a change in odour generated by the skin and contained in the 
sweat and on the hair of infected individuals (Rock et al., 2008). Previous VOC Analyser 
applications have also shown the potential to analyse blood in order to diagnose and 
monitor disease. Research has demonstrated the potential of the VOC Analyser to 
discriminate between pre-dialysis from post-dialysis blood due to the presence of 
different biomarkers (Fend et al., 2004). The ability of VOC Analysers to distinguish 
between these unique chemicals which can then be associated to specific diseases, 
leads to the hypothesis that this technology could potentially be used in the detection 
and diagnosis of parasitic diseases including cVL. 
The production of VOC Analysers which can detect and discriminate between 
parasite specific VOCs, could play a significant role in the development of early, point 
of care (POC) diagnostics for a variety of parasitic diseases (Turner and Magan, 2004). 
The distinct difference already demonstrated between the VOCs on the hair of 
Leishmania infected and uninfected dogs (De Oliveira et al, 2008 Magalhães-Junior et 
al 2014b), in addition to the identification of Leishmania infantum biomarkers in 
infected dog blood (Maia and Campino et al., 2018), suggests that VOC Analysers could 
be used as an alternative tool for the diagnosis of cVL using these sample types. The 
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use of this technology would achieve most of the ASSURED (affordable, sensitive, 
specific, user-friendly, rapid and robust, equipment free and deliverable to end users) 
criteria, which has been outlined by the World Health Organisation for all new POC 
Devices (Staniek et al., 2019). The aim of this part of this study was to determine 
whether a commercially available VOC Analyser could distinguish between the odours 
of Le. infantum infected and uninfected dogs with a high sensitivity and specificity. 
 
4.1.6 Chapter Aims 
In order to disrupt the Leishmania transmission cycle, it is important to 
successfully identify canines infected with Leishmania at an early stage of infection 
and remove them from the population. However, existing in-field methods used for 
cVL diagnosis are ineffective and inaccurate. Previous research has shown that 
Leishmania infected dogs produce a different odour to those that are uninfected (de 
Oliveira et al., 2008; Magalhães-Junior et al., 2014). However, the detection of this 
odour change as a diagnostic methodology has also not been investigated. Due to 
previous research demonstrating the ability of VOC Analysers to distinguish between 
the odour of infected and uninfected individuals with diseases such as TB or cancer, 
the aim of this chapter was to determine whether the VOC Analyser could distinguish 
between cVL infected and ininfected dogs, thereby providing preliminary evidence of 






The collection of the dog hair and buffy coat samples in the field was as 
described in the General Methods Chapter 2.0. As all analysed hair samples from both 
2017 (n=55) and 2018 (n=149) were also used for additional GC/MS analysis (Chapter 
6.0), before VOC Analyser analysis, the samples were split equally between two foil 
bags in a cold room set at 4°C. This temperature was required to minimise the loss of 
volatiles during the transfer. 
 
4.2.2 VOC Analyser System Used 
For this study, a VOC Analyser (Model 307 VOC analyser, RoboScientific Ltd, 
Leeds, United Kingdom) that employed 11 functioning semi-conducting polymer 
sensors was used. Three different sensor arrays were used in total for the analysis of 
the hair and buffy coat samples. The type of sample analysed by each sensor array 
were as follows;  
Sensor array 1: analysis of the 2017 dogs and the 2018 buffy coat  
Sensor array 2: analysis of the 2018 dogs  
Sensor array 3: analysis of the 2018 buffy coat  
Each sensor array was a derivation of one another, with 50% of the sensors 
being identical in each array. Therefore, the arrays had similar characteristics making 
the readings comparable.  
Initial calibration of the device was achieved by two calibration points being 
automatically set by the sensor unit. The first was a baseline which was obtained when 
carbon-filtered air was passed over the sensor at a flow rate of 200ml/min. This was 
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automatically adjusted to zero on the Y axis scale. The second was a reference point 
which was obtained from sampling the head space of 5ml of a water control which was 
placed in a plastic vial.  
For the analysis of the head space of each hair and buffy coat sample, each foil 
bag was connected to the VOC Analyser through the insertion of an 18-gauge needle 
connected to a PTFE tube into the head space of each bag. This was connected to the 
sample port of the VOC analyser and the head space passed over the sensor surfaces. 
Each individual sensor used as part of the array was a different type, chosen from a 
group of polymers that included polypyrrole, polyaniline and polythiophene. Each 
sensor had semi-selectivity to a different group of volatile chemicals; alcohols, 
aldehydes, amines, ketones and organic acids etc. Therefore, a digital fingerprint of 
the VOC mixtures from the samples was generated. The change in the electrical 
properties of each sensor was measured, recorded and displayed on the VOC analyser 
data logger screen. Four different parameters were recorded from each sensor 
response; absorbance, desorption, divergence (maximum response from the baseline) 
and the area under each response curve (Figure 4.3). Each functioning sensor array 
generated 2 outputs; a positive and a negative response. Therefore, the total number 
of VOC measurements for each sample was 88 (11 functioning sensors x 4 parameters 
x 2 outputs). The sampling profile was set at; 2 seconds baseline, 7 seconds absorption 
followed by a 1 second pause, 5 seconds desorption and 12 seconds flush to bring the 
sensors back to baseline. 
The headspace of each foil bag was sampled 4 times. The first sample was 
discarded as it could potentially contain volatile carryover from the previous sample. 
Therefore, data was retained from the next 3 samples for the analysis. The individual 
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dog hair and buffy coat samples in each experiment were tested randomly, with each 
sample used once only. 
 
4.2.3 VOC Analyser Analysis 
4.2.3.1  Optimisation 
Prior to sample analysis of hair collected in the field, differing quantities of 
water were injected into each bag in order to determine the optimal quantity needed 
for the discrimination of hair samples collected from two different breeds of dogs 
(Border Collie n=1 and Cavalier King Charles n=1). The addition of water followed by 
incubation at 50 degrees produced humidity in the samples which assisted in the 
release of the VOCs and removed any variability due to different levels of water found 
Figure 4.3: VOC Analyser data response for each sensor. Each sensor generated an 
individual response based on the VOCs present in each sample. Each response is 
represented by a different coloured line on the graph with each sensor generating a 







in the collected hair samples.  A controlled amount of water keeps the baseline 
humidity level constant.  
Approximately 3 x 1g of hair was collected from each dog and placed in to 
individual 110mm x 185mm Aluminium grip seal foil bag (Polypouch UK Ltd). The 
samples were analysed with the VOC Analyser either dry or following the addition of 
10L or 100L of water. A discriminant function analysis (DFA) within the Excel add-in 
software XLstat version 3.4 was performed on the data. A multivariable discriminant 
plot was generated which summarised the classifications of the observations and 
provided a visual representation of the observations. Two sensor parameters; the 
divergence and area under the response curve were used to perform the analysis.  
 
4.2.3.2  VOC Analyser Analysis of 2017 and 2018 Dog Hair 
Volatile analysis using the VOC Analyser was carried out on all (n=11) of the 
2017 infected dog hair samples and a sub-set (n=44) of the uninfected dog hair 
samples using sensor array 1. The uninfected dogs were randomly selected from 
groups of dogs which matched the infected dogs for age, sex and whether the dogs 
were “treated” with other medication (Table 4.1). Four uninfected dogs for each 
category were selected for each infected dog. For the 2018 samples, VOC Analyser 
analysis was carried out on all the infected dog hair (n=44, including 10 CCZ dogs) and 
all the uninfected dog hair samples (n=105, including 6 CCZ dogs) using sensor array 2. 
Water (10µL) was injected into each foil bag containing individual hair samples 
with a Hamilton syringe and inflated with 140mL of laboratory air using a diaphragm 
pump. All hair samples were incubated at 50°C for 15 minutes in an oven, and then 
allowed to cool for 5 minutes at room temperature prior to the head space analysis. 
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Samples were heated in order to assist in the release of the volatiles from the hair 
samples into the headspace. 
 
4.2.3.3  Buffy Coat 
In order to determine whether the VOC Analyser could distinguish between the 
VOCs found in the blood of infected dogs, VOC Analyser analysis on buffy coat samples 
was performed using sensor arrays 1 and 3. For the analysis, 5 positive dogs were 
selected at random from the 2017 cohort, along with 5 negative 2017 dogs randomly 
selected from the previously selected 44 negative dogs (Table 4.1).  
  Buffy coat samples were centrifuged at 14,000 x rpm for 4 minutes, opened 
and placed into individual foil bags. All bags were inflated with 100mL of laboratory air 
using a diaphragm pump and incubated at 50oC in an oven for 10 minutes and allowed 
to cool at room temperature prior to headspace sampling. 
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4.2.4 Data analysis 
4.2.4.1  Hair Analysis 
In order to test the ability of the VOC Analyser to differentiate between the 
odours of infected and uninfected dogs in 2017 using sensor array 1 and in 2018 using 
sensor array 2, two statistical programs were used. The first was MCLUST (Fraley and 
Raftery 1999), a model-based clustering and classification algorithm embedded in R-
cran statistical software (R-cran, R Core Team 2018) and the second was a discriminant 
function analysis in IBM SPSS Statistics (Version 25). The two different statistical 
Table 4.1: List of 2017 dogs selected for volatile organic chemical (VOC) Analyser 
analysis. The 8 groups which the 2017 positive dogs (n=11) were split into is shown 
in the table above. A list of the chosen 44 uninfected dogs is also shown. Four dogs 
were chosen for every one positive dog in order to gain a statistically robust 
analysis. Dog samples in bold and italic correspond to those samples used for VOC 
Analyser analysis of the buffy coat. 
 
Age Sex Treated Positive Dogs Negative Dogs 
0-2years Female Yes 014, 150 004, 036, 068, 072, 106, 147, 153, 155 
0-2years Female No 041, 132 018, 029, 088, 125, 142, 157, 163, 169 
0-2years Male Yes 105 024, 032, 057, 152 
0-2years Male No 164 009, 052, 115, 161 
3-4years Female Yes 123, 146 001, 013, 016, 043, 061, 094, 107, 171 
3-4years Female No 035 015, 021, 121, 173 
5-8years Male Yes 116 082, 099, 126, 139 
5-8years Male No 026 045, 070, 103, 149 
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analyses aimed to identify any significant differences in the VOC analyser response 
between infected and uninfected dogs in both 2017 and 2018. This would, therefore, 
allow for an accurate prediction of the infection state of newly sampled dogs in the 
field.  
 
4.2.4.2  R-cran statistical software analysis 
Initial discriminant analysis (DA) using R-cran statistical software was 
performed on both sets of data from 2017 and 2018. This initial analysis using one 
class for infected and one class for uninfected dogs indicated that the data was over 
fitting, therefore the infected and uninfected dog classes were divided into sub-classes 
using the function MCLUST and the optimal statistical model determined. The optimal 
number of sub-classes and statistical model for infected and uninfected dogs was 
obtained by Bayesian information criterion (BIC) (Table 4.2 and 4.3). Following the 
determination of the optimal number of subclasses and model, the discriminant 
analysis was repeated. In addition, this further analysis also aimed to identify any 
significant differences in the VOC Analyser variables of 2017 and 2018 infected and 
uninfected dogs. The relative importance of each variable in discriminating between 
the infected and uninfected sub-classes was assessed by variable permutation 
analysis. 
The predictability of the clustering model and the robustness of the 
classification were evaluated within R-cran. This analysis was performed using two 
types of cross-validation; out-of-sample cross validation (CV) and confounder cross 
validation (CCV) (Table 4.8 and 4.9). For this analysis, the replicates were considered 
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independent; the three VOC replicates for each dog were considered as coming from 
three different dogs. 
The statistical program was further employed to compare the uninfected dogs 
collected in 2017 with the uninfected dogs in 2018. This analysis was performed in 
order to determine whether the negative dogs from both years could be discriminated 
between, or whether the data was considered equal i.e. there is no significant 
difference between both sets of dogs. If the negative dogs were considered equal, 
then further analysis could be carried out comparing individual dogs that were 
negative in 2017 but became positive in 2018, thereby allowing for a direct control.  
In addition, the effect of parasite load and clinical signs on VOC Analyser 
discrimination was also determined. This analysis was based on the RT-qPCR results 
and identified clinical signs (Chapter 3, Results Figure 3.11). The probability of an 
infected dog belonging to the established infected clusters was determined.  Those 
positive dogs which were considered to have a high VOC Analyser discrimination when 
compared to the negative dogs produced the highest probability (discriminatory 
factor). This discrimination was then compared to the parasite load in order to 
determine whether parasite load is correlated to VOC Analyser response. Similarly, the 
identified discrimination was also compared to the presence or absence of clinical 
signs to determine whether clinical signs influenced the VOC Analyser discrimination. 
This analysis was performed on the 2018 dogs due to the larger cohort of positive dogs 




4.2.4.3 SPSS Statistics 
Following the discriminant analysis performed in R-cran statistical software, a 
discriminant analysis using IBM SPSS Statistics software was also performed on both 
sets of data from 2017 and 2018. This was done to increase the statistical robustness 
of the analysis in addition to validating the results gathered from the R-cran MCLUST 
analysis. Unlike the R-cran statistical analysis, infected and uninfected dogs were not 
split into sub-classes, instead only two classes were used (uninfected and infected) 
which were the dependent variables. 88 predictor variables were utilized to predict 
category membership. 
Initial analysis was performed assuming that all dog replicates were considered 
independent; therefore, each individual VOC replicate for each dog was considered as 
coming from three independent dogs. Following which, the mean values for each 
variable was taken for each individual dog; giving an average value for the three dog 
replicates (n=55), and the analysis repeated. 
 
4.2.4.4 Buffy Coat Analysis 
The VOC Analyser analysis of the VOCs emitted by the 10 dog buffy coat 
samples (5 positive and 5 negative) was performed 4 times for each sample using 
sensor array 2 and sensor array 3 with the first sensor response removed as with the 
hair analysis. Using discriminant function analysis (DFA), a multivariable discriminant 
plot was generated using Excel add-in software (XLstat version 3.4). Two sensor 
parameters; the divergence and area under the response curve were used to perform 






Three lots of hair (3x1g) were collected from two domesticated dogs and 
analysed using the VOC Analyser following incubation either dry, or after the addition 
of 10ul or 100ul of water. A clear discrimination can be observed between the two 
dogs when a volume of 10ul of water was added to each sample due to the large 
distance shown between samples on the graph (Figure 4.4). However, when analysed 
dry or with 100ul of water, the VOC analyser was unable to effectively discriminate 
between the two different dogs. The the addition of 10ul of water is therefore required 




4.3.2 R-cran Statistics Model Analysis 
The best model for the analysis of 2017 and 2018 infected and uninfected dogs 
using R-cran statistical software was determined to be EEE, apart from infected 2017 
dogs where the best model was VVI (Table 4.2 and 4.3). EEE assumes an ellipsoidal co-
variances and equal shape, volume and orientation for all the classes, while VVI 
Figure 4.4: Discriminant Function Analysis (DFA) (XLstat version 3.4), using sensor 
array 1, of dog hair from a Border Collie (BC) and Cavalier King Charles (CKC). 
Following the addition of 10 L of water, a clear discrimination can be observed 
between the CKC and the BC. When analysed dry or with 100 L of water the DFA 
was unable to clearly discriminate between the two dogs. Furthermore, the addition 
of various quantities of water also results in a different spatial discrimination of the 

















assumes diagonal co-variances with orientation parallel to the coordinate axes and 
variable shape and volume for the classes. This is because Gaussian mixture modelling 
algorithm utilises different forms of eigen decomposition of the covariance matrices 
(Fraley and Raftery 2007). Based on these results, the clustering of infected and 
uninfected dogs in 2017 identified 1 class for uninfected dogs and 3 classes for infected 
dogs using two different models, while for the 2018 data the clustering identified 2 
classes for uninfected dogs and 6 classes for infected dogs both using the same model.  
Table 4.2: Outcome of the mixture model analysis showing the top three models 
for the 2017 uninfected and infected dog data. Bayesian Information Criterion (BIC) 
values are shown within brackets. The closer the BIC value is to zero, the stronger 
the evidence for the model 
 
Table 4.3: Outcome of the mixture model analysis showing the top three models 
for the 2018 uninfected and infected dog data. Bayesian Information Criterion (BIC) 
values are shown within brackets. The closer the BIC value is to zero, the stronger 
the evidence for the model. Analysis provided by Dr Luigi Sedda. 
 
 
2017 Classes Model 1 Model 2 Model 3 
Uninfected EEE 1 class (-90584) EEV 1 class (-90584) EVE 1 class (-90584) 
Infected VVI 3 classes (-25125) VEI 4 classes (-25169) VEI 3 classes (-25180) 
 
2018 Classes Model 1 Model 2 Model 3 
Uninfected EEE 2 classes (-93455) EEE 3 classes (-93621) EEE 4 classes (-
93884) 




4.3.3 Analysis of uninfected vs infected dogs in 2017 and 2018  
4.3.3.1 R Statistics Supervised Classification (discriminant analysis). 
Once the optimal model and number of classes were decided the training 
errors, training sensitivity and training specificity were calculated for both the 2017 
and 2018 cohort. A discriminant analysis was applied to find the separation plane or 
planes between the classes. Results presented here show that in both years infected 
dog odours were significantly different from the uninfected dog odours using the VOC 
analyser. In the 2017 data (Table 4.4 and 4.5), the uninfected and infected dogs were 
discriminated with 99% specificity and 90% sensitivity prior to division into subclasses. 
This was improved to 100% for both specificity and sensitivity when the data was 
divided (1 uninfected dog class and 3 infected dog classes). In 2018 with a larger cohort 
of dogs (Table 4.6 and 4.7), uninfected and infected dogs were discriminated with 89% 
specificity and 100% sensitivity prior to the data being divided into subclasses. 
Following this division (2 uninfected dog classes and 6 infected dog classes) the 
specificity was improved to 95% however, the sensitivity was reduced slightly to 97%. 
The overall training error was reduced from 2.8% to 0% when the 2017 data was 
divided into subclasses and from 7.6% to 4.2% when the 2018 data was divided in 













Table 4.4: Confusion matrix for Gaussian mixture model Eigen Decomposition 
Discriminant Analysis (EDDA) classification for uninfected and infected dogs in 
2017 without subclasses. Training error is the average error, i.e. the ratio between 
correctly predicted class members (in the table above 111+28) and the total 
number of records (143). Analysis provided by Dr Luigi Sedda. 
Table 4.5: Confusion matrix for Gaussian mixture model Eigen Decomposition 
Discriminant Analysis (EDDA) classification for 1 uninfected dog class and 3 
infected dog classes in 2017. Training error is the average error, i.e. the ratio 
between correctly predicted class members (in the table above 112+31) and the 
total number of records (143). Analysis provided by Dr Luigi Sedda. 
 Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  111 1 99  
Infected  3 28  90 
Training error 0.028   
 Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  112 0 100  
Infected  0 31  100 






Table 4.6: Confusion matrix for Gaussian mixture model Eigen Decomposition 
Discriminant Analysis (EDDA) classification for uninfected and infected dogs in 
2018 without subclasses. Training error is the average error, i.e. the ratio between 
correctly predicted class members (in the table above 280+132) and the total 
number of records (446).  Analysis provided by Dr Luigi Sedda. 
Table 4.7: Confusion matrix for Gaussian mixture model Eigen Decomposition 
Discriminant Analysis (EDDA) classification for 2 uninfected dog classes and 6 
infected dog classes in 2018.  Training error is the average error, i.e. the ratio 
between correctly predicted class members (in the table above 298+129) and the 
total number of records (446). Analysis provided by Dr Luigi Sedda. 
 
Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  298 16 95  
Infected  3 129  97 
Training error 0.042   
 
Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  280 34 89  
Infected  0 132  100 
Training error 0.076                                      
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4.3.3.2 Cross-validation (CV) and confounder cross validation (CCV) 
Cross-validation (CV) and confounder cross validation (CCV) were performed 
for both the 2017 and 2018 data using R-cran statistical software to validate the 
chosen model. The number of changed labels that were correctly predicted (i.e. false 
uninfected predicted as real infected and false infected predicted as real uninfected) 
was determined either without sub-class division or following division into subclasses.  
Prior to division into sub-classes, CV analysis on 10% of the data (leaving the 
remaining 90% for training) to assess the risk of overfitting, showed a reduced 
sensitivity of 50% and specificity of 84% for the 2017 data and a sensitivity of 48% and 
specificity of 96% for the 2018 data (Table 4.8 and Table 4.9 first line; first two 
columns). CCV analysis showed a significantly reduced sensitivity of 11% and specificity 
of 60% for the 2017 data and a sensitivity of 18% and specificity of 67% for the 2018 
data (Table 4.8 and Table 4.9 first line; last two columns). Both analyses demonstrate 
a reduced ability to correctly identify true uninfected and infected dogs compared to 
the training set (as reported in Table 4.4, 4.5, 4.6 and 4.7).  
When the analyses were repeated with sub-classes; either 4 classes for 2017 
(1 uninfected dog class and 3 infected dog classes) or 8 classes for 2018 (2 uninfected 
dog classes and 6 infected dog classes) both CV and CCV improved (Table 4.8 and Table 
4.9 second line). CV analysis showed a sensitivity of 75% and specificity of 80% for the 
2017 dogs, However, CCV only showed 60% sensitivity and 70% specificity for the 2017 
data set. Analysis of the 2018 dogs however showed a sensitivity of 93% and a 
specificity of 92% when performing CV analysis, and 74% sensitivity and 84% specificity 




4.3.3.3 IBM SPSS Discriminant Analysis 
Following the discriminant analysis performed in R-cran statistics, a 
discriminant analysis using the discriminant procedure in IBM SPSS was performed. 
Analysis showed that infected and uninfected dogs could be discriminated between 
with a high sensitivity and specificity. In the 2017 data, when all VOC readings were 
considered as independent, the uninfected and infected dogs were discriminated with 
99.1% specificity and 80.6% sensitivity (Table 4.10). This was improved to 100% for 
Table 4.8: Cross Validation and Confounder Cross Validation analysis of 2017 data 2 
groups vs 4 groups. Comparison of sensitivity and specificity analysis of the 2017 data 
analysed as either 2 classes (1 uninfected and 1 infected) or 4 classes (1 uninfected 
and 3 infected) as determined in Table 4.2. Analysis provided by Dr Luigi Sedda. 
Table 4.9: Cross Validation and Confounder Cross Validation analysis of 2018 data 2 
groups vs 8 groups. Comparison of sensitivity and specificity analysis of the 2018 data 
analysed as either 2 classes (1 uninfected and 1 infected) or 8 classes (2 uninfected 
and 6 infected) as determined in Table 4.3. Analysis provided by Dr Luigi Sedda. 
Model CV sensitivity CV specificity CVV sensitivity CVV specificity 
2 classes 0.50 0.84 0.11 0.60 
4 classes 0.75 0.80 0.60 0.70 
 
Model CV sensitivity CV specificity CVV sensitivity CVV specificity 
2 classes 0.48 0.96 0.18 0.67 




both specificity and sensitivity when the means of the data were analysed (Table 4.11). 
In 2018 with a larger cohort of dogs, uninfected and infected dogs were discriminated 
with 91.1% specificity and 50% sensitivity prior to the means being analysed (Table 
4.12). Following which both specificity and sensitivity was improved to 91.4% and 
56.8% respectfully (Table 4.13). The classification results; actual class by predicted 
class, for each analysis are shown in the tables below.  
A Wilks’ Lambda value was determined to demonstrate how well the 
prediction model fit for each individual analysis, with a P value of less than 0.05 
indicating a significant difference. For the 2017 data a P value of 0.043 was determined 
for both the independent analysis and the analysis of the means. For the 2018 data a 
P value of 0.000002 was determined when the data was analysed independently and 










Table 4.10. Discriminant analysis for uninfected and infected dogs in 2017 
(n=143). Summary of number and percent of subjects classified correctly and 
incorrectly. Here, the Lambda of 0.415 has a significant value (P. = 0.043) indicating 
a significant difference. 
 
Table 4.11. Discriminant analysis for the means of uninfected and infected dogs 
in 2017 (n=55). Summary of number and percent of subjects classified correctly and 
incorrectly. Here, the Lambda of 0.113 has a significant value (P. = 0.043) indicating 





Uninfected Infected Specificity (%) Sensitivity (%) 
Uninfected 111 1 99.1  
Infected 6 25  80.6 




Uninfected Infected Specificity (%) Sensitivity (%) 
Uninfected 44 0 100  
Infected 0 11  100 









Uninfected Infected Specificity (%) Sensitivity (%) 
Uninfected 286 28 91.1  
Infected 66 66  50.0 
Wilks’ Lambda (Sig.) 0.727 (0.000002) 
Table 4.12. Discriminant analysis for uninfected and infected dogs in 2018 (n=446). 
Summary of number and percent of subjects classified correctly and incorrectly. 
Here, the Lambda of 0.727 has a significant value (P. = 0.000) indicating a significant 
difference. 
 
Table 4.13. Discriminant analysis for the means of uninfected and infected dogs in 
2018 (n=149). Summary of number and percent of subjects classified correctly and 
incorrectly. Here, the Lambda of 0.681 has a significant value (P. = 0.010) indicating 





Uninfected Infected Specificity (%) Sensitivity (%) 
Uninfected 96 9 91.4  
Infected 19 25  56.8 
Wilks’ Lambda (Sig.) 0.681 (0.0107) 
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4.3.3.4 Selecting important variables  
To compare the importance of each variable in determining the number of sub-
classes in both infected and uninfected dogs for 2017 and 2018, a clustering with 
permuted variable values was performed. In order to perform this analysis, the tested 
variable values were permuted, while the rest of the variables were kept unchanged 
and the clustering was performed. The optimal number of sub-classes was then 
analysed to determine whether they are larger or smaller than the optimal number 
obtained from the un-permuted variables. The permutation was repeated 999 times 
and the P-value produced represented the number of times that the optimal number 
of sub-classes obtained following permutation is larger or smaller than the observed 
one. A P value was then obtained by dividing this number by 1000. A larger P-value 
demonstrates a more important variable. The importance of each variable obtained 
from the VOC analyser in the clustering is shown in Table 4.14. 
4.3.3.5 Uninfected 2017 vs uninfected 2018 
Table 4.14: Relative Importance of the first 5 different sensor variables in the 
contribution to the clustering by R-cran, observed in the 2017 data; A and 2018 
data; B. 0.99 P-value means that in 99% of the permutation the number of optimal 
clusters changed, indicating a strong influence of the variable in the final clustering. 
Analysis provided by Dr Luigi Sedda. 
A  B  
Variable P Value Variable P Value 
F3.Abs.5 0.93 F3.Abs.17 0.99 
F1.Div.20 0.92 F4.Des.21 0.98 
F4.Des.8 0.07 F4.Des.9 0.95 
F1.Div.5 0.06 F4.Des.4 0.94 




A discriminant analysis within R-cran demonstrated that although the 2017 and 
2018 uninfected dogs shared some multivariate space, both groups were not 
sufficiently mixed to be considered equal. The uninfected dogs from both years 
separated with a 79% specificity and 99% sensitivity. Therefore, the 2017 uninfected 
dogs and their corresponding sample from 2018 when they became infected could not 














Specificity (%) Sensitivity (%) 
Uninfected 2017 61 16 79  
Uninfected 2018 1 313  99 
Training error 0.043   
Table 4.15. Confusion matrix for Gaussian mixture model Eigen Decomposition 
Discriminant Analysis (EDDA) classification for uninfected dogs in 2017 and 2018. 
The uninfected dogs in both 2017 and 2018 can be discriminated with 70% 
specificity and 99% sensitivity therefore not considered equal. Training error is the 
average error, i.e. the ratio between correctly predicted class members (in the 
table above 61+313) and the total number of records (374). Analysis provided by 
Dr Luigi Sedda. 
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Parasite load had no effect on VOC analyser discrimination for the 2018 dogs 
upon identification of the dogs which were considered to have a high or low VOC 
Analyser discrimination based on their cluster probability (discriminatory factor). 
Those dogs that were considered as having a high or low VOC Analyser discrimination 
presented with a range of parasite loads as determined by previous RT-qPCR (Chapter 
3, Figure 3.11). However, although the presence or absence of clinical signs had no 
effect on a high VOC Analyser discrimination, with high discriminated dogs being both 
symptomatic and asymptomatic, those dogs which presented with a low VOC Analyser 
discrimination were all asymptomatic (Table 4.16).  
 





Parasite Load parasites 
mL-1 of blood (Chapter 3, 
Figure 3.11) 
Clinical signs (Chapter 3, 
Figure 3.11) 
Dog 176 High 50.91 Symptomatic 
Dog 141 High 13.73 Asymptomatic 
Dog 178 High 28.32 Asymptomatic 
Dog 126 High 853.44 Symptomatic 
Dog 134 High 50.53 Asymptomatic 
Dog 074 Low 115.93 Asymptomatic 
Dog 082 Low 128.00 Asymptomatic 
Dog 102 Low 6.92 Asymptomatic 
Dog 044 Low 27.89 Asymptomatic 
Dog 019 Low 61.59 Asymptomatic 
Table 4.16. Parasite load and clinical signs of high and low VOC Analyser 
discriminated dogs. Dogs which were highly discriminated presented with parasite 
loads ranging from 13.73 parasites mL-1 to 853.44 parasites mL-1. Dogs with a low 
discrimination had parasite loads ranging from 6.92 parasites mL-1, to 128 parasites 
mL-1. For the context of this analysis, symptomatic dogs were considered as those 
which presented with one or more clinical signs. 
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Buffy coat samples obtained from a cohort of naturally infected and uninfected 
dogs in 2017 (Table 4.1) were used to determine, in a preliminary experiment, whether 
the VOC analyser could discriminate between the blood of uninfected and infected 
dogs. Figure 4.5 shows the discriminant function analyses (DFA) using two different 
sensor arrays (sensor array 1 and sensor array 3), of the raw data obtained with the 
VOC analyser (XLstat version 3.4). Using sensor array 1, the VOC analyser was able to 
discriminate effectively between infected and uninfected dogs, with the infected dogs 
forming a tighter cluster than the negative dogs. Sensor array 3 however was unable 




































































Figure 4.5: DFA with multiple variables using sensor array 1 (A) and sensor array 3 
(B) of VOCs released from the buffy coat of dogs naturally infected with Le. infantum 
(Triangles) or from negative controls (Circles). Buffy coat was obtained from each 
animal 5 months prior the analysis and stored at -20oC. F1: discriminant function 1; 
F2: discriminant function 2.  The numbers in parentheses show the percentages of the 
data matrix as described by the functions and relevant components. The ellipses were 





The results presented here show that through the combination of a VOC 
analyser with clustering analysis, dogs naturally infected with Leishmania infantum can 
be identified by analysis of the odour of their hair with high sensitivity and specificity. 
Furthermore, these results also showed no correlation between parasite load, clinical 
signs and VOC Analyser discrimination of the dogs (high medium or low discrimination) 
This outcome was observed in two data sets; samples collected in 2017 and 2018, 
using two different statistical analysis programs (R-cran statistical software and IBM 
SPSS). When the sensitivity and specificity of the data was determined following the 
calculation of means or division into subclasses, using two different statistical 
approaches, a very high specificity and sensitivity was calculated for the 2017 data; 
100% for all analyses. However, the 2018 larger cohort of dogs demonstrated a variety 
of results. Following the division into subclasses and analysis using R-cran, a specificity 
of 95% and sensitivity of 97% was observed. However, using the calculated means and 
analysis with SPSS, the observed specificity and sensitivity were reduced to 91.4% and 
56.8% respectfully demonstrating variability in the results. This variability could be 
mainly due to the type of statistical approach used.  
Despite the relatively low sensitivity demonstrated when performing SPSS 
analysis on the data, the high sensitivity and specificity observed using R-cran statistics 
illustrates the potential of the VOC Analyser to accurately identify those dogs that are 
infected with Le. infantum in Brazil. This novel approach could significantly improve 
cVL diagnosis in Brazil as well as contributing to further research investigating the use 
of this technology for the effective diagnosis of human VL and other parasitic diseases. 
However further improvements still need to be made to the VOC analyser sensor 
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sensitivity, as well as the technologies potential as a point of care diagnostic approach 
which would include an improvement of the sampling methodology. 
 
4.4.1 Optimisation of VOC analyser technology 
Due to the VOC analyser being an innovative technique, with no prior use in 
the diagnosis of leishmaniasis, optimisation experiments were performed in order to 
design appropriate methodology to sample the head space of the dog hair. These 
volatiles were then passed over the sensor head. When 10l of water was added to 
each sample, a high discrimination was observed as shown in Figure 4.4. However, 
when analysing the sample either dry or with 100l of water, the VOC analyser was 
unable to effectively discriminate between the two different breeds of dog.  
Research has shown that water, particularly when in a gaseous form, is not only 
able to trap volatiles (Laaks et al., 2010), but also break down yeast and bacteria 
excreta (Rose et al., 2015). The micro-excreta of bacteria and yeast are present on the 
skin of dogs as well as in dog hair, along with any volatiles that are excreted in 
sebaceous glands. Therefore, the evaporation of water from dog hair is required to 
release these volatiles. Additionally, a pilot study by Young et al., (2002), 
demonstrated that the addition of water to dog hair, followed by incubation, can cause 
a substantial change in the observed VOCs. Certain volatile groups showed an increase 
in concentration following the addition of water including, phenylaldehyde, 
benzaldehyde acetaldehyde, 2methyl butanal and phenol. The importance of the 
addition of water to each sample was confirmed in optimisation experiments above, 
because when the dog hair samples were analysed dry, the analysis was unable to 
discriminate between the two species of dogs. However, results presented here also 
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demonstrated that the addition of too much water; 100l, causes a lack of 
discrimination between the two dog species, as released VOCs are being overpowered 
by the volatile signature of water. Although the addition of 10L caused adequate 
separation, the optimisation experiments only considered three quantities of water. 
Therefore, further optimisation is required in order to identify the optimal quantity of 
water needed to generate the greatest VOC Analyser response. In addition, high water 
content in samples has been found in previous studies to have a significant effect on 
VOC Analyser response as many of the sensors found on the sensor array respond 
strongly to water and therefore prevent any differences in the samples from being 
observed (Mottram and Elmore et al., 2003). This could in turn have implications for 
the use of the VOC Analyser in the field as any water present on the dog hair could 
alter the results. This therefore would need to be controlled through further 
optimisation of the VOC Analyser device or the future development of sensors that are 
not as sensitive to water.  
 
4.4.2 VOC Analyser diagnosis of dogs 
4.4.2.1 Infected vs Uninfected 2017 and 2018 
Although the current recommended protocol used for cVL diagnosis is widely 
adopted throughout Brazil, an observed lack of sensitivity combined with recent 
research which has demonstrated that the current protocol is not entirely reliable, is 
of concern (Belo et al., 2017). It is widely recognised that the current protocol shows 
the same lack of sensitivity and specificity as the protocol which it replaced (Laurenti 
et al., 2014). Furthermore, the accuracy of the DPP test has been evaluated 
independently several times, with the most recent evaluation carried out by 
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Figueiredo et al., (2018) demonstrating a sensitivity of 75% and specificity of 73% when 
diagnosing asymptomatic dogs. Although the sensitivity increases to 94% when 
diagnosing symptomatic dogs, the specificity is even lower at 56%. The inaccuracy of 
the current diagnostics can be demonstrated further with evidence suggesting that 
the current protocols surrounding the culling of infected dogs need reviewing as this 
control strategy is deemed as failing (Ribeiro et al., 2018). This current ineffectiveness 
therefore confirms the need for the development of a new in-field, non-invasive rapid 
diagnostic technique in order to improve VL control strategies in Brazil (Fraga et al., 
2016). 
Results presented here demonstrate the VOC analyser as having a higher 
sensitivity and specificity than the current DPP in-field diagnostic test. Following a 
discriminant analysis performed using R statistical software, the analysed 2017 dog 
samples (n= 55) showed a 100% sensitivity and specificity. The VOC Analyser analysis 
of the 2018 dog samples (n = 149) also determined a 95% specificity and 97% 
sensitivity when discriminating between infected and uninfected dogs. In addition, 
further cross validation analysis of the statistical model also confirmed the accuracy of 
the VOC Analyser. CV analysis demonstrated that the model was able to discriminate 
between the infected and uninfected dogs of the validation set with 75% sensitivity 
and 80% specificity for the 2017 dogs and 93% sensitivity and 92% specificity for the 
2018 dogs. These results not only provide validation of this model as an appropriate 
statistical analysis for the VOC Analyser, but also confirm the use of this device as an 
effective cVL diagnostic technique. 
For a more robust analysis, the discriminant analysis was repeated using IBM 
SPSS. When performing the analysis using the mean variable values for each dog, a 
140 
 
100% sensitivity and specificity was determined for the 2017 data set when using the 
VOC Analyser. However, in 2018 this analysis showed a decreased 91.4% specificity 
and 56.8% sensitivity when discriminating between infected and uninfected dogs. This 
variation in results could be attributed to clustering not being used when the 
discriminant analysis was performed using IBM SPSS. Furthermore, as the SPSS 
analysis is a classical statistical approach, whereas the R-cran analysis is a Bayesian 
statistical approach, the algorithms used for both programmes differ which could 
influence the results produced. 
Although independent VOC Analyser analysis of the 2017 and 2018 dogs 
demonstrated high specificities and sensitivities, a longitudinal study comparing dogs 
that were uninfected in 2017 but became infected in 2018 was unable to be 
performed. This is due to the observation that negative dogs from 2017 could be 
separated from negative dogs from 2018 with 79% specificity and 99% sensitivity. 
Therefore, the 2017 and 2018 sets of hair samples are considered as two independent 
data sets. This statistical difference observed between the uninfected dogs in 2017 
and 2018 could be due to several factors. These include type and age of the VOC 
analyser used with there being a slight variation between the sensor heads used in 
2017 and 2018, as well as the time of sample storage in 4oC. It could be suggested that 
the storage of hair over a long period of time could potentially lead to a change in the 
relative abundance of bacteria on the hair samples (Lauber et al., 2010), as well as 
having an effect on hormone concentrations, such as hair cortisol, with hair stored for 
longer having a lower concentration (Abell et al., 2016). The production of different 
bacteria and hormone concentrations during storage could untimely have a significant 
effect on VOC Analyser sensor response, due to different chemicals being found in the 
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headspace. In fact, research has already identified that VOC Analysers have an ability 
to detect, with a high sensitivity, different bacterial colonies and hormones produced 
(Garcia-Cortes et al., 2009). The length of storage of hair therefore could influence the 
volatiles produced. In order to complete a follow up study, samples would need to be 
analysed at the same time after sample collection using the same sensor array and 
VOC Analyser to produce reliable results. 
Although the use of the VOC Analyser as a diagnostic tool offers many 
advantages over the current in-field DPP (cVL) test, further research needs to be 
undertaken to confirm the practical application and diagnostic capabilities of the 
device. First, the effect of other canine infections on the VOC analyser response was 
not determined. Research has shown that the skin dog mite Demodex canis, which 
affects many dogs with weakened immune systems in Brazil, produces similar clinical 
manifestations as cVL. This ectoparasite lives in the sebaceous glands and hair follicles 
of dogs and therefore could potentially have a significant effect on the volatiles being 
produced (Tsai et al., 2011). Second, the ability of the VOC Analyser to detect and 
distinguish between different Leishmania species needs to be determined. All dogs 
used for this analysis were infected with Le. infantum, which is considered as the main 
causative agent of cVL in Brazil. However, recent studies in Governador Valadares 
found Lutzomyia longipalpis sandflies infected with multiple circulating Leishmania 
parasites including Le. (Viannia) spp. and Le. amazonensis (Cardoso et al., 2019). 
Research has also identified dogs infected with Le. amazonensis in this region (Valdiva 
et al., 2016). 
4.4.2.2 Buffy Coat Analysis 
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Preliminary results presented here demonstrate that the blood of Leishmania 
infantum infected and uninfected dogs can be discriminated between using the VOC 
Analyser and sensor array 1. Furthermore, infected dogs formed a visibly tighter 
cluster than uninfected dogs suggesting a similar VOC signature being produced 
following Leishmania infection. These results therefore suggest the potential to use 
blood instead of hair for VOC Analyser analysis of Leishmania infected and uninfected 
dogs. However, when performing the analysis using sensor array 3, no such 
discrimination was observed. This is interesting as it confirms the importance of 
selecting the optimal chemical composition of each sensor when designing a sensor 
array for the specific diagnosis of cVL using a VOC Analyser. 
The identification of blood metabolites as a potential diagnostic technique has 
been demonstrated throughout research. For example, previous studies have 
identified octane and 1-octen-3-ol as potential biomarkers of liver cancer following the 
analysis of VOCs in the blood of patients (Xue et al., 2008). Furthermore, research has 
also identified plasma biomarkers which can be used for the discrimination between 
individuals with tuberculosis and those who are healthy (La Manna et al., 2018). 
Regarding parasitological research, a cohort of malaria research has focused on the 
identification and analysis of malaria blood biomarkers. Studies have demonstrated 
that blood biomarker identification may facilitate the identification of malaria species, 
estimation of the parasite load, and determination of the intensity of immune 
response (Krampa et al., 2017). In addition, a variety of different Leishmania blood 
biomarkers have also been identified (Maia and Campino, 2018). It has been 
demonstrated that the Leishmania parasite itself produces a variety of different 
metabolites which have previously been found in infected blood (Atan et al., 2018). In 
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addition, the immune response produced during Leishmania infection leads to the 
production of different metabolites through changes in the metabolic pathways 
(Akpunarlieva et al., 2017) with lipids, threonine, alanine and lactate found to be the 
most prominent Leishmania metabolites found in infected blood (Tafazzoli et al., 
2010). Additionally, research has shown that blood metabolites differ substantially 
between cellular extracts of different Leishmania species (Westrop et al., 2015). This 
therefore suggests that not only can the VOC Analyser differentiate between the blood 
of infected and uninfected dogs but could also be used to identify the specific 
Leishmania species present within the blood itself. 
 
4.4.2.3 Effect of parasite load on VOC Analyser diagnosis  
The results presented suggested that VOC analyser response was not related 
to the parasite load in the dog peripheral blood. This can be demonstrated as most 
infected animals, regardless of parasite load (determined in Chapter 3, Figure 3.11), 
were identified as infected, with a high sensitivity and specificity being produced, 
particularly following clustering and R statistical analysis. Those dogs that were 
considered as having a high VOC Analyser discrimination presented with a wide range 
of parasite loads (13.73 parasites/mL to 853.44 parasites/mL), as did those dogs which 
were considered to have a low discrimination (6.92 parasites/mL, to 128 parasites/mL) 
(Table 4.16). The results presented here also suggest that there is no correlation 
between clinical signs and VOC Analyser discrimination, with highly discriminated dogs 
being both symptomatic and asymptomatic. This observation suggests that the VOC 
Analyser could facilitate the early diagnosis of asymptomatic dogs with a high 
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sensitivity, a quality currently lacking with the DPP (cVL) diagnostic (Figueiredo et al., 
2018). 
Despite these observations, previous parasitological research has 
demonstrated that an increase in malaria volatile biomarkers is directly correlated 
with parasite load during infection (Berna et al., 2015). In addition, research regarding 
the use of volatiles to discriminate between Leishmania infected and uninfected dogs 
also challenge the response of the VOC Analyser. Previous research using gas 
chromatography mass spectrometry (GC/MS) to analyse the volatile profiles of dogs, 
has suggested that the odour profiles of symptomatic dogs which therefore present 
with a higher parasite load, differ to asymptomatic dogs (Magalhães-Junior et al., 
2014b). GC/MS is a technique 10,000 times more sensitive than a VOC Analyser. This 
difference in sensitivity could explain the observed variation in results as a higher 
sensitivity will detect a broader range of VOCs. However, as their study only analysed 
36 dogs, 24 of which were positive for CVL, a far smaller sample size then was analysed 
here (n = 55 for 2017; n = 149 for 2018) the validity of their study could be undermined.  
Despite a large amount of research which has identified an observed difference 
in the volatiles produced during parasitic infections, the origin of these volatiles is still 
debated. Regarding Leishmania, the demonstrated correlation between parasite load 
and odour profile of infected dogs, suggests that the volatiles produced during 
infection may be related to the immune response (Magalhães-Junior et al., 2014b). 
This is due to research which has not only demonstrated that an immune response 
produces a variety of VOC that are released externally by an infected individual 
(Shirasu and Touhara et al., 2011), but also studies demonstrating that a high parasite 
load is directly correlated with immune response to Leishmania (Verma et al., 2010). 
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The results presented here however suggest an alternative origin for these volatiles as 
there was no correlation observed between parasite load and VOC Analyser response. 
Interestingly, recent research has identified a distinct transmissible dysbiotic skin 
microbiota that is induced by cutaneous leishmaniasis infection (Gimblet et al., 2017). 
This report also suggested that there is no correlation between parasite load and skin 
microbiota. It could therefore be suggested that the difference in volatile profiles 
observed between Leishmania infected and uninfected dogs could be related to 
changes in the skin microbiome. However, due to the variety of contradictory studies 
available, further research needs to be undertaken in order to confirm the origins of 
the volatiles produced during cVL infection. 
Despite the lack of correlation shown between VOC Analyser response and 
parasite load, determining the Analysers limit of detection will be important in the 
future to validate this device as an early diagnostic technique. The results presented 
here suggest that the change in odour profile occurred soon after infection. This is 
because infected dogs with very low parasite loads could be differentiated from 
uninfected dogs. However, the exact quantity of parasites required to generate a VOC 
Analyser response is unknown. Furthermore, the use of blood parasite load as an 
indicator for the stage of cVL infection is disputed. This is due to research which has 
suggested that there is no correlation between the levels of circulating parasites and 
disease severity (Borja et al., 2016). Therefore, in order to determine the VOC 
Analysers limit of detection collecting skin samples over blood may be suggested for 
future research. This is due to increasing evidence which has highlighted the 
importance of parasites found in the skin regarding the distribution of parasite load 
and disease severity (Doehl et al., 2017). Aditionally, changes in skin odour profiles 
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have been shown to occur soon after infection in other disease states such as malaria, 
where changes in the odour profiles of skin volatiles were affected 6 to 8 days after 
infection (de Boer et al., 2017).   
 
4.4.3 Summary 
The application of VOC Analyser technology could potentially be an important 
step towards the non-invasive diagnosis of cVL through disease volatile biomarkers. 
The results presented here suggest the potential for a modified VOC Analyser as a 
rapid, accurate and non-invasive diagnostic tool for the diagnosis of cVL. As only a 
small proportion of the sensor variables; 2 out of 88 in 2017 and 5 out of 88 in 2018 
(Table 14) had a significant effect on the discrimination between infected and 
uninfected dogs, it can be suggested that the sensitivity and specificity of the device 
could be further enhanced. This could be achieved through modifications to the sensor 
head, with the addition of more Leishmania specific sensors. Additionally, improving 
the methods used for hair collection in the field and the odour analysis could provide 
the opportunity for a longitudinal study which could also enhance the sensitivity and 
specificity of a future device. Further developments in the portability and simplicity of 
the VOC Analyser would also improve the reliability and convenience of the device in 
a field-based setting.  
The use of the VOC Analyser as part of the current Ministry of Health protocol 
for cVL diagnosis in Brazil; either in addition to the DPP cVL or as a replacement, could 
potentially remove the need for the ELISA confirmatory test that is relatively expensive 
and time consuming. Due to the rapid, accurate and non-invasive nature of the VOC 
Analyser which identifies cVL by using a different set of disease markers, a future 
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device could prove highly effective in the ongoing control of Leishmania transmission. 
Furthermore, the results presented here demonstrate the ability of the VOC Analyser 
to diagnose not only asymptomatic dogs, but also dogs with low levels of infection, 
which would be an additional benefit to current cVL control programs. However, 
further work is required to compare the sensitivity and specificity of a VOC Analyser 
combined with DPP cVL diagnosis protocol against the current Ministry of Health 
protocol.  
There is a need for the current VOC Analyser technology to be adapted into a 
simpler and more portable device which would provide accurate and rapid diagnostic 
tests. This is due to growing demand for improved healthcare techniques that are non-
invasive and would speed up POC diagnosis, allowing for faster treatment for diseases 
as well as an improved prognosis and a reduction in healthcare costs (Wilson, 2018). 
Continued research into POC diagnostics, as demonstrated here, will help to bring VOC 
Analyser technology into routine clinical practice. The development of a VOC Analyser 
POC diagnostic tool for cVL that is based on host odour opens up the opportunity to 
diagnose not only Leishmania in dogs, but also potentially Leishmania infections in 









Parasite manipulation of vertebrate hosts is a common occurrence that is likely to 
have significant consequences for disease epidemiology and ecology (Lafferty and 
Shaw, 2013) In the case of vector-borne pathogens which move between hosts, such 
a manipulation includes both the vector and the animal host. Such a manipulation has 
been demonstrated in research which has shown that vector-borne parasites may 
enhance their own transmission by directly effecting vector behaviour (Rogers and 
Bates, 2007). In addition, successful transmission also requires extensive contact 
between the host and insect vector, usually during blood feeding. Due to the intricate 
lifestyle of many vector borne diseases which require vertebrate hosts for successful 
parasite transmission and development, establishing vector attraction to hosts is vital 
for disease ecology.  
Research has demonstrated that blood sucking insects, show an increased 
attraction to some hosts more than others (Heil, 2016). However, the explanation for 
this difference in attractiveness is yet to be established. It has been suggested that 
certain individual hosts are naturally more attractive to insect vectors, with sandflies 
and mosquitoes having shown a higher degree of attraction to certain individuals, 
regardless of their infection status (Fernández-Grandon et al., 2015; Tavares et al., 
2018). However, epidemiological models have shown that vector preference for 
infected hosts could boost disease transmission during the early stages of disease 
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epidemics. This suggests that vector attraction to infected hosts may be a result of 
parasite manipulation (Hosack et al., 2008). Recent research has established parasite 
alteration of certain traits of their primary vertebrate hosts. It has been suggested that 
transmission mechanisms are an important factor that influence such vector‐borne 
pathogen manipulations. Such manipulations which influence vector dispersal and 
attraction, as well as increase the likelihood of parasite acquisition by vectors during 
vector-host interactions has been demonstrated (Hafer, 2016). Previous research has 
demonstrated that malaria-infected individuals are more attractive to the mosquito 
vector (Robinson et al., 2018). This suggests that a vector’s choice to feed on infected 
or uninfected hosts could have an effect on the epidemiology of vector‐borne diseases 
(Gandon et al., 2017). It is thought that vector attractiveness is odour-mediated, with 
studies not only demonstrating that parasite infected individuals produce a different 
odour profile to those who are healthy (Magalhães-Junior et al., 2014b), but also 
showing an increased vector attraction to infected odour profiles (De Moraes et al., 
2014; Robinson et al., 2018). Therefore, behavioural bioassays can be utilised to 
establish vector attraction to specific volatiles and odour profiles. For this reason, such 
bioassays can be employed in order to determine the role that Leishmania infection 
plays on sandfly vector attraction. By establishing the attractiveness of Leishmania 
infected dogs to sandfly vectors, a further understanding of parasite transmission due 
to an increase in sandfly biting could be established. Furthermore, an increase in 
overall attraction to infected hosts could be predicted to optimise transmission. 
The identification of Leishmania induced changes to host odours which influence 
vector behaviour could have further potential applied implications (De Oliveira et al, 
2008; Magalhães-Junior et al, 2014b). In addition to establishing a greater 
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understanding of parasite transmission in Leishmania endemic areas, laboratory-
based bioassays could also be used to determine the potential of infected dog odour 
as a sandfly lure, facilitating the development of potential vector control 
methodologies. The use of vector control to reduce the transmission of disease is 
considered an effective method (Golding et al., 2015). Many of the vector control 
strategies currently in place involve the use of interior residual spraying as well as 
insecticide-treated nets. However, as shown throughout mosquito research, the 
development of vector insecticide resistance is an emerging issue (Chaiphongpachara 
et al., 2018). Therefore, the use of traps to capture and subsequently reduce the 
number of adult sandflies is becoming increasingly more popular. Research has 
proposed the used of synthetic attractants as baits in sandfly traps in order to improve 
specificity (Andrade et al., 2008; Magalhães-Junior et al., 2014). This has stimulated 
the search for specific volatile compounds that are known to attract Lutzomyia (Lu.) 
longipalpis. The identification of these volatiles or odour profiles would allow for the 
modification of light traps by either using the volatiles directly as attractants or 
associating the compound with light. Identifying the attraction of Lu. longipalpis to 
natural odour of dogs infected with Le. infantum could prove vital in the identification 
of new volatiles for sandfly control, and the development of effective odour baited 
traps. 
 
5.1.1 Sandfly olfaction 
In order to identify a specific host or mate, insects must be able to not only 
recognise a specific blend of odour, but also discriminated this odour from a complex 
and continuously changing background. Therefore, they have evolved a highly efficient 
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and sensitive olfactory system in order to detect behaviourally relevant compounds 
and properly decode olfactory messages to lead to appropriate adapted behaviours 
(Martin et al., 2011). Insect vectors of disease rely heavily on their olfactory system to 
locate hosts which is essential for blood feeding and, in turn, parasite transmission. As 
vector control has previously been demonstrated as an efficient way of reducing 
canine leishmaniasis (Courtenay et al., 2019), understanding the sensory biology of 
sandflies and their attractiveness to host odour is becoming increasingly more 
important.  
Various selection pressures have led to a remarkable diversity in the 
morphology of different insect peripheral olfactory systems. This therefore means that 
sandflies can detect specific volatile chemicals. Many of the volatiles which can be 
detected by sandfly olfactory sensory neurons have already been identified. These 
include aggregation, sex and alarm pheromones and compounds associated with egg-
deposition behaviour (Guidobaldi et al., 2014). Previous research has also identified 
many specific volatiles that female Lu. longipalpis use to locate suitable hosts. These 
include ketones such as 4-methyl-2-pentanone, carboxylic acids such as 2-methyl 
propanoic acid and aldehydes such as benzaldehyde (Dougherty et al., 1999). As with 
other insects, sandflies respond weakly to relevant single odour compounds however 
natural mixtures induce a strong response.  
The evolution of the sandfly olfactory system, which has evolved to be highly 
specific for certain volatiles, could prove important for further research. As parasite 
manipulation of host odour has been shown previously, understanding the interaction 
between the sandfly olfactory system and the volatiles released by a Leishmania 




5.1.2 Sandfly attraction to host odour 
The survival of vector-borne parasites is highly dependent on its ability to pass 
from one host to another via an insect vector. Parasites that are predominantly found 
in the circulatory system or superficially in the skin, have been shown to influence 
vector transmission from one host to another through the manipulation of both the 
vector and the host animal. Such a manipulation has been demonstrated through 
parasitic manipulation of the odour of the host animal (Hughes and Libersat, 2019). 
This phenomenon has been demonstrated for both malarial infections (De Moraes et 
al., 2014) and leishmaniasis (Tavares et al., 2018). Understanding the influence that 
parasitic infections have on infected individuals would lead to a greater understanding 
of parasite transmission and ecology. 
Developing an in depth understanding of the chemical and ecological 
relationship between sandflies and host organisms is vital in gaining knowledge on the 
vectors biology and could prove important in the development of improved strategies 
related to leishmaniasis control. Research regarding parasite/vector interactions have 
identified and investigated compounds which demonstrate an increased 
attractiveness to vectors of neglected tropical disease, such as Anopheles gambiae 
(malaria), Aedes aegypti (yellow fever, dengue fever, chikungunya, Zika virus) and 
phlebotomine sandflies (leishmaniasis) (Geier et al., 2002; Logan et al., 2008; Verhulst 
et al., 2010; Tavares et al., 2018). Research has demonstrated the importance of 
odours in the host-seeking behaviour of sandflies with an increased attraction to 
odours produced by animal baits having been observed in the field (Bongiorno et al., 
2003). In Brazil, canines play a vital role in the Leishmania transmission cycle, being 
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considered the primary source of infection for the Lu. longipalpis sand-fly; the vector 
of visceral leishmaniasis, in both the domiciliary and pre domiciliary environment 
(Travi et al., 2018). 
Previous research has observed that vector-borne pathogens can manipulate 
host odours in order to influence vector attraction and transmission, with infected 
individuals demonstrating an increased attractiveness. As the insect’s main orientation 
mechanism is based primarily on the recognition of different odours, this increase 
attractiveness is more than likely to be related to different odours that are exhaled by 
infected animals. This enhanced attraction is extensively shown throughout literature, 
particularly regarding malaria infection. Research has shown that humans infected 
with malaria have altered blood components and skin volatiles when carrying the 
infective parasitic stage these changes have been shown to alter mosquito behaviour, 
causing an increase in attraction to infected human hosts (Lacroix et al., 2005). Due to 
the longitudinal nature of the study, it could be suggested that host odour is directly 
altered by the parasite, with the observed modification of mosquito behaviour being 
the ultimate effect. This manipulation of host odour causes an increase in parasite 
transmission to the vector with more mosquitoes feeding on infected hosts and 
therefore an increase in the transmission of the parasite (Emami et al., 2017). This 
enhanced attraction has also been demonstrated with mice infected with Plasmodium 
chabaudii; a rodent malaria parasite, having an enhanced attraction of mosquitoes (De 
Moraes et al., 2014). This enhanced attraction was facilitated not only by an overall 
elevation of volatiles emitted by infected mice, but also due to specific changes in the 
quantities of individual compounds. Furthermore, a clear difference in the odour 
profiles of infected and uninfected mice was persistent throughout the duration of the 
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infection (De Moraes et al., 2014). An enhanced mosquito attraction to infected 
humans has also been demonstrated, with individuals infected by malaria parasites in 
its gametocyte stage attracting roughly twice as many mosquitoes when compared to 
both uninfected individuals and individuals infected with the asexual stage of the 
malaria parasite (Lacroix et al., 2005).  
More relevant Leishmania research has also observed differences between the 
odour profiles of Leishmania infected and uninfected individuals causing an enhanced 
attraction. Earlier research has demonstrated an increase in the attractiveness of Lu. 
Longipalpis to exhaled compounds from foxes (Vulpes vulpes) (Dougherty et al., 1999), 
as well as alcohols that are found in plants (Magalhães-Junior et al., 2014). In addition, 
a recent study demonstrated, that hamsters infected with Le. infantum emit an odour 
that enhances the attraction the sandfly vector Lu. Longipalpis. Six out of 13 hamsters 
used in this study became significantly more attractive following infection. (Nevatte et 
al., 2017). In nature however, due to differences in habitats, potential hosts are not 
equally exposed to sandfly vectors; hosts which live in a closer proximity to vector 
breeding sites are more likely to be exposed. Furthermore, host characteristics such 
as age, size, sex, health status and blood type may also influence host attractiveness 
to sandfly vectors. Interestingly, the location of the parasite in the skin of an infected 
host has also been shown to effect host infectiousness. Sandflies have demonstrated 
a preference to feed on patches of skin which contain larger numbers of parasites 
thereby increasing their infection load and potential outward transmission (Doehl et 
al., 2017). This not only highlights the skin as important in the attraction of sandflies 
and subsequent disease transmission, but also suggests a parasite manipulation of the 
volatiles excreted in the skin in skin parasite patches. 
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This attraction phenomenon has also been reported in research investigating 
the attractiveness of human skin odours that are predominantly produced by skin 
microbiota, to sand-flies. These bacteria have been proven to have an effect on the 
attraction of insects, therefore affecting an individual’s risk of infection (Smallegange 
et al., 2011). A recent study identified a transmissible dysbiotic skin microbiota 
induced by cutaneous leishmaniasis that promotes a skin inflammatory response 
(Gimblet et al., 2017). Interestingly, skin appendages such as hair also provide an ideal 
specific environment which aids in microbiota growth (Kong and Segre, 2012) which 
could prove an important insight into insect attraction to host odour. As previously 
reported, hair analysis has provided a means of odour profile determination in dogs 
with cVL using metabolomics techniques and has been considered as a potential tool 
in the detection of Le. infantum markers, which could prove invaluable in the 
development of diagnostic techniques (Oliveira et al., 2008; Magalhães-Junior et al., 
2014b). It could therefore be suggested that the reported distinction between dogs 
infected with Leishmania and those that are uninfected could be linked to a change in 
skin microbiota. 
 
5.1.3 Behavioural Bioassay 
Experiments which demonstrate the behavioural activity of specific 
compounds or group of compounds are important for establishing factors which may 
influence insect behaviour. Bioassays which determine a chemical(s) effect on 
different insects allows for the identification of the type of response they elicit. Well-
designed behavioural bioassays therefore, can be highly beneficial when deducing the 
communicative function relating to a chemical and the insect tested, as well as 
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furthering our understanding of disease transmission and potential parasite 
manipulation of host odour (Smallegange and Takken, 2010). 
 
5.1.3.1 Olfactometers 
Olfaction is the major sense involved in the host-seeking and oviposition 
behaviour of insects. It is also known that these olfaction-based activities play an 
important role in the natural survival of vector borne diseases such as Leishmania 
through periodic travelling between insect vectors and hosts. 
Several different types of olfactometers have been developed in order to study 
the host-seeking behaviour of vectors such as mosquitoes and sand-flies. Briefly a 
commonly used type of insect olfactometer consists of a glass Y-tube, in which insects 
are introduced to the long stem of the Y and move up the tube being attracted by 
samples that are contained at the free ends of the arms (Figure 5.1). The principle 
behind this design of insect olfactometer is to attract insects equally towards the 
entrances of the forks by a volatile stimulus however, when an insect reached the forks 
they are influenced unequally by the odours, with each fork containing a different 
volatile stimulus (Omrani et al., 2010). 
It has been proposed that olfactometers could prove beneficial in 
understanding qualitative manipulation theories, in which insects develop a feeding 
preference for specific hosts (Lefevre et al., 2006). It has been suggested that this 
qualitative manipulation could be achieved in two ways. First, preference towards an 
infected host could be achieved by host infection inducing a sensory bias in the vector 
through the alteration of the volatiles released during infection. However, although 
research has demonstrated a change in the volatiles within Leishmania infected hosts 
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(Oliveira et al., 2008; Nevatte et al., 2017; Magalhães-Junior et al., 2014b), limit 
research is available which has confirmed whether this VOC alteration has an effected 
on sandfly attraction to naturally infected hosts. Second, it has been suggested that 
certain hosts are naturally more attractive to insect vectors and therefore more likely 
to become infected (Fernández-Grandon et al., 2015). This phenomenon, however, 
has currently not been demonstrated in sandflies and their hosts. Previous research, 
however, has demonstrated a Leishmania manipulation of sandfly host-seeking 
behaviour (Rogers and Bates, 2007). This observed increase in attraction towards a 
specific host could be achieved by parasitic manipulation of the insect sensory system, 
increasing attraction towards a specific host and host traits that are correlated with 
the optimal suitability for the parasite. There are three potential ways in which vector 
manipulation could occur; (i) infected vectors could feed on a specific host species for 
the parasite, (ii) infected vectors may feed on hosts with a weakened immune system 
or (iii) infected vectors may be more attracted to uninfected hosts that do not harbour 
any potential competitors (Lefevre et al., 2006). 
Regardless of the proposed mechanisms of parasite manipulation, be it 
manipulation of the sandfly or of the host, with the aid of olfactometers to study 
vector attraction research could be able to provide further information on the 
physiological principles behind the host-seeking behaviour of sandfly vectors, and 
further our understanding of Leishmania transmission. Olfactometers have the 
potential to quantify the behavioural responses of both infected and uninfected 
vectors to volatiles that are emitted by different hosts both infected and uninfected. 
 
5.1.3.2 Sandfly behavioural bioassays 
158 
 
Despite recent research which has identified Leishmania specific VOCs in both dogs 
(e.g. Magalhães-Junior et al., 2014b) and humans (Tavares et al., 2018), there is limited 
research which has investigated the role of these volatiles in the attraction of sandflies 
to Leishmania infected dogs, which would prove important in our understanding of 
disease transmission in Brazil. Female Lu. longipalpis, have been shown to be attracted 
to specific volatiles identified from Leishmania infected human patients, with research 
suggesting that 2-phenylacetaldehyde, 6-methylhept-5-en-2-one and icosane 
stimulate an attraction response to female sandflies (Tavares et al., 2018).  
Additionally, in vivo experiments demonstrated that the odours of hamsters infected 
with Leishmania infantum are more attractive to female Lu. longipalpis sand flies when 
compared to the odours of uninfected hamsters (O’Shea et al., 2002; Nevatte et al., 
2017).  
Bioassays have provided an ideal tool to identify important volatiles related to 
sandfly attraction. Although in excess of 400 VOCs have been identified as being 
produced from skin (Dormont et al., 2013), limited research has shown the effect of 
these volatiles on sandfly attraction to naturally infected hosts. As changes in the skin 
VOCs of infected dogs in endemic areas has been observed, understanding the role 
these changes may have on sandfly attraction would prove vital in our understanding 
of disease transmission and provide further evidence for potential sandfly attractants. 
 
5.1.4 Chapter Aims 
Research suggests that vector-borne pathogens may manipulate host odour in 
order to influence vector attraction (Robinson et al., 2018). Such effects could have 
implications in the development of olfactory lures to improve current vector control, 
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as well as further our understanding on parasite-host interactions and the mechanisms 
underpinning parasite transmission. By utilising Y-tube olfactometer behavioural 
bioassays, I aim to determine whether Le. infantum infected dogs are significantly 
more attractive to Lu. longipalpis sandflies, compared to dogs which are uninfected. 
Such an attraction could imply host odour manipulation by Leishmania, aiding its own 
transmission through increasing sandfly attraction to infected individuals. 
Additionally, the use of canine host odour in the devlopment of odour-baited traps to 






5.2.1 Sample collection and Entrainment  
Canine hair was collected in the field as described in the general methods section 
for both 2017 and 2018. Following sample collection, a minimum of 1g of hair was 
introduced into a portable entrainment system in order to collect released volatiles. 




5.2.2.1 Sandflies  
Bioassays were performed using both male and female Lu. longipalpis sand-
flies. The sandflies were originally collected in Jacobina, Brazil (40°31′ W, 11°11′S) and 
routinely fed on a membrane feeding system in order to maintain the colony. 
 
5.2.2.2 Optimisation 
In order to perform the bioassay, the ideal dilution factor needed to achieve 
optimal sandfly response was determined. Three uninfected dogs were chosen at 
random; dogs 138, 128 and 027 and compared to a hexane control standard. Initial 
experiments tested the effect of various dilution factors; 1:1, 1:4, 1:8, 1:10 and 1:15, 
on female sandfly response to dog 138. Once the optimal dilution factor was 
determined for this specific dog sample, the remaining two dog samples were 
analysed. The experiment was performed using three separate dogs using this 
determined dilution factor in order to confirm sandfly responsiveness and investigate 
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whether sandflies are attracted to dog volatiles over a hexane blank. Following 
confirmation of the optimal dilution, all further bioassay experiments were carried out 
using this dilution. A binomial test P value <0.05 was considered significant. This value 
was calculated as the proportion of female sandflies which responded to the test side, 
out of the total number of that responded. 
 
5.2.2.3 Infected vs uninfected dogs 
Initially, 9 infected dogs and 9 uninfected dogs were selected from the VOC 
Analyser results based on their discrimination following data analysis. As described 
previously, the VOC analyser discrimination was determined based on a dog’s cluster 
probability (discriminatory factor).  
Infected dogs chosen were as follows:  
High discrimination: Dogs 141, 176 and 178; medium discrimination: Dogs 105, 140 
and 003; low discrimination: Dogs 74, 82 and 102. 
Uninfected dogs chosen were as follows:  
High discrimination: Dogs 021, 037 and 093; medium discrimination: Dogs 137, 004 
and 175; low discrimination: Dogs 181, 130 and 124. 
The samples which were compared for the female sandfly bioassays are shown in 
Table 5.1. The initial bioassay comparisons are cross comparisons between infected 
and uninfected groups to allow for a more robust analysis. The P-value was calculated 




Following the initial analysis, the bioassay was then performed following a 
blinded experimental protocol. This was done in order to confirm female sandfly 
response and remove any experimental bias. 6 new pairs of dogs were chosen at 
random (n = 12 individual dogs). Infected (n = 6) and uninfected (n = 6) dogs were 
compared against each other with 2 highly discriminated pairs, 2 medium 
discriminated pairs and 2 low discriminated pairs chosen. The pairs of dogs selected 
for the blinded trail were chosen based on VOC Analyser discrimination criteria. 
Samples were randomly labelled A through to M, with the samples to be compared 
shown in Table 5.2. Individual entrained dog samples were diluted to a 1:10 dilution 
using hexane and the response of 80 female sandflies was recorded.  
1g of dog hair/2.5 hour entrainment  
(1:10 dilution) (infected dogs in bold) 
VOC Analyser discrimination of dogs 
(infected in bold) 
Dog 176 vs Dog 021 High vs High 
Dog 141 vs Dog 137 High vs Medium 
Dog 178 vs Dog 181 High vs low 
Dog 105 vs Dog 037 Medium vs High 
Dog 140 vs Dog 004 Medium vs Medium 
Dog 003 vs Dog 130 Medium vs Low 
Dog 074 vs Dog 093 Low vs High 
Dog 082 vs Dog 175 Low vs Medium 
Dog 102 vs Dog 124 Low vs Low 
Table 5.1: Samples compared during the female sandfly unblinded bioassay. Dog 
samples which were compared are shown in the left-hand column. Each individual 




Following the bioassays using female sand-flies, the experiment was repeated 
using male sand-flies. All 15 dog pairs; 9 pairs from the initial female bioassay (Table 
5.1) and 6 pairs from the blinded experimental protocol (Table 5.2) were re-
randomised. Individual bioassays were then performed initially on 9 dog pairs, 
followed by a blinded protocol using the remaining 6 dog pairs. Entrained dog samples 
were diluted to a 1:10 dilution using hexane and the response of 80 male sandflies was 
recorded. The orders in which the bioassays were performed, and the dog samples 
used for both the blinded and non-blinded experiments are shown in the Table 5.3 
and 5.4. Again, a binomial test P value <0.05 was considered significant. This value was 
calculated as the proportion of male sandflies which responded to the test side, out of 
the total number of that responded. 
1g of dog hair/2.5 hour 
entrainment (1:10 dilution) 
(infected dogs in bold) 
Dog Number (infected 
dog in bold) 
VOC Analyser 
discrimination of dogs 
(infected in bold) 
K vs H Dog 126 vs Dog 169 High vs High 
L vs C Dog 047 vs Dog 153 High vs Medium 
M vs G Dog 044 vs Dog 005 Low vs Low 
A vs F Dog 080 vs Dog 136 Medium vs Medium 
J vs D Dog 134 vs Dog 070 High vs High 
B vs E Dog 019 vs Dog 043 Low vs Low 
Table 5.2: Samples compared during the female sandfly blinded bioassay. Dog 
samples which were compared are shown in the middle column and their assigned 
letter in order in the left-hand column. Each individual bioassay was performed 





1g of dog hair/2.5 hour entrainment  
(1:10 dilution) (infected dogs in bold) 
VOC Analyser discrimination of dogs 
(infected in bold) 
Dog 176 vs Dog 021 High vs High 
Dog 080 vs Dog 136 High vs Medium 
Dog 082 vs Dog 175 High vs low 
Dog 019 vs Dog 043 Medium vs High 
Dog 074 vs Dog 093 Medium vs Medium 
Dog 105 vs Dog 037 Medium vs Low 
Dog 003 vs Dog 130 Low vs High 
Dog 140 vs Dog 004 Low vs Medium 
Dog 044 vs Dog 005 Low vs Low 
1g of dog hair/2.5 hour 
entrainment (1:10 dilution) 
(infected dogs in bold 
Dog Number (Infected 
dog in bold) 
VOC Analyser 
discrimination of dogs 
(infected in bold) 
C vs G Dog 141 vs Dog 137 High vs Medium 
E vs A Dog 178 vs Dog 181 High vs Low 
D vs L Dog 134 vs Dog 070 High vs High 
F vs I Dog 126 vs Dog 169 High vs High 
B vs J Dog 047 vs Dog 153 Medium vs Medium 
K vs H Dog 102 vs Dog 124 Low vs Low 
Table 5.3: Samples compared during the male sandfly unblinded bioassay. Dogs 
classified as high, medium or low discrimination based on VOC Analyser analysis. 
Table 5.4 Samples compared during the male sandfly blinded bioassay. Dogs 





5.2.3.1 Lutzomyia longipalpis 
80 female, virgin Lutzomyia longipalpis sand flies or 80 male Lu. longipalpis 
sandflies were collected 1-day post emergence and held for 5 to 7 days in a Barraud 
cage (18x18x18 cm) at 27oC with a 70% relative humidity within a plastic bag, without 
any excess sugar. One hour prior to the start of the experiment the sand fly cage was 
moved into the bioassay room (68.0% rH; 27.8°C), the plastic bag removed and the 
sandflies allowed to acclimatise to the room conditions. The humidity and 
temperature within the room were kept constant with bioassays performed at the 
same time of day. This is due to research demonstrating that flight activity is triggered 
by daily changes in abiotic factors such as temperature and relative humidity but also 
by changes in light intensity (Rivas et al., 2014). 
5.2.3.2 Y-tube olfactometer 
The Y-tube olfactometer was formed of three lengths of glass tubing (10mm id, 
1.27cm od). Two long arms measuring 10cm were joined at an angle of 65° with a long 
stem measuring 10 cm being centrally positioned between the two arms in the same 
plane in order to form the Y shape (Figure 5.1).  
A gentle flow of bottled, zero grade air was fed through two charcoal traps 
(flow rate 2 ml/sec) and allowed to flow down to the Y-tube via Teflon tubing (¼″ od). 
Airflow was confirmed using a bubble meter. Prior to reaching the Y-tube, the tubing 
was divided into two using a brass Swagelok T-junction. A 15cm length of Teflon tubing 
was connected to each side of the T-junction and these were pushed into a 3cm long 
section of Teflon tubing. Each of these short sections had a small hole pierced through 
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the wall, with a 2cm diameter of rolled up grade 1 filter paper inserted into it. 
Extracted sample (1l) was injected onto the piece of filter paper.  The other end of 
the short pieces of Teflon tubing were connected to a 40cm long section of Teflon 
tubing which was connected to the arms of the Y-tube with a brass reducing union 
(1.27cm to 0.64cm). Glass wool was inserted into the Swagelok connector at the end 
of each arm to prevent sandflies escaping up the Teflon tubing. All connections and 
tubing joints were sealed with PTFE ® tape. All Teflon tubing and glassware was 
thoroughly cleaned 24 hours prior to the experiment. Glassware was cleaned by 
washing with 10% Teepol solution, followed by being washed in distilled water and 
then acetone before being baked over night at 225oC. All Teflon tubing was washed 
with hexane (pesticide grade) and allowed to air dry overnight. 
In order to carry out the bioassay experiment, the Y-tube was placed horizontally 
on a solid bench. Before each replicate, an additional 1ul of extract was injected onto 
the filter paper contained in the 3cm long section of Teflon tubing. The hole was sealed 
with PTFE ® tape. To test the attraction of individual sand-flies, each fly was released 
individually at the base of the Y-tube and walked upwind towards the far end of one 
of the arms of the Y. A timer was started and the final position of the sandfly within 
the Y-tube was recorded after three minutes; either the test or control arm or, if it 
remained in the stem, a “no choice” was recorded. In order to reduce bias in the 
experimental set up, after 10 replicates, the rolled-up filter paper was removed and 
replaced, and the test and control ports were swapped round with the Y-tube also 




Figure 5.1: Basic Y-tube olfactometer design. Flies were introduced into the lower 
port and travelled upwind, making a locomotor choice at the Y split. Flies were 
recorded as having made a definitive choice when they had travelled a minimum of 
15 cm up a Y-tube arm (Image adapted from Haselton et al., 2015). 
Filter paper with 1ul of extract 
Stem air flow 2ml/sec 
Fly introduction port 
Arm air flow 1ml/sec 
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5.3     Results 
5.3.1 Optimisation 
Following the entrainment of VOCs from canine hair collected in the field (as 
described in Chapter 2), three uninfected dogs from the 2018 cohort were chosen at 
random. In order to determine the optimal dilution required to generate the greatest 
sandfly response, dilutions were performed on eluted volatiles from one of the 
uninfected dogs (dog #138). Dilutions were as follows; 1:1, 1:4, 1:8, 1:10, 1:15. The 
optimal dilution was assessed by determining at which dilution female sandflies 
showed a significant attraction to the entrained dog sample. If there was no definitive 
choice observed, a response of Undecided was reported. Table 5.5 and Figure 5.2 
show that at a dilution of 1:10, a significant number of female sandflies responded to 
the dog sample, with 60.0% of all sandflies analysed for that dilution actively choosing 
the dog odour. 
 No. of Female sand-flies  
Dog 138 1g of hair/2.5hr 
entrainment 
Dog 138 Hexane Undecided 
P-Value 
(Binomial Test) 
1:1 17 25 38 0.0579 
1:4 21 19 40 0.1194 
1:8 31 24 25 0.0691 
1:10 48 21 11 0.0005 
1:15 30 27 23 0.0973 
Table 5.5: Number of female sandflies which responded to Dog #138. Dog #138 
was diluted using hexane to 1:1, 1:4, 1:8, 1:10 or 1:15 dilutions. The number of 
female sandflies attracted to each sample was recorded. 80 sandflies were used per 




Following the determination of a 1:10 dilution as being the optimal dilution, 
the bioassay was repeated using female sandflies for dog #128 and #027 (Table 5.6 
and Figure 5.3). This experiment was performed in order to confirm the optimal 











































Dilutions of Dog 138 1g of hair/2.5hr entrainment 
Figure 5.2: Dog #138 bioassay to determine optimal dilution. 5 bioassays were 
performed in total using 80 female sandflies. The number of female sandflies which 
responded to the test dog sample (Dog #138) is shown in black. Hexane control; light 
grey, undecided; Dark grey. * = P-value <0.05 which was considered significant. 
170 
 
Not only was a 1:10 dilution confirmed as the optimal dilution to provoke 
sandfly response, female sandflies were also shown to be significantly more attracted 
to dog volatiles compared to a hexane blank, with 57.9% (n = 139) all the sandflies 
analysed (n = 240) responding to the dog volatiles over the hexane blank and 66.5% of 
all sandflies which responded (n=209) also favouring the dog odour. 
  







Dog #138 - 1:10 dilution 48 21 11 0.0005 
Dog #128 - 1:10 dilution 45 29 6 0.0166 
Dog #027 - 1:10 dilution 46 20 14 0.0006 
Table 5.6: Number of female sandflies which responded to Dogs #138, #128 and 
#027. Dogs #138, #128 and #027 were diluted using hexane to a 1:10 dilution. The 
number of sandflies which responded to each sample was recorded in the table 
above.  80 sandflies were used per bioassay. P<0.05 dog sample vs hexane control 














































Figure 5.3: Dogs #138, #128 and #027 bioassay to confirm optimal dilution.  3 
bioassays were performed using 80 female sandflies. The number of female 
sandflies which responded to the test dog sample is shown in black. Hexane control; 





5.3.2 2018 Dogs Female Sandfly Bioassay using (Unblinded Protocol) 
Bioassays were performed following an unblinded experimental protocol using 
9 pairs of infected and uninfected dog samples; dogs were diagnosed using PCR. 
Overall, female Lu. longipalpis were shown to respond to both infected and uninfected 
dog volatile samples (85.4%) with only a minority (14.6% of all sand flies analysed) 
being recorded as undecided (Table 5.7). However, the bioassay response showed a 
significant attraction (P=<0.05) of female sandflies to infected dog odour, with 56.9% 
(n = 410) of all flies used during the bioassays (n = 720) responding to the infected dog 
odour (Figure 5.4). Furthermore, of those sandflies which responded to the odour 
profile (n=615), 66.7% responded to the infected dog sample. 
The response of 80 female sandflies was recorded to 1:10 diluted dog samples. 
The pairs of dogs which were analysed were chosen based on VOC Analyser 
discrimination criteria (Table 5.1). If there was no definitive choice observed, a 




 No. of Female Sand-flies  
1g of dog hair/2.5 
hour entrainment  
(1:10 dilution)  
Infected Uninfected Undecided 
P-Value 
(Binomial test) 
Dog 176 vs Dog 021 49 21 10 0.0003 
Dog 141 vs Dog 137 46 21 13 0.0009 
Dog 178 vs Dog 181 51 18 11 0.0000 
Dog 105 vs Dog 037 44 24 12 0.0051 
Dog 140 vs Dog 004 51 20 9 0.0001 
Dog 003 vs Dog 130 42 22 15 0.0062 
Dog 074 vs Dog 093 40 24 16 0.0136 
Dog 082 vs Dog 175 45 26 9 0.0075 
Dog 102 vs Dog 124 42 29 10 0.0237 
  
Table 5.7: Number of female sandflies which responded to infected and uninfected 
dog odour; Unblinded protocol. All dog samples were diluted using hexane to a 1:10 
dilution. Samples were chosen based on VOC Analyser discrimination criteria and a 
cross comparison performed. The number of sandflies which responded to each 
sample was recorded in the table above. 80 sandflies were used per bioassay. All 
















































1g of dog hair/2.5 hour entrainment (1:10 diltuion)
Figure 5.4: Female sandfly behavioural bioassay using an unblinded protocol of 
2018 infected vs uninfected dogs. 9 bioassays using an unblinded experimental 
protocol were performed using 80 female sandflies per bioassay (720 sandflies in 
total) with each individual sandfly response recorded. Positive dog sample; black, 












5.3.3 2018 Dogs Female Sandfly Bioassay (Blinded Protocol) 
Following the initial unblinded experiments, the bioassays were performed 
following a blinded protocol using 6 pairs of infected and uninfected dog samples (A 
through to M).  
The blinded experiment confirmed that female Lu. longipalpis respond to both 
dog volatile samples (infected and uninfected) with only a minority (10.8% of all sand 
flies analysed) being recorded as undecided. A significant attraction of female sandflies 
to infected dog odour (p=<0.05) was also seen following the blinded bioassay, with 
57.3% (n = 275) of all flies used during the bioassays (n = 480) responding to the 
infected dog odour. Furthermore, of those sandflies which responded (n=428), 64.3% 
responded to the infected dog sample (Table 5.8 and Figure 5.5). By performing the 
experiment blinded, any experimental bias that could have occurred during the 
conduction of each individual bioassay was removed. 
Dogs were diagnosed using PCR. The response of 80 female sandflies was 
recorded to 1:10 diluted dog samples. If there was no definitive choice observed, a 






 No. of Female Sand-flies  
1g of dog hair/2.5-hour 
entrainment  
(1:10 dilution) Sample 1 dog 
in bold 
Sample 1 Sample 2 Undecided 
P-Value 
(Binomial test) 
K (Dog 126) vs H (Dog 169) 48 25 7 0.0025 
L (Dog 047) vs C (Dog 153) 45 26 9 0.0075 
M (Dog 044) vs G (Dog 005) 48 26 6 0.0035 
A (Dog 80) vs F (Dog136) 45 25 10 0.0055 
J (Dog 134) vs D (Dog 70) 42 29 9 0.0290 
B (Dog 019) vs E (Dog 43) 47 22 11 0.0010 
Table 5.8: Number of female sandflies which responded to infected and uninfected 
dog odour. Blinded protocol. All dog samples were diluted using hexane to a 1:10 
dilution. Samples were chosen based on VOC Analyser discrimination criteria with 
pairs of dogs being randomised and assigned a random letter. The corresponding dog 
which was assigned to each letter and the infection status is shown in Table 5.4. The 
number of sandflies which responded to each sample was recorded in the table 



















































K (Dog 126) vs H
(Dog 169)
L (Dog 047) vs C
(Dog 153)
M (Dog 044) vs G
(Dog 005)
A (Dog 80) vs F
(Dog136)
J (Dog 134) vs D
(Dog 70)

















1g of dog hair/2.5 hour entrainment (1:10 diltuion) 
Figure 5.5: Female sandfly behavioural bioassay performed using a blinded 
protocol of 2018 infected vs uninfected dogs. 6 bioassays performed using a 
blinded experimental protocol were performed using 80 female sandflies per 
bioassay (480 sandflies in total) with each individual sandfly response recorded. 
Sample 1; black, Sample 2; light grey, undecided (U); dark grey. * = P-value <0.05 








5.3.4 2018 Dogs Male Sandfly Bioassay (Unblinded Protocol) 
The behavioural bioassay using male sandflies determined that male Lu. 
longipalpis respond to both dog volatile samples (infected and uninfected) with only a 
minority (9.5% of all sand flies analysed) being recorded as undecided (Table 5.9). 
However, a significant attraction to the infected dog sample was not observed (Figure 
5.6). Of the males which responded (n = 706), 46.0% (n = 325) responded to the 
infected dog, and 54.0% (n = 381) responded to the uninfected dog. 
Bioassays using an unblinded experimental protocol were performed using 9 
pairs of infected and uninfected dog samples; re-randomised following female sandfly 
bioassays. The response of 80 male sandflies was recorded to 1:10 diluted dog 



























 No. of Male Sand-flies  
1g of dog hair/2.5-
hour entrainment  
(1:10 diltuion) 
infected dog in bold 
Infected Uninfected Undecided 
P-value (Binomial 
Test) 
Dog 176 vs Dog 021 35 37 8 0.0912 
Dog 080 vs Dog 136 35 35 10 0.0950 
Dog 082 vs Dog 175 38 31 11 0.0674 
Dog 019 vs Dog 043 38 35 7 0.0876 
Dog 074 vs Dog 093 36 34 10 0.0924 
Dog 105 vs Dog 037 34 38 8 0.0840 
Dog 003 vs Dog 130 37 36 7 0.0924 
Dog 140 vs Dog 004 37 37 6 0.0924 
Dog 044 vs Dog 005 35 38 7 0.0876 
Table 5.9: Number of male sandflies which responded to infected and uninfected 
dog odour; Unblinded protocol. All dog samples were diluted using hexane to a 1:10 
dilution. The number of sandflies which responded to each sample was recorded in 
the table above. 80 sandflies were used per bioassay. All infected dogs are in bold. 








































1g of dog hair/2.5 hour entrainment (1:10 diltuion) 
Figure 5.6: Male sandfly behavioural bioassay performed using an unblinded 
experimental protocol of 2018 infected vs uninfected dogs. 9 bioassays were 
performed using 80 male sandflies per bioassay (720 sandflies in total) with each 
individual sandfly response recorded. Positive dog sample; black, negative dog 




5.3.5 2018 Dogs Male Sandfly Bioassay (Blinded Protocol) 
In order to confirm the male sandfly response to dog volatiles and relive any 
experimental bias, the behavioural bioassay was repeated using a blinded 
experimental protocol. This involved the remaining 6 dog pairs to be analysed being 
randomised and then assigned a letter, A through to M. 
The blinded bioassay confirmed that although male Lu. longipalpis respond to 
both dog volatile samples (infected and uninfected), there is no significant attraction 
to either the infected or uninfected sample. Only a minority (10.2% of all sand flies 
analysed) were recorded as undecided demonstrating that male sandflies respond to 
dog odour (Table 5.10). Unlike female sandflies, males were not significantly attracted 
to infected dog odour (Figure 5.7). Of the flies which responded (n = 431) during the 
blinded bioassay, 50.2% (n = 216) responded to the infected dog odour and 49.8% (n 
= 215). Blinding the bioassay removed the possibility of any experimental bias that 
could have occurred during the conduction of each individual bioassay. 
Individual entrained dog samples were diluted to a 1:10 dilution using hexane 
and the response of 80 male sandflies was recorded. If there was no definitive choice 





 No. of Male Sand-flies  
1g of dog hair/2.5-hour 
entrainment  
(1:10 diltuion) sample 1 in 
bold 
Sample 1 Sample 2 Undecided 
P-Value 
(Binomial test) 
C (Dog 141) vs G (Dog 137) 34 36 10 0.0924 
E (Dog 178) vs A (Dog 181) 36 36 8 0.0937 
D (Dog 134) vs L (Dog 070) 38 35 7 0.0876 
F (Dog 126) vs I (Dog 169) 34 38 8 0.0840 
B (Dog 047) vs J (Dog 153) 35 38 7 0.0860 
K (Dog 102) vs H (Dog 124) 39 32 9 0.0671 
Table 5.10: Number of male sandflies which responded to infected and uninfected 
dog odour. Blinded protocol. All dog samples were diluted using hexane to a 1:10 
dilution. The dog samples used for the bioassay which followed a blinded 
experimental protocol were re-randomised and assigned a random letter. The 
corresponding dog which was assigned to each letter and the infection status is 
shown in Table 5.4. The number of sandflies which responded to each sample was 
recorded in the table above. 80 sandflies were used per bioassay. P<0.05 Sample 1 vs 
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E (Dog 178) vs A
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D (Dog 134) vs L
(Dog 070)
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(Dog 169)
B (Dog 047) vs J
(Dog 153)
















1g of dog hair/2.5 hour entrainment (1:10 diltuion) 
Figure 5.7: Male sandfly behavioural bioassay following a blinded experimental 
protocol of 2018 infected vs uninfected dogs. 6 bioassays following a blinded 
experimental protocol were performed using 80 male sandflies per bioassay (480 
sandflies in total) with each individual sandfly response recorded. Sample 1; black, 
Sample 2; light grey, undecided (U); dark grey. * = P-value <0.05 which was 
considered significant.  
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5.4     Discussion 
The results presented here suggest that female Lu. Longipalpis sandflies are 
significantly more attracted to the odour of dogs infected with Leishmania infantum. 
Of the female sandflies which responded to either the infected or uninfected dog 
(n=1,043), a total of 685 (65.7%) were attracted to the infected dog sample, therefore 
indicating a significant attraction (P<0.05). Over the two bioassays performed 1,043 
out of the 1,200 female flies used throughout the study responded to dog odour. This 
result confirms the ability to obtain a behavioural response to the entrained odour of 
dog volatiles in a Y-tube olfactometer in the lab, which to our knowledge is a first. 
Recent research has however described a similar phenomenon using a wind tunnel 
and individual volatile components of the dog odour (Magalhães‐Junior et al., 2019). 
However, the use of a Y-tube olfactometer requires sandflies to make a locomotive 
choice between infected and uninfected dogs allowing for a more robust analysis. The 
male sandfly bioassays however, demonstrated an equal attraction to both dog 
samples with no significant difference being observed between the infected and 
uninfected dogs. This observation could impact transmission of Leishmania, with male 
sandflies producing pheromone equally around infected and uninfected dogs. This 
production of pheromone would therefore facilitate female blood feeding of 
uninfected dogs and reducing extreme preference for just those dogs that are 
infected.  
 
5.4.1 Sandfly attraction to hosts  
In order to optimise not only the concentration of the dog volatiles to be used, 
but also to determine female sandfly attractiveness to dog odour over a hexane 
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control, optimisation bioassay experiments were performed using female Lu. 
Longipalpis sandflies and the volatiles entrained from three separate uninfected dogs. 
Initial experiments indicated a 1:10 dilution of dog odour with hexane was required in 
order to provoke a response from the female sand-fly. Subsequent experiments using 
this dilution when determining the attractiveness of female sandflies to dog odour, 
indicated a significant attraction of the flies to the uninfected dog (66.5%). This result 
confirms the importance of the sandfly olfactory system in the response to animal 
odours in order to gain a blood meal, that is important for oviposition. 
This demonstrated attractiveness to dogs is not a surprising result. Blood meal 
analysis has identified that female Lu. Longipalpis sandflies are known to feed on many 
animals including dogs, rodents, chickens and humans (Sales et al., 2015). However, 
research in Brazil has shown that Lu. Longipalpis is an opportunistic feeder, with 
studies demonstrating that chicken blood is the most common blood meal source, 
inducing the greatest egg production. This was followed in descending order by 
livestock, humans and finally dogs (Guimaraes-E-Silva et al., 2017). Due to the 
proximity of chickens and dogs in the domestic environment in Brazil and the 
opportunistic nature of Lu. Longipalpis, it is therefore understandable that female 
sandflies are attracted to dogs as blood meal source despite there being more 
satisfactory blood meal sources. This increased attraction in dogs could therefore lead 
to a high incidence of canine leishmaniasis within the domestic environment which in 
turn could lead to more cases of human VL due to the opportunistic feeding nature of 
Lu. longipalpis. 
 
5.3.2 Female sandfly attraction to infected dogs 
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Results presented here demonstrate a significant attraction of female Lu. 
longipalpis to the entrained odour of dogs infected with Le. infantum. During the initial 
unblinded behavioural bioassay, 66.7% of female sandflies which responded (n=615) 
were significantly attracted to the infected dog odour. During the subsequent blinded 
bioassay, 64.3% of female sandflies which responded (n=428) demonstrated a 
significant response to the infected dog samples. In addition, the results here also 
demonstrate that the odour of those dogs which were considered highly discriminant, 
based on previous VOC Analyser analysis, have the highest quantity of female sandflies 
responding to the infected dog. This result further implies the importance of infected 
dog odour in the attraction of female sandflies and therefore the transmission of 
Leishmania. 
Several studies have previously identified potential compounds which may 
have an involvement in the mediation of the differential attractiveness of Lu. 
longipalpis sandflies to Leishmania infected and uninfected dogs. An increased 
attraction of female sandflies to the individual compounds decanal and nonanal,, 
possible biomarkers for Le. infantum infected in dogs has been shown (Magalhães-
Junior et al., 2014b; Magalhães-Junior et al., 2019). Not only do the results presented 
here coincide with such research, but this study demonstrated an increased female 
attraction to the whole volatile profile of an infected dog rather than individual 
volatiles found in infected dog odour. In nature different blood sources, such as dog 
hosts, release volatile compounds simultaneously therefore the components released 
intermingle forming a fluctuating and complex olfactory environment. Therefore, the 
female sandfly attraction demonstrated here provides a more accurate representation 
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of the natural interaction between infected dogs and female Lu. longipalpis, thus 
providing a more robust ideology of the transmission of Leishmania infantum in Brazil. 
This observed response of female sandflies could have implications on the 
transmission of human visceral leishmaniasis throughout Brazil.  Transmission of 
Leishmania infantum from dogs to humans is predominantly through the bite of 
infected sand-flies. The observed increase in attraction of female sandflies to 
Leishmania infantum infected dog odour and the proximity of dogs to humans in the 
urban environment in Brazil could lead to an increased transmission of the parasite to 
humans. Furthermore, the adoption and transportation of dogs in Brazil from areas 
endemic for cVL has caused the introduction and spread of the disease to areas where 
the infection was previously not found (Otranto et al., 2009). This movement of dogs 
throughout Brazil combined with the increased female sandfly attraction to infected 
dogs further highlights the need for the removal and/or treatment of infected dogs 
which could be made more efficient by the development of more accurate diagnostics 
as presented in preceding chapters (Staniek et al., 2019).  
Despite this observed attraction and therefore an increased transmission of 
the disease which ultimately benefits the parasite, the benefit to the sandfly remains 
unclear. Research has demonstrated that Leishmania infection causes severe anaemia 
and leukopenia in infected hosts and therefore a poorer quality of blood meal (Lafuse 
et al., 2013). However, it has also been shown that female sandflies that are infected 
with Leishmania are able to withstand infection from bacterial entomopathogens, 
reducing the mortality of the fly. This suggests that Leishmania infection may benefit 
the sandfly vector, whilst also increasing its potential to establish itself within the sand 
fly vector (Sant’Anna et al., 2014). This potential benefit to the sandfly could explain 
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the increase in attraction to infected dogs, providing further evidence of parasite 
manipulation leading to an increase in parasite transmission. 
Despite this observed increase in attraction, research has demonstrated that 
the host choice behaviour of insect vectors may be influenced by the infection status 
of the vector itself. Studies have shown that uninfected vectors are more attracted 
towards infected hosts however, after becoming infected they are more attracted 
towards uninfected hosts. Research has demonstrated the consequences of these 
behavioural shifts and the impact such behavioural alterations has on disease 
epidemiology (Roosien et al., 2013). Such an important modification of vector 
behaviour seems to be very adaptive for parasite transmission however this 
hypothesis remains to be investigated thoroughly. Regarding the results shown here, 
further investigation into the attraction of infected female sandflies to uninfected dogs 
is vital to further the current understanding surrounding disease transmission and 
ecology in endemic areas. 
 
5.3.2.1 Parasite Manipulation Inducing Increased Transmission 
The longitudinal study performed by Nevatte et al., (2017) combined with the 
results presented here suggests a parasitic manipulation of the canine metabolism in 
order to favour the biology of the parasite. Despite these results however, it cannot 
be discounted that female Lu. Longipalpis sandflies are also naturally more attracted 
to some dogs over others. Research has demonstrated that female mosquitoes show 
a preference for certain host individuals over others, with differences in VOCs 
produced by the host being detected by mosquitoes and causing a difference in 
attraction (Fernández-Grandon et al., 2015). Therefore, a longitudinal follow up study 
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would need to be undertaken in order to demonstrate an increase in the 
attractiveness of the odour of the same dog after infection compared to before 
infection. 
 
5.3.3 Male sandfly attraction to infected dogs 
Although results shown here demonstrate a significant attraction of female 
sandflies to infected dog odour, no such difference was observed in the male sand-
flies. Although the males were generally more attracted to dog odour, with only 10% 
(n=123) of all the males analysed (n=1200) remaining “undecided”, infection status 
appeared to have no influence on attraction. In total, only 541 of the 1077 male 
sandflies which were responsive were attracted to infected dog odour (50%) 
compared to 685 of the 1043 females which responded (66%).  This is an important 
observation as it not only suggests a difference between female and male host-seeking 
behaviour, but also suggests that parasite manipulation is specific for the host-seeking 
behaviour of female sandflies. Furthermore, this observation also furthers our 
understanding on Leishmania transmission, with the male formation of lekking sites 
around both infected and uninfected dogs playing a vital role in the attraction of 
females to both infected dogs to gain a parasite blood meal, and uninfected dogs to 
continue disease transmission.  
There are a few reasons that could be suggested for this observation. First, 
despite many olfactory morphological features being the same between male and 
female vectors, differences have been observed. For example, female mosquitoes 
have been found to possess three/four times more antennal sensilla than males 
(McIver et al., 1982). Research in Brazil has also demonstrated a difference between 
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the type and number of sensilla present on male and female Lu. longipalpis antennae, 
with the mean number of sensilla being significantly greater on male sandflies 
(Fernandes et al., 2008). Such observed differences may reflect function, as only 
female feed on blood and therefore rely on olfactory stimuli to locate hosts. These 
differences could therefore potentially explain the difference in attraction observed in 
the results presented here. Additionally, in nature male Lu. longipalpis are attracted 
to a possible blood source first in order to form a lekking site. Research has 
demonstrated the attraction of male Lu. longipalpis sandflies to octenol and nonanol 
that are related to skin odour (Magalhães-Junior et al., 2014). Following the formation 
of lekking sites around a host, female sandflies are then attracted (Kelly & Dye, 1997). 
This aggregation dynamic and formation of lekking sites around suitable hosts, that is 
facilitated by the production of host kairomones, may explain the unbiased attraction 
of male Lu. Longipalpis to canine volatiles as demonstrated in this study.  
When present together, host kairomones and male pheromones have been 
found to attract a higher number of female sandflies compared to the host odour or 
male pheromone alone (Bray and Hamilton 2007). The observed attraction of male 
sandflies to both infected and uninfected dog odour would therefore facilitate an 
increase in the copulation of sandflies. This is due to the formation of lekking sights 
around a larger number of hosts as infection status has no influence on male 
attraction. However, the relative attraction of infected dog odour compared to male 
pheromone and uninfected host odour has not been investigated. In order to further 
understand the importance of the volatiles produced by an infected dog in a natural 
setting and their role in female sandfly attraction, additional experiments should be 
undertaken to investigate whether females have a greater attraction to infected dogs 
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compared to lekking sites formed around uninfected dogs. Uninfected dogs with a 
lekking site could potentially be more attractive than an infected dog, therefore having 
a major effect on disease transmission and disease control. 
The observed attraction dynamic of the male sandflies may also prove 
beneficial to the Leishmania parasite. As demonstrated here, although female Lu. 
longipalpis sandflies are significantly more attracted to the odour of infected dogs, 
extreme preference of female sandflies to infected dogs could limit or even stop 
transmission. It can therefore be suggested that the equal aggregation of male 
sandflies around both infected and uninfected dogs and the subsequent production of 
pheromones, would attract infected females to uninfected dogs thereby aiding 
parasite transmission. Furthermore, recent studies have shown that sequential blood 
meals promote the replication of Leishmania parasites (Serafim et al., 2018). 
Therefore, the formation of male lekking sites around both infected and uninfected 
dogs promotes the intake of further blood meals and subsequent parasite replication, 
further aiding disease transmission.  
The demonstrated male attraction and subsequent formation of lekking sites 
around both infected and uninfected dogs will lead to a combined odour blend of male 
pheromone with infected and uninfected host kairomones. As male pheromone has 
already been identified as an effective attractant used when combined with insecticide 
for sandfly vector control (Brey et al., 2014; Bell et al., 2018), further research into the 
attraction of male pheromone plus infected dog odour should be undertaken as a 
possible aditional contribution to vector control. 
 
5.3.4 Odour Baited Sandfly Traps 
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The results presented here showing an increase in the attraction of female Lu. 
longipalpis to the whole odour profile of Le. infantum infected dogs, demonstrates the 
potential for the development of a novel tool for vector control. Additional evidence 
regarding sandfly attractiveness to infected dog volatiles further supports such an 
approach, with female sandflies showing a significant attraction to decanal and 
nonanal, two VOCs which have previously been identified in the hair of Le. infantum 
infected dogs (Magalhães-Junior et al., 2014b; Magalhães-Junior et al., 2019).  
The combination of synthetic odours and chemicals with current vector control 
methods has already been demonstrated. Traps baited with human odour (socks worn 
for 12 hours) have been proven to attract a significant amount of Anopheles 
mosquitoes (Njiru et al., 2006; Jawara et al., 2009). Previous research has also 
demonstrated that traps baited with chemical attractants significantly increases the 
number of female sandflies caught. For example, the use of pheromones baited light 
traps as a sandfly control method has shown a significant increase in the attraction of 
female sandflies, which when combined with insecticides, could result in more 
sandflies being killed and therefore a potentially more effective control programme 
(Bell et al., 2018). Other studies have also demonstrated an increase in the attraction 
of certain vectors to specific odour profiles as well as specific target sizes, shapes and 
other visual stimuli such as light. Research has demonstrated that Anopheles 
mosquitoes are highly attracted to matte black card. Traps which were baited with 
human odour plus the black card visual stimuli caught significantly more Anopheles 
than traps which were baited with odour alone (Hawkes et al., 2017). These studies 
provide evidence that suggests a similar trapping methodology could be employed to 
sandflies. The use of light traps baited with whole dog odour profile, with or without 
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a visual stimulus, could produce an innovative vector control methodology for the 
trapping and killing of sandflies in Brazil. 
 
5.3.5 Summary 
Existing research has demonstrated that synthetic odour baits have the 
potential to be used successfully as a lure of sandfly vectors to traps (Bell et al., 2018; 
Magalhães-Junior et al., 2019). Malaria research which modelled the effect of mass 
trapping techniques has already demonstrated that such an approach could be used 
for effective malaria control programmes where odour-baited traps are used together 
with Insecticide-treated walls or nets (Homan et al., 2016). One such example is the 
development of the SolarMal Project, a vector control project which developed and 
tested odour-baited traps for malaria vector control in Western Kenya. This project 
resulted in a decrease in malaria prevalence, which was explained by the reduction in 
the densities of An. funestus (Hiscox et al., 2012; Homan et al., 2016). Odour-baited 
traps therefore demonstrate effective disease intervention. 
Results here therefore indicate that the use of infected dog odour-baited traps 
as part of a mass trapping control programme for Leishmania vectors, could potentially 
contribute to vector control and lead to a reduction of disease burden. This is due to 
the observed attraction of female sandflies to the odour of naturally infected dogs. 
However, due to the unbiased attraction of male sandflies to dog odour regardless of 
infection status, further studies must be done in order to further understand the effect 
of pheromone with regards to infected dog odour and baited sandfly traps. Despite 
this, odour-baited traps have the potential to be used as a complementary method 







Chapter 6 - Gas Chromatography-Mass Spectrometry (GC/MS) Analysis 
of Hair samples 
 
6.1 Introduction 
Systems biology is a vital component of biological analysis. It allows for the 
modelling of different biological systems through the analysis of the components and 
metabolites that are produced by biological interactions (Breitling, 2010). 
Metabolomics, as a component of system biology, involves the scientific study of the 
metabolites produced by an organism, tissue or cell. It has developed rapidly in recent 
years, being used extensively throughout biomedical research (Daviss, 2005). Such 
research has emphasised the importance of metabolites as biomarkers for detecting 
and diagnosing various diseases, with metabolomics analysis allows for the 
identification of the whole spectrum of metabolites within an organism in various 
disease conditions in a non-invasive manner (Atan et al., 2018).  
A variety of volatile components have been identified as being directly related to 
different diseases. For example, numerous cancer specific biomarkers, such as 
chemokine ligand 2 and chemokine receptor type 2 for breast cancer, have been 
identified (Buonaguro et al., 2019) along with biomarkers such as an increase in 
neurofilament light chain during neurological disorders as well as biomarkers of tau 
and amyloid pathology for Parkinson’s disease (Parnetti et al., 2019) as well as 
biomarkers for various parasitic diseases (Ndao 2009). Recent research has shown that 
volatiles in Leishmania infantum infected dog hair can serve as biomarkers that are 
associated with Leishmania infantum infection. The individual VOCs determined have 
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not only allowed for the discrimination between infected and non-infected dogs 
(Magalhães-Junior et al., 2014b) but have also been demonstrated to elicit the 
attraction of female sandflies (Magalhães-Junior et al., 2019; Chapter 5). Therefore, 
further isolation, quantification and identification of the different biomarkers in the 
hair of Leishmania infantum infected dogs, through metabolomics techniques, could 
pave the way for the future development of new diagnostic tools (Staniek et al., 2019) 
and vector control methodologies. 
 
6.1.1 Metabolomics 
Metabolites are small endogenous molecules that are produced as end products 
of biochemical pathways and play a vital role in biological systems. They represent a 
useful dataset to allow for the understanding of disease phenotypes, with the 
identification of changes in metabolite levels having been shown to help with the 
diagnosis of diseases in early stages. The variations in metabolite levels have been 
applied as a tool for disease prediction with metabolites already having been used to 
characterise many diseases from a variety of different biological samples. These 
include, the diagnosis of breast cancer by analysing exhaled air (Herman-Saffar et al., 
2018), cholera by analysing stools (Garner et al., 2009), and cardiovascular disease by 
analysing plasma (Rupérez et al., 2012). The discovery of biomarkers for various 
diseases and their application in the field of integrative systems biology, are 
considered as the main areas in which metabolomics analysis is applied. Biomarker 
identification using metabolomics is a promising approach leading to the diagnosis of 
disease in early stages, which has led to an increase in effective disease diagnosis. For 
example, research has demonstrated that the identification of urinary volatile organic 
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compounds could lead to a non-invasive methodology for the diagnosis of prostate 
cancer (Gao et al., 2019). Recent research has also demonstrated the non-invasive 
diagnosis of malaria through the detection of breath and skin VOCS produced by 
infected individuals (Berna et al., 2015; De Moraes et al., 2018). These studies confirm 
the advantages of identifying specific biomarkers for the early, non-invasive and 
accurate diagnosis of disease. 
The study of metabolomics could contribute to the development of an innovative 
way to improve the current cVL diagnostic tests in Brazil. Research has already shown 
that metabolomics analysis can be used for the diagnosis of canine VL, distinguishing 
between the hair of Leishmania infected and uninfected dogs (Magalhães-Junior et al., 
2014b). Hair as a skin appendage is an important biological sample to consider when 
performing metabolomics analysis. This is due to the bodily functions that hair 
possesses, which includes the secretion and excretion of substances that are produced 
by biological endogenous mechanisms (Stenn and Paus, 2001). Hair samples have been 
used in the forensic and biomedical fields for the detection of a variety of exogenous 
compounds. Specifically, the analysis of animal hair has shown great potential as an 
indicator of the internal metabolic processing of different medicines (Gratacos-Cubarsi 
et al., 2006), the identification of specific drugs in the field of toxicology (Bararpour et 
al., 2018) and for the profiling of endogenous hormones such as cortisol (Shih et al., 
2018). Hair samples allow for easy non-invasive collection with the additional benefit 
of becoming naturally impregnated with substances that are excreted and secreted by 
the body during metabolic processes (Stenn and Paus, 2001). This offers chemical 
stability to the analysis, capturing long-term exposures to disease, unlike plasma or 
urine (Seymour et al., 2018). Research has demonstrated that pathogenic infections 
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cause an alteration in substances that are exogenously secreted by an individual 
(Shirasu and Touhara, 2011). Therefore, there is real potential to detect different 
diseases through the analysis of hair samples from individuals who are infected. The 
odour that is emitted during infection could prove to be one of the first clues which 
will lead to a successful early diagnosis. 
 
6.1.2 Gas chromatography mass spectrometry (GC-MS) 
Gas chromatography mass spectrometry (GC/MS) is a complex technique that 
produces, separates and detects ions from a sample in a gaseous phase (Figure 6.1). 
GC/MS is an effective system used for separating VOCs present in a complex sample 
based on their chemical properties and by their mass to charge (m/z) ratio (Bindu et 
al., 2013). GC/MS consists of two functional components; a gas chromatograph and a 
mass spectrometer. Gas chromatography (GC) (performed by a gas chromatograph) is 
widely used in many branches of science and over the last 50 years has played an 
essential role in the isolation and quantification of volatile organic compounds (VOCs) 
in a mixture (Stashenko and Martinez, 2014). GC is a separation technique, which uses 
the flow of a carrier gas through a column to separate compounds based on their 
volatility and their interaction with a liquid stationary phase present inside the column. 
The column itself is in an oven which controls the temperature of the gas. There are 
two types of columns used for GC analysis; packed and capillary, however capillary 
columns are considered more efficient and therefore more widely used. Capillary 
columns are divided into two types; support coated open tubular (SCOT) or wall-
coated open tubular (WCOT) (Figure 6.2). To achieve optimum column efficiency, the 
sample introduced to the column should be small and introduced as a plug of vapour. 
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The most common method of injection is using a micro-syringe, which injects the 
sample through a rubber septum and into a flash vaporiser port that is present at the 
head of the column. For capillary GC, the injector can be either split or splitless. For a 
split injection, when the sample is vaporised only a proportion of the sample passes 
onto the column with most exiting through a split outlet. A splitless injection however, 
results in the entire sample passing onto the column (Pravallika, 2016). 
To establish the chemical structure of these GC separated compounds however, 
an additional spectroscopic step such as mass spectrometry (MS) is required. In 
coupled GC/MS, a mass spectrometer receives the effluent from the GC. MS measures 
the m/z ratio of the ions in the sample, presenting the results as a mass spectrum 
which is a plot of intensity as a function of the m/z ratio. A mass spectrum is often 
described as a "fingerprint" of the VOC as it provides information on the elemental 
composition, molecular weight and abundance of each volatile component of the 
sample. The structural and chemical information provided by the analysis can assist 
with the identification of compounds through a library fitting. However, any 
identification obtained by the library tends to be unambiguous with further 
experiments normally required to confirm identification. Mass spectrometry has 
proven to be useful across diverse scientific fields and applications including forensic 






Figure 6.1: Schematic diagram of a GC/MS system. GC/MS is a technique that is 
comprised of a gas chromatograph (GC) that is coupled to a mass spectrometer 
(MS). Instrument allows for the separation, identification and quantification of 
complex mixtures of chemicals. O; Oven, I; Injector, C; Column, TL; Transfer Line, IS; 
Ion Source, E; Electron Beam, A; Analyser, D; Detector, CPU; Central Processing Unit, 
S; Data Storage Device (Adapted from Wu et al, 2012). 
Figure 6.2: Types of Capillary columns. There are two types of Capillary column 
used for GC analysis. A; Wall coated open tubular column (WCOT). B; support 
coated open tubular column (SCOT). In SCOT columns, the capillary inner wall is 
lined with a thin layer of support material, on which the liquid stationary phase is 
adsorbed. WCOT columns however consist of a capillary tube which has its walls 
coated with the stationary phase (Adapted from Engewald et al., 2014) 
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6.1.2.1 Application of GC/MS in Clinical Research 
GC/MS has been used extensively for the detection and identification of VOCs 
which have been found to be emitted in sweat, blood, urine, faeces and breath, the 
expression levels of which reflect an organism’s metabolic state. There is an increasing 
interest in the evaluation and use of VOCs in the diagnosis of various diseases, with 
emerging analytical technologies such as GC/MS being at the forefront of this research 
(Sethi et al., 2013).  
GC/MS is considered to be highly sensitive and robust, with the added 
advantages of having a high chromatographic separation power, reproducible 
retention times and fast compound identification through the possession of large 
commercial and public compound libraries (Beale et al., 2018). This technology allows 
for the simultaneous profiling of several hundred chemically diverse compounds which 
include most amino and organic acids, sugars and sugar alcohols, fatty acids and 
aromatic amines (Roessner et al., 2000). Volatile organic metabolites can also be 
separated and quantified directly by GC–MS, with research demonstrating the 
successful identification of metabolites for the diagnosis of gastrointestinal diseases 
such as Crohn’s disease (CD) and ulcerative colitis using GC/MS analysis. Specifically, 
93% sensitivity and 78 % specificity were demonstrated when distinguishing between 
patients with CD and healthy controls (Cauchi et al., 2014). Research has also 
demonstrated the use of GC/MS for the identification and classification of different 
mycobacterial species. Mycobacteria species-specific VOC profiles which cause serious 
mammalian zoonotic diseases have been identified. These included Mycobacterium 
(M.) tuberculosis which causes tuberculosis (TB) in dogs, elephants, parrots and 
humans as well as Mycobacterium caprae and Mycobacterium bovis which causes TB 
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in humans and ruminants respectively (Küntzel et al., 2018). For specific disease 
diagnosis, research has shown the successful use of GC/MS as a TB diagnostic through 
the identification of high and low abundant biomarkers of Mycobacterium 
tuberculosis. This analysis was performed on human serum samples with a variety of 
lipid biomarkers specific for Mycobacterium tuberculosis identified in the serum of TB 
infected samples (Joseph et al., 2016). 
Metabolomics analysis can be applied to a range of disease states in order to 
identify disease biomarkers as well as follow disease progression and severity or 
provide a therapeutic target (Smoleńska and Zdrojewski 2015). However, despite its 
effectiveness, GC/MS still requires expensive preparations of samples and expert 
personnel to handle the samples and technology (Saalberg and Wolff, 2016). Another 
issue is that the method of volatile collection, whether through the collection of breath 
or indeed headspace entrainment on Tenax of hair samples, can affect the original 
concentration of VOCs in the sample. Furthermore, the relative stability of the 
collected compounds, as well as the effect of different storage bags on collected VOCs 
can influence the results generated by the GC/MS analysis (Nardi-Agmon and Peled, 
2017). Therefore, very short sample storage times are needed to minimize the effect 
on the sample. It was important to recognise and minimise these limitations when the 
analysis of collected hair was undertaken using GC/MS for this study. Despite these 
limitations however, the use of GC/MS as an analytical approach to distinguish 
between the volatile profiles of individuals in various disease states is a highly effective 
methodology. This technology could therefore be used to validate the results gathered 
through VOC Analyser analysis of Leishmania infected dogs (Staniek et al., 2019; 
Chapter 4). The identification of Leishmania specific volatile compounds using a 
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GC/MS could also further enhance the development of the VOC Analyser as a 
Leishmania specific diagnostic. These identified compounds could also be utilised in 
the development of odour baited sandfly traps due to the demonstrated increase in 
attraction of Lu. longipalpis to infected dogs (Chapter 5). 
 
6.1.2.2 GC/MS for the identification of Leishmania VOCs  
Previous studies have identified 53 volatile and non-volatile potential 
biomarkers of Leishmania infection using GC/MS analysis. These include direct 
markers (of parasite origin) and indirect markers (from host cells), for both cutaneous 
and visceral leishmaniasis (Kip et al., 2015). GC/MS specific identification of volatile 
biomarkers has been exploited in various studies. Recent research identified changes 
in the composition of both fatty acids and lipids during the transformation of Le. 
donovani from promastigotes to amastigotes inside the macrophages (Messaoud et 
al., 2017). Furthermore, metabolomics analysis identified various circulating 
biomarkers that are related to immune activation, inflammation and oxidative stress 
in Leishmania infected dog serum (Solcà et al., 2016). Specific volatile metabolomics 
analysis also identified a small number of primarily low molecular weight aldehydes, 
alkanes and esters (Oliveira et al., 2008; Magalhães-Junior et al., 2014b) which were 
found to be present in the odour of VL infected dogs, with six specific VOCs identified 
as biomarkers for Leishmania infection.  Again, this research shows the potential 
application of biomarkers as the basis for the identification of infected and uninfected 
individuals. 
Regardless of the origin of VOCs, GC/MS analysis has given researchers an 
insight into the pathogenesis, biology and mechanisms of Leishmania infection. The 
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clear observed change in biomarkers following infection, whether related to the 
immune system or from another source can be utilised by GC/MS, as the identification 
of biomarkers which have been previously linked to leishmaniasis would allow for the 
diagnosis of an infected individual. The use of biomarkers in the diagnosis of 
leishmaniasis may have several advantages including their use as an additional 
analysis, but more importantly the relatively non-invasive collection of samples which 
has been observed (Kip et al., 2015, Staniek et al., 2019). The identification of specific 
biomarkers in infected individuals which have been linked to a change in odour profile 
could also provide further information as to the transmission cycle of Leishmania via 
parasitized host interaction with the sandfly vector. 
 
6.1.3 Chapter Aims 
Previous research (Oliveira et al., 2008; Magalhães-Junior et al., 2014b) in 
addition to the results presented here demonstrate a distinct difference between the 
odour of Lesihmania infected and uninfected dogs. Although a VOC Analyser can 
distinguish between dog samples with a high sensitivity and specificity (Staniek et al., 
2019), the device is still a novel approach which requires further research to improve 
diagnostic potential. By utilising gas chromatography mass spectrometry, I aim to not 
only confirm the results determined through the VOC Analyser analysis, but also 




6.2.1 Sample collection and Headspace Entrainment on Tenax  
Dog hair was collected in the field as described in the general methods section 
in both 2017 and 2018. Following sample collection, a minimum of 1g of hair was 
introduced into a portable entrainment system in order to collect released volatiles. 
Methodology for the entrainment of VOCs from the dog hair samples is described in 
the general methods section (Chapter 2). 
 
6.2.2 GC/MS Set Up 
6.2.2.1 Machine specifications 
The VOCs present in the 2017 and 2018 entrained samples were analysed by a 
gas chromatograph (Agilent Technologies 5890B) coupled to a mass spectrometer 
(Agilent Technologies 5975C) using either a fitted 10l auto sampler syringe (G4513A 
model, Agilent/SGE) or manually under the following conditions: 2ml/min carrier gas 
(H2) flow with an oven temperature program as follows; 40°C for 3 min, then increased 
at 10oC/min to 180oC and then held for 5 minutes (total run time, 28 minutes). The 
injector was a splitless injection with an inlet temperature of 65oC that is held for 
0.5mins prior to an increase in temperature to 180oC at 720oC/min. This temperature 
was held for the remainder of the run. An Agilent premium inlet septum 5183-4757 
which was not pre corded was used with the pressure inside the inlet increased from 
6psi to 40psi and held for 2 mins. The mass spectrometer consisted of a heated 
transfer line (280oC) and a MS scan range of 30-400 amu with a scan frequency of 12.5 
scans per second. The solvent delay prior to data acquisition was 6.5 minutes. The 
purpose of the solvent delay was to protect the MS filament from the effects of a high 
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concentration of solvent vapour at the source and therefore overcome a large solvent 
peak at the beginning of the analysis. 
 
6.2.2.2 Methodology 
GC/MS analysis on each sample of dog hair was carried out using two separate 
columns;  
• HP5-MS Ultra Inert non-polar column; 30m × 0.25mm id × 0.25μM film 
thickness. 
• DB-Wax capillary polar column; 30m × 0.25mm id × 0.25μM film thickness. 
The use of two columns allowed for the identification of the broad range of 
volatiles present on the dog hair samples. The HP5-MS detected non-polar compounds 
and the DB-Wax detect polar compounds. Hydrocarbon standards were injected 
randomly throughout the experiment (after approximately every 5 uninfected dog 
samples) as an external standard and with a hexane blank prior to and immediately 
following infected dog samples. 
 
6.2.2.3 Preparation of Entrainment Samples Prior to GC/MS Analysis 
For all auto sampler injections (2017 HP5-MS analysis), 200l of each sample 
was collected from the 500l of original sample. The sample was then dispensed into 
small evaporation containers. The 200l of each sample was reduced to 20l by 
blowing nitrogen air into the sample. The quantity of the sample was confirmed by 
measurement with a 100l syringe. The 20l of sample was placed into a glass insert 
inside an auto injector vial which was sealed with PTFE tape and tin foil to reduce 
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evaporation. For all manual injections (2017 DB-Wax, 2018 HP5-MS and 2018 DB-Wax 
analysis) 50l of dog-hair entrainment sample was collected from the 500l of original 
sample. A copper nitrogen line was used to reduce the sample to 5l. The quantity of 
the sample was confirmed by measurement with a 100l syringe. This sample was 
subsequently manually injected into the GC/MS.  
An internal standard (caryophyllene, 10l of 50ng/l) was added to each 
sample. The internal standard was used to improve the precision of the analysis by 
providing a known concentration of a substance present in each analysed sample. 
Caryophyllene was used as it does not occur naturally and therefore can provide a 
signal which can be distinguished from any other analyte present. 
A syringe fitted with a long needle was used to collect all extracts from the 
original sample and rinsed with 1ml of hexane before withdrawing. All evaporation 
containers were made by cutting down glass ampules to 20mm lengths. This allowed 
for the remaining sample to be stored for future experiments and reduced the 
possibility of sample contamination. The cut-down ampules were rinsed with 1-2 ml 
hexane and then baked in a drying oven at 240oC before use. The residual dog-hair 
hexane extract ampule was immediately heat-sealed before proceeding with the 
GC/MS sample injection. The opening of the copper nitrogen line used for blowing-
down samples was rinsed daily with hexane before proceeding with the experiment in 
order to remove any accumulated volatiles on the tubing and to reduce cross 
contamination between samples. The 10l injection syringe and external needle 





6.2.3 GC/MS 2017 Dog Sample Analysis 
Following the previous VOC analyser analysis of 55 dogs (44 negatives and 11 
positives) from the 2017 cohort, the entrained samples collected from the same 
cohort of dogs were run in triplicate (i.e. 3 replicates: A, B and C, supplementary 
material Tables 9.1A, 9.1B and 9.1C) on the HP5-MS column using an auto sampler 
injection. A further replicate D was analysed on the DB-wax column (Supplementary 
material Table 9.2) however these samples were manually injected.  
For the HP5-MS analysis, samples were placed in an auto injector rack which 
formed part of the injection tower (Agilent 7693A Automatic liquid sampler). This 
allowed for the automated analysis of a maximum of 16 samples with a capacity for 
one waste bottle and two solvent bottles. The auto sampler injected 5l of each 
individual sample into the GC/MS (equivalent of 50ml of original sample) according to 
the schedules shown in supplementary material Tables 9.1A, 9.1B and 9.1C. During 
the analysis, the room temperature was set at 16oC to reduce hexane evaporation as 
the samples were stored in the rack for up to 10 hours. Following analysis, the lid on 
the sample vial was replaced and the samples stored at -20oC prior to replicates B and 
C. For the 2017 DB-Wax analysis 5l was manually injected using a 10l injection 
syringe following a randomised analysis schedule (Supplementary Table 9.2). 
 
6.2.4 GC/MS 2018 Dog Sample Analysis 
Following the VOC analyser analysis of all 149 samples collected in 2018 (44 
infected and 105 negatives), 60 samples (30 infected and 30 uninfected) were selected 
and injected manually according to a predetermined randomised schedule 
(supplementary material Tables 9.3 and 9.4). The entrained samples which were 
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analysed were from the same cohort of dogs which were used for the bioassay analysis 
(30 dog pairs; 15 infected and 15 negative, Chapter 5 methodology section 3.2) and an 
additional randomly chosen 30 entrained samples (15 infected and 15 negative). 
Initially the analysis was done on the HP5-MS column, following which the samples 
were also run on the DB wax column. All samples were manually injected using a 10l 
injection syringe. 
 
6.2.5 Agilent Qualitative Analysis 
Post-acquisition, all raw data files were subjected to supervised deconvolution 
analysis. This is an automated program in the Agilent MassHunter Qualitative Analysis 
B.07.00 software package (Agilent technologies UK). This analysis resulted in the 
removal of some samples which had a high level of background noise allowing for a 
better peak alignment and comparison. The chemical noise can result from a variety 
of different sources, such as the GC mobile phase or buffers which have a high 
contribution in the signal.  
The samples removed from the analysis because of background noise were:  
2017 HP5-MS: 21 samples (1 infected and 20 negatives) 
2017 DB-Wax: 20 samples (3 infected and 17 negatives) 
2018 HP5-MS: 14 samples (8 infected and 6 negatives) 
2018 DB-Wax: 21 samples (13 infected and 8 negatives) 
The total samples removed were roughly a third of the data set. 
 
 
6.2.6  Agilent Quantitative analysis: the “Unknowns Analysis” 
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Initial analysis identified and quantified all the known and unknown 
compounds which were present within the dog samples using Agilent MassHunter 
Workstation- Unknowns Analysis software (Agilent Technologies, UK). This program 
used a chromatographic deconvolution algorithm to resolve the complexity of the 
chromatogram where different compounds may have co-eluted or eluted closely 
together. This method consisted of fitting a linear regression to the single or multi-
peaks of the chromatograms. The software can recognise these peaks, remove 
background noise and determine the spectra of components from the underlying ion 
chromatograms (Dromey et al., 1976).  
The deconvoluted chromatograms containing the reconstructed spectra were 
then searched in the National Institute of Standards and Technology 2014 library 
(NIST14) within the Agilent MassHunter Workstation- Unknowns Analysis software. In 
addition to mass spectral data, this process also utilised the retention times of the 
compounds to provide very accurate comparison of compounds in different 
chromatograms. These deconvoluted chromatograms (Agilent termed extracted ion 
chromatograms (EICs)) were saved as cef format files for subsequent statistical 
analyses and data visualisation in Agilent Mass Profiler Professional (MPP) v15.0 
software (Agilent Technologies, UK). 
 
6.2.7 Mass Professional Profiler (MPP) Analysis  
6.2.7.1 Data filtering and Identification of VOCs characteristic for cVL infection 
For analysis of the GC/MS data files, a project file was created in Agilent Mass 
Profiler Professional (MPP) containing the data from the four separate analytical 
experiments i.e. the deconvoluted GC/MS data from the 2017, 2018 HP5-MS and DB-
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Wax analyses. For each of the experiments the data files were grouped and a condition 
of either infected or uninfected was assigned to each sample based on previous PCR 
diagnosis. The chromatograms were then aligned using a RT correction function using 
three compounds present in all the chromatograms; caryophyllene (mw 204.36amu) 
and nonadecane (mw 268.5amu) and Phenanathrene (mw 178.23amu). The 
chromatograms were then baselined using the Pareto scaling method. Pareto scaling 
reduces the influence of intense peaks by reducing their loadings and emphasises 
weaker peaks which may be more biological relevant by increasing their loadings 
(Worley and Powers, 2013), further aligning the chromatograms at their baseline. 
The compounds (individual VOCs) which were identified in the deconvoluted 
GC/MS data files were then filtered based on a Relative Frequency (Rel Freq) 
threshold. For this project, only compounds which were present in 70% of the samples 
in at least one or more condition (70% Rel Freq threshold) were retained for the 
analysis. Further filtering of the compounds was also performed using an unpaired T-
test analysis in order to identify the compounds which were considered as significantly 
important for distinguishing between infected and uninfected samples (volatiles 
characteristic for cVL infection). A cut of value of P <0.05 was considered statistically 
significant for all experiments apart from the DB-Wax 2018 analysis in which P-value 
<0.5 was set. This analysis used a Benjamini-Hochberg False Discovery Rate set to 5% 
for multiple testing corrections (Hochberg and Benjamini, 1990). This reduced the rate 
of incorrectly rejecting the true null hypothesis. Finally, the remaining compounds 
were automatically identified and annotated by comparison with the NIST14 library 




6.2.7.2 CVL identification: Statistical analysis and Visualisation 
Following the acquisition of the compounds which were considered as 
important for distinguishing between infected and uninfected dogs, a principle 
component analysis (PCA) was performed in order to classify samples belonging to 
infected or uninfected infection status. The PCA was performed using by centring and 
scaling the variables which displayed the relationship between the infected and 
uninfected dogs. PCA is a multivariate analysis technique using an unpaired t-test to 
detect the grouping trends of the VOCs with respect to the two studied groups 
(infected and uninfected) and then displays this information as a matrix. This allowed 
us to predict which group a dog belonged based on their VOC profile. A P value of 
<0.05 was considered statistically significant for all experiments apart from the DB-
Wax 2018 analysis in which a P value of <0.5 was set. 
 
6.2.7.3 Class Prediction Model 
Following the PCA analysis, confusion matrices of the separation of the 
uninfected vs infected dogs in 2017 and 2018 using both the HP5-MS and DB-Wax 
columns were obtained. The analyses were performed using the class prediction 






6.3.1 Qualitative Analysis  
6.3.1.1 2017 Dogs 
The Agilent MassHunter Qualitative Analysis of the 2017 dogs detected 6,991 
VOCs in the DB-Wax column analysis and 11,638 VOCs in the HP5-MS column analysis 
as being recognisable compounds. These volatiles were chemically identified using 
Agilent MassHunter Workstation- Unknowns Analysis (Agilent Technologies, UK) 
which utilised the NIST14 electronic library and individual retention times. Although 
all these volatile compounds were recognised, only 1,546 VOCs from the DB-Wax 
analysis and 3,587 VOCs from the HP5-MS analysis were subsequently identified and 
named in all the chromatograms analysed.  
 
6.3.1.2 2018 Dogs 
The Agilent MassHunter Qualitative Analysis of the 2018 dogs detected 5,858 VOCs 
in the DB-Wax column analysis and 6,273 VOCs in the HP5-MS column analysis and 
recognisable compounds. As with the 2017 data, these volatiles were chemically 
identified using Agilent MassHunter Workstation- Unknowns Analysis (Agilent 
Technologies, UK) which utilised the NIST14 electronic library and individual retention 
times for each compound. Although all volatiles were recognised, only 1,478 VOCs 
from the DB-Wax analysis and 1,397 VOCs from the HP5-MS analysis were 
subsequently identified and named in all the chromatograms which were analysed.  
 
6.3.1.3 Identification of the VOCs characteristic for cVL infection 
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Agilent Mass Profiler Professional (MPP) analysis identified 5 entities for 2017 
HP5-MS, 3 entities for 2017 DB-Wax, 27 entities for 2018 DB-Wax and 4 entities for 
2018 HP5-MS which were considered as being significantly important in distinguishing 
between infected and uninfected dogs. However, due to the diversity and quantity of 
VOCs found within samples, and the identification only being performed using the 
libraries inbuilt into the MPP software, some significantly important volatiles remained 
unnamed. The most significantly important VOCs to differentiate infected from 














Silane, trichlorodocosyl- Decrease 
(-)-cis-Myrtanylamine Increase 
Octanal, 2-(phenylmethylene)- Increase 
5-Tridecene, (Z)- Decrease 
2017 DB-Wax o-Terphenyl Increase 




Benzene, (1-butylhexyl)- Decrease 
4- Trifluoroacetoxytetradecane Decrease 
Biphenyl Increase 
2-Methylhexacosane Increase 
Butanoic acid, 2-hexenyl ester, (Z)- Increase 
Benzene, (1-pentylhexyl)- Decrease 
Benzene, (1-ethylnonyl)- Decrease 
Styrene Increase 
Diethyl Phthalate Decrease 
Table 6.1: Significantly important volatiles identified in the hair samples from dogs 
in 2017 and 2018. All samples were identified following further filtering using an 
unpaired t-test significance analysis in Agilent MPP software. P<0.05; 2017 HP5-
MS/DB-Wax and 2018 HP5-MS. P<0.5; 2018 DB-Wax. 
216 
 
6.3.2 CVL identification: Statistical analysis and Visualisation 
6.3.2.1 Principle Component Analysis (PCA) 
The PCA was performed on the conditions set for the data (infected or 
uninfected) which allowed for the detection of any similarities between samples, 
which were discriminated by major trends in the data. The results of the PCA analyses 
for each of the four different experiments are shown in score graphs of the first and 
second principle components (PC) (Figures 6.3 and 6.4). This pair of PCs were chosen 
because of the better grouping tendencies which were obtained. The score graphs 
illustrated in figures 3 and 4 of the samples from both 2017 and 2018 using the two 
different columns (HP5-MS and DB-Wax) illustrates segregation between infected and 
uninfected dogs.  
Visual analysis of the PCA score graphs suggests that most of the samples from 
infected dogs displayed a degree of tighter clustering than the uninfected dogs. 
However, when performing the analysis of the 2017 dogs with the HP5-MS column, 
the uninfected dogs tend to show tighter clustering with the infected dogs showing a 






Figure 6.3: PCA score plots of dog hair volatile samples from the GC/MS analyses of 
2017 dogs on A) DB-Wax column and B) HP5-MS column. Uninfected dogs are shown 
in red solid and infected dogs in yellow. The numbers next to each positive dog 
represent the individual dog analysed (and replicate A, B or C for HP5-MS experiment). 
The corresponding parasite loads are shown in supplementary Tables 1A, 1B, 1C and 
2. PCA preformed using Agilent Mass Profiler Professional (MPP) v15.0 software 
(Agilent Technologies, UK). A) PC1=73.33%, PC2=21.26%; B) PC1=57.59%, PC2=17.8%. 






Figure 6.4: PCA score plots of dog hair volatile samples from the GC/MS analyses of 
2018 dogs on A) DB-Wax column and B) HP5-MS column. Uninfected dogs are shown 
by the solid red ellipse and infected dogs by the yellow ellipse. The numbers next to 
each positive dog represent the individual dog analysed. The corresponding parasite 
loads are shown in supplementary Tables 3 and 4. PCA preformed using Agilent Mass 
Profiler Professional (MPP) v15.0 software (Agilent Technologies, UK). A) 
PC1=73.33%, PC2=21.26%; B) PC1=57.59%, PC2=17.8%. The solid colour ellipses were 





6.3.2.2 Class Prediction Model 
For the 2017 dogs (Table 6.2), HP5-MS non-polar column analysis shows a 
distinct segregation with a specificity of 95.8% and sensitivity of 100% being 
determined. However, although showing some separation, the 2017 DB-Wax analysis 
showed less specificity (66.7%) and sensitivity (87.5%) with some samples being 
misclassified.  
For the 2018 dogs (Table 6.3), the HP5-MS non-polar column analysis showed 
a high segregation with a specificity of 91.7% and sensitivity of 95.5% being 
determined. The 2018 DB-Wax analysis also showed a relatively high specificity 





Table 6.2: 2017 Confusion matrixes for the Principle Component Analyses (PCA’s) 
using Agilent Mass Professional Profiler software (MPP) v15.0. Class prediction of 
the 2017 infected/uninfected dogs using both the DB-Wax and HP5-MS columns.  
 
Table 6.3:  2018 Confusion matrixes for the Principle Component Analyses (PCA’s) 
using Agilent Mass Professional Profiler software (MPP) v15.0. Class prediction of 
the 2018 infected/uninfected dogs using both the DB-Wax and HP5-MS columns. 
 
2017 DB-Wax     
Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  18 9 66.7  
Infected  1 7  87.5 
2017 HP5-MS     
Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  23 1 95.8  
Infected  0 10  100 
 
2018 DB-Wax     
Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  20 2 90.9  
Infected  3 14  82.4 
2018 HP5-MS     
Observed\Predicted Uninfected  Infected  Specificity (%) Sensitivity (%) 
Uninfected  22 2 91.7  




The PCA performed using Agilent MPP software demonstrates the ability of the 
GC/MS to identify and discriminate between Leishmania infected and uninfected dogs. 
However, unsurprisingly the type of column used had a significant effect on the 
discrimination capabilities of this diagnostic technique, with samples analysed using 
the HP-MS non-polar column for both years discriminating between infected and 
uninfected dogs with a higher sensitivity and specificity. This can be demonstrated by 
the confusion matrices performed on the PCA data for the HP5-MS column which 
demonstrated 100% sensitivity for the 2017 dogs and 95.5% sensitivity for the 2018 
dogs. These results further validate the capabilities of the VOC Analyser to distinguish 
between infected and uninfected dogs (Staniek et al., 2019), with GC/MS analysis also 
identifying a differentiation between dogs. In addition, as with the VOC Analyser 
analysis, the origin of the observed change in volatiles following Leishmania infection 
is still under debate as parasite load also appears to have no effect on GC/MS 
distribution of the infected dogs. This result further suggests evidence that the change 
in odour profile is not related to an immune response, contradicting previous cVL 
research (Magalhães-Junior et al., 2014b)  
GC/MS analysis of the dog samples also provided the structural and chemical 
information of specific volatiles which were up or downregulated in positive dogs. This 
allowed for a GC/MS library search to preliminary identify those volatiles which could 
be considered as being Leishmania specific. This is an important observation, not only 
as a contribution to the further development of a VOC Analyser as a new and minimally 
invasive diagnostic technique, but also for the future development of vector control 
methodologies based on odour baited sandfly traps. Both observations are likely to 
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reinforce the clinical diagnosis and prognosis of cVL currently performed by classical 
techniques as well as to improve clinical decisions which currently consist of the 
removal of infected dogs by culling. 
 
6.4.1 GC/MS discrimination between infected and uninfected dogs 
Volatile organic compounds (VOCs) have previously been used to characterise 
a range of disease conditions. These include the analysis of various parasitic diseases 
such as the diagnosis of malaria through the odour of socks worn by children (Guest 
et al., 2019), but also cVL through the analysis of VOCs found in hair (Magalhães-Junior 
et al., 2014; Staniek et al., 2019). Through this research, particularly the identification 
of parasite specific biomarkers and volatiles, metabolomics has offered the potential 
for the development of promising laboratory tools for the analysis of parasitic 
diagnostic biomarkers. This analysis may be used to not only assess disease 
susceptibility, but also to diagnose an infected individual and evaluate the therapeutic 
response to treatment. To this end, the use of GC/MS in the diagnosis of cVL shows 
great promise as shown in previous work by Oliveira et al., (2008) and Magalhães-
Junior et al., (2014b), but also the results demonstrated here.  
The results presented here demonstrate the use of GC/MS technology as a 
non-invasive and sensitive diagnostic technique. Despite a small amount of overlap 
following PCA analysis, confusion matrices demonstrated the ability of the GC/MS 
fitted with a HP5-MS non-polar column to distinguish between 2017 infected and 
uninfected dogs with 95.8% specificity and 100% sensitivity and 2018 infected and 
uninfected dogs with 91.7% specificity and 95.5% sensitivity. However, analysis using 
the DB-Wax polar column demonstrated a lower sensitive and specificity when 
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distinguishing between 2017 dogs (66.7% specificity and 87.5% sensitivity) and 2018 
dogs (90.9% specificity and 82.4% sensitivity). These results are however not 
surprising. Although different types of volatile compounds are found in different 
biological media, many of the molecules found in sweat, which are excreted onto hair 
samples, are non-polar with the outer layer of skin also predominantly consisting of 
non-polar molecules (Dormont et al., 2013). Therefore, the use of a non-polar GC 
column such as the HP5-MS that is made using the least selective non-polar stationary 
phase would be expected to produce more accurate results due to the general 
chemical principle of like dissolving like. In order to improve the potential sensitivity 
of the analysis however, various other biological samples should be considered for 
GC/MS analysis. Although sweat contains predominantly non-polar molecules, 
research has demonstrated other biological samples as containing both polar and non-
polar compounds thereby allowing for the utilisation of both columns in a 
simultaneous statistical analysis to generate a higher sensitivity. For example, a variety 
of polar and non-polar volatiles have been identified in the breath of individuals in 
certain disease states such as cancer (Amor et al., 2019) and respiratory tract 
infections (Christ-Crain and Muller, 2007). Specific Leishmania research has 
demonstrated an increase in the levels of certain chemokines in the skin cells of dogs 
naturally infected with Le. infantum (Menezes-Souza et al., 2012). A variety of both 
polar and non-polar interactions contribute to the production of chemokines 
production and their receptor binding; therefore, the use of skin scrapings or aspirates 
could be suggested as a biological sample a more robust GC/MS analysis. The results 
presented here can be further validated by recent research which also demonstrated 
a distinctive differentiation between the VOC profiles of Leishmania infected and 
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uninfected dogs (Magalhães-Junior et al., 2014b). However, this study not only 
demonstrated more overlap between infected and uninfected dogs following partial 
least squares discriminant analysis (PLS-DA), but in addition only 36 dogs were used 
for the analysis. It could therefore be suggested that the data present here provides a 
more robust analysis and accurate representation of the discrimination between the 
volatile profiles of cVL infected and uninfected. 
Further analysis of the results presented her demonstrate a high level of 
dispersion between individual hair samples, particularly within the uninfected dog 
groups (Figure 6.3 and 6.4). This variation is to be expected due to hair not being a 
homogeneous matrix as well as several intrinsic factors which can influence the 
analysis. The colour and texture of the hair as well as the use of products to prevent 
ectoparasites and for cosmetic purposes, the hair growth rate and the anatomical 
origin of the sample may also interfere with the dispersion results (Vincenti et al., 
2013). Therefore, in order to relieve bias in this work, the dorsal area of all dogs 
sampled was standardised. Furthermore, due to the study consisting of a variety of 
genders, species and age, the colour and texture of the hair are less of a contributing 
factor towards bias. 
Many mechanisms have been identified which occur during Leishmania 
infection in dogs. These responses range from internal immune responses (Pinelli et 
al., 1994), to alteration of the microbiome on the skin of infected dogs (Gimblet et al., 
2017). Therefore, the use of hair to diagnose the pathological changes which occur 
during cVL infection is an interesting metabolomic approach to standardising the 
biomarkers of the endogenous metabolism in cVL. This is due to not only the ease of 
sample collection, but also the nature of hair follicles which secrete and excrete 
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substances that are produced endogenously (Harkey, 1993). Therefore, regardless of 
the mechanism behind the change in the volatiles produced by infected and 
uninfected dogs, hair follicles will represent the biological changes which occur during 
cVL infection. 
 
6.4.2 Leishmania specific compounds 
Following further filtering in Agilent MPP Software using an unpaired t-test 
significance analysis, a total of 6 VOCs for 2017 (5 for HP5-MS; 1 for DB Wax) and 12 
VOCs for 2018 (1 for HP5-MS; 11 for DB Wax) whose expression profiles varied 
comparatively according to the infected or uninfected infection status of the dogs 
evaluated were preliminary identified. Although the identity of the compound can be 
suggested (Table 4), GC/MS analysis can only provide structural and chemical 
information which can assist with the identification of the compounds. Therefore, the 
identification of the compounds obtained from the library fitting is ambiguous with 
further experiments normally required in order to achieve the exact identification. 
However, despite the exact identity of the compounds being unknown, due to the 
HP5-MS column providing the best differentiation between infected and uninfected 
dogs in both 2017 and 2018 it can be suggested that 5 VOCs for 2017 dogs and 1 VOC 
for 2018 dogs are significant for differentiating between infected and uninfected dogs. 
Of the 5 volatiles identified in 2017, 3 were found to have an increase in concentration 
in infected dogs in addition to singular volatile for the 2018 dogs (Table 6.4). This 
therefore suggests these volatiles as potential biomarkers for Le. infantum infection in 
dogs which could be utilised for the further development of the VOC Analyser 
diagnostic technique (Staniek et al., 2019). Previous research has also demonstrated 
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an increase in sandfly attractiveness to cVL specific volatiles (Magalhães‐Junior et al., 
2019) in addition to the results presented in Chapter 5, suggested that these volatiles 
could lead to the development of synthetic odorant traps to improve current vector 
control in Brazil. However, in order to further our understanding of the role that these 
volatiles have in sandfly attractiveness, further research should be undertaken to 
demonstrate the sandfly behavioural response when exposed to these individual 
chemicals. 
As shown in Table 6.1, the volatiles identified as being Leishmania specific 
differ depending on the column used with all the chemicals found in the HP5-MS 
analysis differing to those identified following the DB-Wax analysis. This is not 
surprising however, due to the polar and non-polar nature of the different columns 
having differing sensitivities to different volatiles. What is surprising however is the 
difference between the groups of volatiles which were identified as being up or 
downregulated in the 2017 dog volatiles compared to the 2018 dog volatiles when 
using the same column.  Although the exact reason for this difference is unknown, it 
could be suggested that the storage time of the samples could have had an effect. The 
2017 hair samples were stored for a longer period compared to the 2018 samples prior 
to entrainment. Previous research has demonstrated the production of different 
bacteria and hormone concentrations during different storage times (Lauber et al., 
2010). Furthermore, the 2018 analyses used a larger data set with a larger number of 
positive dogs being analysed. Therefore, it could be suggested that these analyses 
were more robust, providing a greater representation of the volatiles that are 
considered as being Leishmania specific as they were identified in a larger number of 
positive dogs. The volatiles identified here also differed from those identified by 
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Magalhães‐Junior et al., (2014b) who suggested 6 volatiles as being Leishmania 
specific; octanal.,  nonanal.,   -hydroxyethyl phenyl ether, decanal.,  heptadecane and 
2-ethylhexyl-salicylate. Although the exact reason for this difference in identified 
volatiles is unknown, it could be suggested that the use of two different extraction 
techniques; Solid phase micro extension (SPME) (Magalhães‐Junior et al., 2014b) and 
the headspace entrainment on Tenax methodology used here, could be a contributing 
factor. There are a few suggested disadvantages identified for SPME including a lack 
of absorption of light volatiles (e.g. acetaldehydes) when using certain SPME fibres, in 
addition to the preferential absorption of heavier volatiles. Additionally, polar volatiles 
have been shown to be present in higher levels in SPME extracts, a further 
disadvantage of this methodology as the molecules that are found on hair samples are 
predominantly non-polar. Further research has also demonstrated that headspace 
entrainment on Tenax allows for the extraction of higher amounts of most volatiles, in 
particular low-boiling compounds. (Elmore et al., 2001). This evidence not only 
provides an explanation for the observed differences between the two studies, but 
also suggests headspace entrainment as being a more efficient entrainment 
methodology for the analysis of Leishmania infected hair samples. 
The identification of these biomarkers as potential Le. infantum specific volatiles could 
have a major impact on the development of the VOC Analyser technology as a non-
invasive diagnostic device for cVL. The use of VOC Analysers for the diagnosis of 
specific diseases present in animal hosts has already been achieved (Fend et al., 2005). 
Through the development of specific sensor arrays and improvements made in the 
design of new sensors, VOC Analysers have been adapted for specific host types as 
well as chemical classes of volatiles which have been identified as being closely 
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associated with certain diseases (Wilson, 2016). A significant amount of progress in 
the development of VOC Analysers for animal disease detection, combined with 
metabolomics, has already proven effective in the veterinary medicine field. Important 
biomarkers and aroma profiles have been discovered for major infectious diseases of 
wildlife, fish and livestock (Moore et al., 2007). Results presented in this report along 
with Staniek et al., (2019) demonstrate a high sensitivity and specificity when using a 
Table 6.4: VOCs identified as potential biomarkers for Le. infantum infection in 
Dogs. In the 2017 samples, 3 volatiles were found to have an increase in 
concentration in infected dogs; 2-(phenylmethylene)-octanal (-)-cis-myrtanylamine 
and n-tridecan-1-ol. In the 2018 samples, 1 volatile was found to have an increased 














VOC Analyser to diagnose Leishmania infected dogs. For the purpose of this study, a 
random array of electronic chemical sensors, which had partial specificity, was utilised. 
The individual sensors used for the VOC Analyser diagnosis had semi-selectivity to 
different groups of volatile chemicals such as alcohols, aldehydes, ketones and organic 
acids. However, following analysis only a small percentage of the sensor variables 
(2/88 in 2017 and 3/88 in 2018) contributed significantly to the separation of infected 
and uninfected dogs (Staniek et al., 2019). This therefore suggests that there is the 
potential to improve the sensitivity and specificity of the VOC Analyser device. This 
could be achieved by modifying the sensor array through the addition of new sensors 
that are highly sensitive to the individual volatiles identified here as being Leishmania 
specific VOCs. This will therefore lead to the development of a Leishmania specific 
sensor array. The development of a specific sensor array made using the known 
compounds identified here could increase the sensitivity and specificity of the VOC 
Analyser device whilst maintaining the non-invasive qualities of this technique. 
 
6.4.3 Summary 
The results presented here suggest that the VOCs that are emitted in the hair 
of infected dogs can be used as biomarkers of Le. infantum infection. Furthermore, the 
specific volatiles identified could be used to further develop methodologies for the 
diagnosis of Leishmania in dogs through the modification of a VOC Analyser. The 
results presented here identified 4 VOCs which may prove important in the further 
development of VOC Analyser technology as a diagnostic tool for cVL in Brazil through 
the development of a Leishmania specific sensor array (Staniek et al., 2019). Increasing 
the specificity of such a device through the addition of adapted sensors based on these 
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results, could improve the current Leishmania control methods in Brazil which rely on 
the use of an accurate diagnostic device in order to achieve effective culling. 
Additionally, it can be suggested that these identified volatiles may be attractive to 
sandfly vectors due to previous research which has shown an increase in sandfly 
attraction to Leishmania specific volatiles identified through the SPME/GC/MS analysis 
of infected canine hair samples (Magalhães‐Junior et al., 2019). The results presented 
here could lead to the development of synthetic odorants that are attractive to sand-
flies, as well as developing improved entomological traps and other instruments which 






Chapter 7 – Discussion 
 
Despite recent advances in modern medicine, infectious diseases continue to 
devastate developing countries. Visceral leishmaniasis is still a problem in Brazil, with 
approximately 3,500 cases reported annually and a peak lethality rate of 20% reported 
from 2011 to 2016 (Luz et al., 2018). In addition to the early diagnosis of Leishmania 
infected individuals and case management, current control methods employed in 
Brazil in order to control the spread of leishmaniasis include the diagnosis and 
subsequent culling of infected dogs as well as methods of vector control in order to 
reduce sandfly numbers and disease transmission (Boelaert et al., 2018). 
Despite the use of dog-based strategies for the control and prevention of VL in 
Brazil, including dog culling and vaccinations, there is still no satisfactory dog control 
strategy currently available which aids in a reduction of disease transmission (Ribeiro 
et al., 2018).  Dogs have been found to respond poorly to anti-leishmanial therapy, 
with the current commercial vaccine used in Brazil having a protective efficacy of 71% 
(Regina-Silva et al., 2016). Furthermore, despite hundreds of thousands of dogs being 
culled every year in Brazil, the prevalence of canine leishmaniasis is still very high in 
several endemic areas due, in part, to inaccurate diagnostics (Dantas-Torres et al., 
2019). New diagnostic tests that are rapid, affordable and highly accurate therefore 
need to be developed in order to help control the continual spread of infection and 
reduce disease transmission and incidence throughout Brazil. The effective use of 
volatile analysis as a potential diagnostic tool for cVL has already been demonstrated. 
Research has observed that different VOCs are produced by Leishmania infected and 
uninfected dogs, with multivariate analysis able to group these dogs based on the 
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VOCs produced (Magalhães-Junior et al., 2014). These results combined with research 
which has demonstrated the effective use of VOC Analysers in the diagnosis of 
diseases such as tuberculosis (Teixeira et al., 2017) and lung cancer (Tirzite et al., 2018) 
through the analysis of changes in VOC profiles, suggest the potential use of VOC 
Analysers as a non-invasive diagnostic for cVL.  
In addition to the development of new diagnostic approaches to improve 
current leishmaniasis control methods in Brazil, a reduction in the number of female 
sandflies will also reduce disease transmission. Sandfly control is an important 
component of many of the anti-Leishmania programs currently in place in Brazil. These 
currently include the spraying of aggregations sites with insecticides such as DDT and 
the use of deltamethrin insecticide-impregnated collars (Coulibaly et al., 2018; Leite et 
al., 2018). Although it has been suggested that the use of insecticides may be effective 
in reducing the transmission of Leishmania, it has been demonstrated that insecticide 
resistance may result in the failure to control sandfly population numbers. Spraying of 
aggregation sites that are near reported human cases of VL has not proved effective 
in the reduction of disease prevalence (Amora et al., 2009). Research has also 
demonstrated a 36.3% rate of resistance of Lu. longipalpis to deltamethrin in Brazil 
(Alexander et al., 2009). Therefore, the development of new, more effective vector 
control methods which result in a reduction in the number of female sandflies will not 
only have an impact on disease transmission but also help with a reduction in the 
current reliance on insecticides and subsequent development of insecticide resistance. 
Recent research has demonstrated the use of pheromone lures as a potential sandfly 
control program in Brazil. Lutzomyia longipalpis showed a significant increase in 
attraction to chicken sheds which were sprayed with a combination of pheromone and 
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insecticide. Interestingly, sheds which were treated with insecticide alone resulted in 
fewer males being attracted and a significant decrease in female sandfly attraction 
(Bell et al., 2018). Therefore, the successful development vector control 
methodologies which utilise a combination of sandfly lures and insecticide could be 
suggested. This approachcould have a major impact on the transmission of 
leishmaniasis throughout Brazil, resulting in an increase of the numbers of sandflies 
caught and killed.  
 
7.1 CVL in Field Diagnostics  
Canine visceral leishmaniasis, caused by Leishmania infantum, is considered a 
zoonosis that is potentially fatal to both dogs and humans. Dogs are the main reservoir 
host and source of human infection in Brazil (Roque and Jansen et al., 2014). The ability 
of dogs to acts as a reservoir host for the Leishmania parasite is of major concern not 
only due to the rapid spread of cVL among dogs, but also the close proximity of dogs 
to humans in the domestic environment (Baneth et al., 2008; Woodroffe et al., 2012). 
The increasing awareness that the control of human VL is highly dependent on the 
effective control of cVL has prompted an increase in research regarding Leishmania 
infection in dogs. However, there is still no cVL diagnostic technique that is 100% 
specific and sensitive (Pessoa-e-Silva et al., 2019). The cVL diagnostic protocol adopted 
by the Brazilian Ministry of Health in 2012 included the use of the invasive, in-field and 
rapid Dual-Path Platform (DPP) test, which has demonstrated a low sensitivity of 56% 
when diagnosing symptomatic dogs and 75% when diagnosing asymptomatic dogs 
(Coura-Vital et al., 2014; Almeida et al., 2017b; Figueiredo et al., 2018). The 
development of new in-field diagnostic tests that are cheap, non-invasive and reliable 
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is essential to improve diagnosis of cVL in the field, which will subsequently help 
reduce disease transmission. 
The use of point of care diagnosis of cVL has many advantages over current 
laboratory-based techniques. First, this type of analysis would provide a faster access 
to test results enabling clinicians to make rapid clinical decisions as well as suggest 
more appropriate interventions and treatments due to early stage diagnosis 
(Kazmierczak, 2011). Second, point of care analysis also minimises time-dependent 
changes in disease state by giving an accurate diagnosis in the field rather than waiting 
for laboratory results. This is particularly important for the diagnosis of cVL due to 
positive dogs currently remaining in the environment for a few months following 
sampling due to the transport of blood samples to laboratories in order to perform 
diagnosis. Third, the adaptation of current diagnostic tests to provide point of care 
testing could facilitate large-scale screening programs (Duthie et al., 2018).  Finally, 
point of care analyses predominantly require a smaller volume of sample then that 
which is needed for testing in a laboratory (John and Price, 2014). Although new rapid 
diagnostic tests could deliver a faster, less invasive and accurate disease diagnosis, 
with all new diagnostic tests there are many barriers which need to be overcome 
following their introduction. New diagnostics are subjected to uncertainties 
concerning coverage decisions, slow and maladapted regulatory approval processes, 
ethical and social issues, as well as resistance among physicians to new diagnostic 
methods, all of which combine to hinder innovation and slow the distribution of new 
diagnostic tests into mainstream clinical use (Ivanov, 2013). These hurdles are an 
important aspect to consider when developing a new diagnostic and could have a 
significant effect on the introduction of a new, non-invasive in-field diagnostic for cVL. 
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The use of VOC Analysers as a point of care diagnostic tool for cVL is a novel idea. 
Results presented here demonstrate that the VOC Analyser can distinguish between 
cVL infected and uninfected dogs with a 97-100% sensitivity and 95-100% specificity 
(Staniek et al., 2019). These results were further confirmed through a more sensitive 
GC/MS analysis which demonstrated 96-100% sensitivity and 92-96% specificity. 
Although this study did not compare the VOC Analyser with the current Brazilian 
diagnostic protocol in the field, results presented here suggests that this method is 
more reliable than the current in-field DPP diagnostic test. This suggests the potential 
use of a VOC Analyser as a non-invasive, accurate, point of care cVL diagnostic 
technique which could be adopted by the Brazilian Ministry of Health. The non-
invasive nature of the VOC Analyser will result in both a higher rate of dog owner 
compliance and an increase in dog welfare, thereby allowing for a larger number of 
dogs to be sampled in the field (Lefort et al., 2019).  
Despite recent developments the novel nature of VOC Analyser technology means 
that further investigative research, particularly on sensor development and design, 
still needs to be undertaken in order to improve the accuracy of the diagnostic 
(Teixeira et al., 2017; Wilson et al., 2018). Recent research has demonstrated the 
importance of sensor design in significantly increasing the accuracy of VOC Analyser 
lung cancer screening (Li et al., 2017). In order to improve the accuracy of the VOC 
Analyser in the diagnosis of cVL, the development of a sensor array which contains a 
specific sensor array that is sensitive for Leishmania specific volatiles would be highly 
beneficial (Brekelmans et al., 2016). GC/MS analysis using the HP5-MS non-polar 
column of the hair samples collected in 2017 and 2018 provided information on the 
structure and chemical identity of 4 volatiles which had an increase in concentration 
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in Le. infantum infected dogs. A preliminary library search suggested the identify of 
these volatiles as; 2-(phenylmethylene)-octanal (-)-cis-myrtanylamine, n-tridecan-1-ol 
and 2,3-dimethyl-undecane. Therefore, developing a sensor array that is highly 
specific for these volatiles could improve the specificity of the VOC Analyser leading to 
the development of a cVL specific diagnostic test. The methodology used for hair 
collection could also be an important factor to consider in the future development of 
a VOC Analyser diagnostic tool. The collection of hair samples here which was 
performed in the dorsal region of all dogs could prove a disadvantage, as recent 
research has demonstrated that there are distinct differences between the microbial 
communities which originate from different regions of the body (Torres et al., 2017). 
Therefore, in order to increase the accuracy of the VOC Analyser as a cVL diagnostic 
tool, further research identifying the optimum location for hair collection should be 
considered.  
However, despite the limitations, the high sensitivity, specificity and non-invasive 
nature of the VOC Analyser, along with the potential to develop a more specific 
Leishmania sensor array strongly supports the use of a VOC Analyser as a new, rapid, 
point of care diagnostic tool for cVL in Brazil. 
 
7.2 Vector Control 
In addition to canine control strategies, vector control methods are also 
recommended by the Brazilian Ministry of Health for the prevention and control of VL. 
Sandflies play a vital role in the maintenance of VL with transmission occurs through a 
cycle between the sandfly species Lu. longipalpis, which transmits Le. infantum 
through dog reservoir hosts. Due to the ineffectiveness of current dog vaccines 
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(Regina-Silva et al., 2016), expensive treatment and ineffective culling strategies 
(Sousa-Paula et al., 2019), more cost-effective and efficient approaches to sandfly 
control should be considered in order to reduce the transmission of Leishmania. The 
use of insecticides, which involves the indoor residual spraying (IRS) of households and 
aggregations sites that are within 200m of reported cases of human VL as well as the 
use of insecticide-impregnated dog-collars, are currently recommended in Brazil. 
However, the long-term sustainability and success of these methods is threatened by 
the development of sandfly insecticide resistance (Dhiman and Yadav, 2016) with little 
evidence suggesting that IRS is reducing disease burden (Quinnell and Courtenay, 
2009). Therefore, new complementary and novel approaches to vector control must 
be explored.  
Using an appropriate parasite/vector combination, the results presented here 
demonstrate that female Lu. longipalpis sandflies are significantly more attracted to 
the whole odour profile of Leishmania infantum infected dogs. A total of 685 (65.7%) 
of all female sandflies which responded (n=1043) showed an increased attraction to 
infected dog odour. This increase in attraction confirms previous research which 
identified an increase in female attraction to individual VOCs of Leishmania infected 
dogs (Magalhães-Junior et al., 2019) as well as previous results which demonstrated 
an increase in attraction of female sandflies to the whole odour profile of infected 
golden hamsters (Nevatte et al., 2017). These results further confirm the 
differentiation observed between infected and uninfected dogs following VOC 
Analyser and GC/MS Analysis. This increased attraction to the whole odour profile of 
infected dogs could also further our understanding of diseases epidemiology due to 
the required dog/sandfly interaction necessary for Leishmania transmission in Brazil. 
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The results also demonstrated that male Lu. longipalpis are equally attracted to both 
infected and uninfected dog odour, with only 10% (n=123) of all the males analysed 
(n=1200) remaining “undecided” and infection status having no influence on 
attraction. This is an important observation which furthers our understanding on 
Leishmania transmission in Brazil. The formation of male lekking sites equally around 
infected and uninfected dogs, not only facilitates the attraction of female sandflies to 
infected dogs to gain a parasite blood meal but will also result in female attraction to 
uninfected dogs and continued Leishmania transmission. This heterogeneous 
distribution of female sandflies between hosts as a result of leks is a known 
phenomenon (Lane et al., 1990). Despite this observation however, the relative 
attraction of female sandflies to infected dog odour compared to uninfected dog 
odour plus a lekking site remains to be explored. Understanding this relative attraction 
could prove highly significant as uninfected dogs with lekking sites may prove more 
attractive than infected dog odour. This would potentially influence disease 
transmission if fewer female sandflies gained a parasite blood meal. Despite the 
further work that needs to be undertaken, the results presented here not only suggest 
that infected dog odour profile could have a major effect on Leishmania transmission, 
but also provides evidence to facilitate the development of novel vector control 
strategies. 
It has previously been suggested that the development of odour-baited traps 
combined with insecticides would improve capture and kill vector methodologies 
(Matowo et al., 2013). Research has demonstrated that natural human odour-baited 
traps have shown potential as affordable and effective vector control methodologies 
for luring and killing mosquitoes. Additional research has also demonstrated an 
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increase in attraction to the whole odour profiles of cows, humans and pigs for both 
teste flies and Anopheles mosquitoes (Njiru et al., 2006; Jawara et al., 2009; Rayaisse 
et al., 2010). These results are in concordance with the results presented here, 
demonstrating an increase in sandfly attraction to the whole odour profile of infected 
dogs. This provides evidence to suggest the use of the whole dog odour profile of 
infected dogs in the development of new vector control methods such as those seen 
using human odour baited traps for mosquitoes. However, further studies which 
implement and evaluate the use of dog odour baited traps for sandfly control in 
diverse eco-systems throughout Brazil are needed in order to develop this 
methodology for the incorporation into integrated vector management strategies for 
sandfly control (World Health Organisation, 2012). In addition, the development of a 
cost effective and reproducible lure based on the odour profile of infected dogs should 
be explored. The structural and chemical information of potential Leishmania specific 
volatiles provided by the GC/MS analysis could contribute to this further research. 
Despite the additional research required, the observed increase in attraction to 
infected dogs demonstrates a potential novel approach for the development of a novel 
tool to use in vector control. The use of infected dog odour as a lure could be a 





In conclusion, the research presented here demonstrates that Le. infantum 
infected dogs have a different odour profile to those dogs which were uninfected. This 
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differentiation has been demonstrated not only through GC/MS analysis, which 
confirms and improves upon previous research due to a larger sample size and 
improved instrument sensitivity (Magalhães-Junior et al., 2014b), but also through the 
use of two new approaches; sandfly behavioural bioassays and a VOC Analyser. This 
observed difference in odour profile could not only lead to the development of an 
innovative diagnostic technique (Staniek et al., 2019), but also lead to the 
development of novel sandfly vector control methodologies utilising odour baited 
traps previously been shown for other vector borne diseases (Abong’o et al., 2018; 
Matowo et al., 2013). 
The results obtained during this study, demonstrate the potential use of a VOC 
Analyser to accurately and rapidly identify dogs infected with Le. infantum. The use of 
dog hair is not only a non-invasive sampling method, thereby benefiting animal 
welfare and improving owner compliance, but also provides further knowledge of the 
interactions that are occurring between host animal and parasite. However, in order 
to improve the sensitivity of the device further improvements to the sensor array, 
portability of the device and sampling methodology could be suggested. The structural 
and chemical information of potential Leishmania specific volatiles provided by the 
GC/MS analysis could contribute to further sensor array development. Despite these 
suggested improvements, the VOC Analyser demonstrates potential not only as a 
future in-field diagnostic device for cVL, modifying the current Brazilian Ministry of 
Health protocol, but also as an effective diagnostic for VL in humans and other parasitic 
diseases.  
With respect to sandfly behaviour and vector control, the results presented here 
confirm previous research which demonstrated an increased attraction to golden 
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hamsters infected with Le. infantum (Nevatte et al., 2017). However, the use of an 
appropriate parasite-vector combination here furthers our understanding of the 
natural transmission of Leishmania. This observed attraction also suggests the use of 
whole dog odour profile as a means of vector control throughout Brazil, using odour 
baited traps. Combining such traps with current insecticide-based methodologies in 
Brazil, could lead to a significant reduction in the number of female sandflies (Coulibaly 
et al., 2018). Furthermore, through GC/MS analysis, the structural and chemical 
information of specific VOCs that are emitted in infected dog hair have the potential 
to be employed as chemical attractants for odour baited traps which could contribute 
to vector control. 
 
7.4 Future work 
• The development of a new in-field diagnostic test for the accurate diagnosis of 
Leishmania infected dogs in Brazil is essential for the success of the current 
control methods. Although the results here demonstrate the ability of a VOC 
Analyser to discriminate between infected and uninfected dogs, future 
improvement to the device need to be made. The current device used was a 
bench top version of the technology. In order to make the device suitable for 
the in-filed diagnosis of dogs a portable, hand-held device should be 
developed. Additionally, to improve diagnostic sensitivity and specificity, a 
Leishmania specific sensor array should be developed using, in part, the GC/MS 
identification of Leishmania specific volatiles identified here.  
• It is also important to follow up the current investigation with further in-field 
studies including the comparison of the sensitivity and specificity of the VOC 
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Analyser diagnostic test when combined with DPP cVL diagnostic against the 
current protocol of the DPP cVL combined with an ELISA. 
• Furthermore, the ability of the VOC Analyser to distinguish between different 
Leishmania species is also essential for the future development of this device. 
Previous work has identified dogs infected with Le. amazonensis and Le. 
braziliensis in Brazil. Although this study only demonstrated the diagnosis of 
Le. infantum infection, results presented in the supplementary material (Table 
9.5) demonstrate the ability of the VOC Analyser to distinguish between 
different Leishmania species in vitro. This suggests the ability of a VOC Analyser 
to distinguish between dogs naturally infected with other Leishmania species 
in Brazil.  
• Further proposed research also involves the identification of the attraction of 
Lu. longipalpis female sandflies to the individual volatiles identified as being 
Leishmania specific through GC/MS analysis (2-(phenylmethylene)-octanal, (-)-
cis-myrtanylamine, n-tridecan-1-ol and, 2,3-dimethyl-undecane). This 
determination of sandfly behaviour could further research into chemical 
attractants which can be combined with baited light traps. 
•  In order for the proposed vector control methods to have an immediate 
impact on sandfly populations, field-based studies should be undertaken in 
which either whole dog odour or individual volatiles identified as being 
Leishmania specific is incorporated into disease control activities that are 
already undertaken (such as insecticide residual spraying).  
• Performing a longitudinal study or a controlled comparison between different 
Brazilian municipalities which currently employ different vector control 
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methodologies will need to be undertaken in order to test the ability of dog 
volatiles to attract and reduce the numbers of female sandflies as well as help 
in the refinement of odour-based vector control strategies. 
• Identifying sandfly visual stimuli could also lead to the development of dog 
odour baited traps that are combined with a specific coloured material. By 
exploiting sandfly behavioural responses to visual stimuli, further research 
could develop new innovative methodologies which could revolutionise vector 
surveillance and disease control. There is also the potential through this further 
work to develop a practical way of delivering killing agents such as insecticides 
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12 mins to 
reinject 
       
1 hydrocarbons   hyd_001A 1 0:40 
2 Blank   blk_001A 1 1:20 
3  dog 014 + 103.41 dog_014A 1 2:00 
4 Blank   blk_002A 1 2:40 
5 057 - 0 dog_057A 1 3:20 
6 045 - 0 dog_045A 1 4:00 
7 152 - 0 dog_152A 1 4:40 
8 161 - 0 dog_161A 1 5:20 
9 155 - 0 dog_155A 1 6:00 
10 hydrocarbons   hyd_002A 1 6:40 
11 009 - 0 dog_009A 1 7:20 
12 107 - 0 dog_107A 1 8:00 
13 004 - 0 dog_004A 1 8:40 
14 126 - 0 dog_126A 1 9:20 
15 Blank   blk_003A 1 10:00 
16 116 + 5.06 dog_116A 1 10:40 
17 Blank   blk_004A 1 11:20 
18 hydrocarbons   hyd_003A 1 12:00 
19 088 - 0 dog_088A 1 12:40 
20 115 - 0 dog_115A 1 13:20 
21 103 - 0 dog_103A 1 14:00 
22 018 - 0 dog_018A 1 14:40 
23 Blank   blk_005A 1 15:20 
24 105 + 1.03 dog_105A 1 16:00 
25 Blank   blk_006A 1 16:40 
26 hydrocarbons   hyd_004A 1 17:20 
27 001 - 0 dog_001A 1 18:00 
28 149 - 0 dog_149A 1 18:40 
29 016 - 0 dog_016A 1 19:20 
30 147 - 0 dog_147A 1 20:00 
31 072 - 0 dog_072A 1 20:40 
32 hydrocarbons   hyd_005A 1 21:20 
33 Blank   blk_007A 1 22:00 
34 150 + 0.44 dog_150A 1 22:40 
35 Blank   blk_008A 1 23:20 
36 070 - 0 dog_070A 1 24:00 
37 052 - 0 dog_052A 2 0:40 
38 hydrocarbons   hyd_006A 2 1:20 
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39 Blank   blk_009A 2 2:00 
40 164 + 0.73 dog_164A 2 2:40 
41 Blank   blk_010A 2 3:20 
42 157 - 0 dog_157A 2 4:00 
43 blank   blk_011A 2 4:40 
44 123 + 33.74 dog_123A 2 5:20 
45 blank   blk_012A 2 6:00 
46 hydrocarbons   hyd_007A 2 6:40 
47 121 - 0 dog_121A 2 7:20 
48 blank   blk_013A 2 8:00 
49 026 + 8.89 dog_026A 2 8:40 
50 blank   blk_014A 2 9:20 
51 035 + 12.82 dog_035A 2 10:00 
52 blank   blk_015A 2 10:40 
53 hydrocarbons   hyd_008A 2 11:20 
54 173 - 0 dog_173A 2 12:00 
55 021 - 0 dog_021A 2 12:40 
56 082 - 0 dog_082A 2 13:20 
57 094 - 0 dog_094A 2 14:00 
56 099 - 0 dog_099A 2 14:40 
59 hydrocarbons   hyd_009A 2 15:20 
60 163 - 0 dog_163A 2 16:00 
61 153 - 0 dog_153A 2 16:40 
62 169 - 0 dog_169A 2 17:20 
63 171 - 0 dog_171A 2 18:00 
64 013 - 0 dog_013A 2 18:40 
65 hydrocarbons   hyd_010A 2 19:20 
66 106 - 0 dog_106A 2 20:00 
67 036 - 0 dog_036A 2 20:40 
68 blank   blk_016A 2 21:20 
69 132 + 32.73 dog_132A 2 22:00 
70 blank   blk_017A 2 22:40 
71 hydrocarbons   hyd_011A 2 23:20 
72 032 - 0 dog_032A 3 0:40 
73 061 - 0 dog_061A 3 1:20 
74 068 - 0 dog_068A 3 2:00 
75 blank   blk_018A 3 2:40 
76 146 + 0.41 dog_146A 3 3:20 
77 blank   blk_019A 3 4:00 
78 hydrocarbons   hyd_012A 3 4:40 
79 142 - 0 dog_142A 3 5:20 
80 015 - 0 dog_015A 3 6:00 
81 blank   blk_020A 3 6:40 
82 041 + 2.14 dog_041A 3 7:20 
83 blank   blk_021A 3 8:00 


















12 mins to 
reinject 
       
1 hydrocarbons   hyd_001B 1 0:40 
2 70 - 0 dog_070B 1 1:20 
3 155 - 0 dog_155B 1 2:00 
4 173 - 0 dog_173B 1 2:40 
5 169 - 0 dog_169B 1 3:20 
6 Blank   blk_001B 1 4:00 
7 35 + 12.82 dog_035B 1 4:40 
8 Blank   blk_002B 1 5:20 
9 hydrocarbons   hyd_002B 1 6:00 
10 29 - 0 dog_029B 1 6:40 
11 82 - 0 dog_082B 1 7:20 
12 9 - 0 dog_009B 1 8:00 
13 Blank   blk_003B 1 8:40 
14 123 + 33.74 dog_123B 1 9:20 
15 Blank   blk_004B 1 10:00 
16 106 - 0 dog_106B 1 10:40 
17 hydrocarbons   hyd_003B 1 11:20 
18 Blank   blk_005B 1 12:00 
19 14 + 103.41 dog_014B 1 12:40 
20 Blank   blk_006B 1 13:20 
21 150 + 0.44 dog_150B 1 14:00 
22 Blank   blk_007B 1 14:40 
23 152 - 0 dog_152B 1 15:20 
24 52 - 0 dog_052B 1 16:00 
25 hydrocarbons   hyd_004B 1 16:40 
26 163 - 0 dog_163B 1 17:20 
27 43 - 0 dog_043B 1 18:00 
85 139 - 0 dog_139A 3 9:20 
86 125 - 0 dog_125A 3 10:00 
87 043 - 0 dog_043A 3 10:40 
88 029 - 0 dog_029A 3 11:20 
89 024 - 0 dog_024A 3 12:00 
90 hydrocarbons   hyd_014A 3 12:40 
91 Blank   blk_022A 3 13:20 
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28 13 - 0 dog_013B 1 18:40 
29 Blank   blk_008B 1 19:20 
30 146 + 0.41 dog_146B 1 20:00 
31 Blank   blk_009B 1 20:40 
32 hydrocarbons   hyd_005B 1 21:20 
33 103 - 0 dog_103B 1 22:00 
34 142 - 0 dog_142B 1 22:40 
35 126 - 0 dog_126B 1 23:20 
36 88 - 0 dog_088B 1 24:00 
37 99 - 0 dog_099B 2 0:40 
38 hydrocarbons   hyd_006B 2 1:20 
39 15 - 0 dog_015B 2 2:00 
40 121 - 0 dog_121B 2 2:40 
41 57 - 0 dog_057B 2 3:20 
42 Blank   blk_010B 2 4:00 
43 164 + 0.73 dog_164B 2 4:40 
44 Blank   blk_011B 2 5:20 
45 1 - 0 dog_001B 2 6:00 
46 hydrocarbons   hyd_007B 2 6:40 
47 147 - 0 dog_147B 2 7:20 
48 Blank   blk_012B 2 8:00 
49 132 + 32.73 dog_132B 2 8:40 
50 Blank   blk_013B 2 9:20 
51 139 - 0 dog_139B 2 10:00 
52 125 - 0 dog_125B 2 10:40 
53 hydrocarbons   hyd_008B 2 11:20 
54 Blank   blk_014B 2 12:00 
55 26 + 8.89 dog_026B 2 12:40 
56 Blank   blk_015B 2 13:20 
57 161 - 0 dog_161B 2 14:00 
58 24 - 0 dog_024B 2 14:40 
59 hydrocarbons   hyd_009B 2 15:20 
60 72 - 0 dog_072B 2 16:00 
61 21 - 0 dog_021B 2 16:40 
62 18 - 0 dog_018B 2 17:20 
63 94 - 0 dog_094B 2 18:00 
64 hydrocarbons   hyd_010B 2 18:40 
65 Blank   blk_016B 2 19:20 
66 41 + 2.14 dog_041B 2 20:00 
334 
 
67 Blank   blk_017B 2 20:40 
68 68 - 0 dog_068B 2 21:20 
69 36 - 0 dog_036B 2 22:00 
70 hydrocarbons   hyd_011B 2 22:40 
71 153 - 0 dog_153B 2 23:20 
72 115 - 0 dog_115B 2 24:00 
73 4 - 0 dog_004B 3 0:40 
74 157 - 0 dog_157B 3 1:20 
75 Blank   blk_018B 3 2:00 
76 116 + 5.06 dog_116B 3 2:40 
77 Blank   blk_019B 3 3:20 
78 hydrocarbons   hyd_012B 3 4:00 
79 32 - 0 dog_032B 3 4:40 
80 149 - 0 dog_149B 3 5:20 
81 45 - 0 dog_045B 3 6:00 
82 107 - 0 dog_107B 3 6:40 
83 16 - 0 dog_016B 3 7:20 
84 hydrocarbons   hyd_013B 3 8:00 
85 171 - 0 dog_171B 3 8:40 
86 Blank   blk_020B 3 9:20 
87 105 + 1.03 dog_105B 3 10:00 
88 Blank   blk_021B 3 10:40 
89 61 - 0 dog_061B 3 11:20 
90 hydrocarbons   hyd_014B 3 12:00 
















12 mins to 
reinject 
1 hydrocarbons   hyd_001C 1 0:40 
2 126 - 0 dog_126C 1 1:20 
3 Blank   blk_001C 1 2:00 
4 105 + 1.029 dog_105C 1 2:40 
5 Blank   blk_002C 1 3:20 
6 4 - 0 dog_004C 1 4:00 
7 Blank   blk_003C 1 4:40 
8 26 + 8.893 dog_026C 1 5:20 
9 Blank   blk_004C 1 6:00 
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10 hydrocarbons   hyd_002C 1 6:40 
11 1 - 0 dog_001C 1 7:20 
12 163 - 0 dog_163C 1 8:00 
13 169 - 0 dog_169C 1 8:40 
14 121 - 0 dog_121C 1 9:20 
15 149 - 0 dog_149C 1 10:00 
16 16 - 0 dog_016C 1 10:40 
17 107 - 0 dog_107C 1 11:20 
18 hydrocarbons   hyd_003C 1 12:00 
19 32 - 0 dog_032C 1 12:40 
20 Blank   blk_005C 1 13:20 
21 146 + 0.413 dog_146C 1 14:00 
22 Blank   blk_006C 1 14:40 
23 29 - 0 dog_029C 1 15:20 
24 hydrocarbons   hyd_004C 1 16:00 
25 Blank   blk_007C 1 16:40 
26 35 + 12.82 dog_035C 1 17:20 
27 Blank   blk_008C 1 18:00 
28 41 + 2.139 dog_041C 1 18:40 
29 Blank   blk_009C 1 19:20 
30 106 - 0 dog_106C 1 20:00 
31 hydrocarbons   hyd_005C 1 20:40 
32 Blank   blk_010C 1 21:20 
33 150 + 0.442 dog_150C 1 22:00 
34 Blank   blk_011C 1 22:40 
35 139 - 0 dog_139C 1 23:20 
36 52 - 0 dog_052C 1 24:00 
37 36 - 0 dog_036C 2 0:40 
38 57 - 0 dog_057C 2 1:20 
39 hydrocarbons   hyd_006C 2 2:00 
40 15 - 0 dog_015C 2 2:40 
41 Blank   blk_012C 2 3:20 
42 116 + 5.06 dog_116C 2 4:00 
43 Blank   blk_013C 2 4:40 
44 61 - 0 dog_061C 2 5:20 
45 hydrocarbons   hyd_007C 2 6:00 
46 9 - 0 dog_009C 2 6:40 
47 18 - 0 dog_018C 2 7:20 
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48 68 - 0 dog_068C 2 8:00 
49 24 - 0 dog_024C 2 8:40 
50 153 - 0 dog_153C 2 9:20 
51 hydrocarbons   hyd_008C 2 10:00 
52 Blank   blk_014C 2 10:40 
53 14 + 103.409 dog_014C 2 11:20 
54 Blank   blk_015C 2 12:00 
55 155 - 0 dog_155C 2 12:40 
56 21 - 0 dog_021C 2 13:20 
57 171 - 0 dog_171C 2 14:00 
58 hydrocarbons   hyd_009C 2 14:40 
59 103 - 0 dog_103C 2 15:20 
60 152 - 0 dog_152C 2 16:00 
61 115 - 0 dog_115C 2 16:40 
62 72 - 0 dog_072C 2 17:20 
63 157 - 0 dog_157C 2 18:00 
64 hydrocarbons   hyd_010C 2 18:40 
65 43 - 0 dog_043C 2 19:20 
66 82 - 0 dog_082C 2 20:00 
67 173 - 0 dog_173C 2 20:40 
68 88 - 0 dog_088C 2 21:20 
69 hydrocarbons   hyd_011C 2 22:00 
70 Blank   blk_016C 2 22:40 
71 123 + 33.739 dog_123C 2 23:20 
72 Blank   blk_017C 2 24:00 
73 70 - 0 dog_070C 3 0:40 
74 147 - 0 dog_147C 3 1:20 
75 142 - 0 dog_142C 3 2:00 
76 hydrocarbons   hyd_012C 3 2:40 
77 Blank   blk_018C 3 3:20 
78 164 + 0.731 dog_164C 3 4:00 
79 Blank   blk_019C 3 4:40 
80 125 - 0 dog_125C 3 5:20 
81 Blank   blk_020C 3 6:00 
82 132 + 32.726 dog_132C 3 6:40 
83 Blank   blk_021C 3 7:20 
84 hydrocarbons   hyd_013C 3 8:00 
85 161 - 0 dog_161C 3 8:40 
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86 45 - 0 dog_045C 3 9:20 
87 94 - 0 dog_094C 3 10:00 
88 99 - 0 dog_099C 3 10:40 
89 13 - 0 dog_013C 3 11:20 
90 hydrocarbons   hyd_014C 3 12:00 
91 Blank   blk_022C 3 12:40 
  
Supplementary Tables 9.1A, 9.1B and 9.1C. HP5-MS GC/MS run schedule 
for 2017 cohort of dogs. For the HP5-MS analysis the samples were run in 
triplicate (replicate A, B and C) using the automatic injection function on the 
GC/MS. Hexane blanks were run before and after each positive dog samples, 










ml of blood 
GC/MS file 
name 
Run Time (hr:mins) 
12mins to reinject 
1 hydrocarbons   hyd_001DB 0:40 
2 Blank   blk_001DB 1:20 
3  dog 014 + 103.41 dog_014DB 2:00 
4 Blank   blk_002DB 2:40 
5 045 - 0 dog_045DB 4:00 
6 152 - 0 dog_152DB 4:40 
7 155 - 0 dog_155DB 6:00 
8 hydrocarbons   hyd_002DB 6:40 
9 009 - 0 dog_009DB 7:20 
10 107 - 0 dog_107DB 8:00 
11 004 - 0 dog_004DB 8:40 
12 126 - 0 dog_126DB 9:20 
13 Blank   blk_004DB 11:20 
14 hydrocarbons   hyd_003DB 12:00 
15 088 - 0 dog_088DB 12:40 
16 115 - 0 dog_115DB 13:20 
17 103 - 0 dog_103DB 14:00 
18 018 - 0 dog_018DB 14:40 
19 Blank   blk_005DB 15:20 
20 105 + 1.03 dog_105DB 16:00 
21 Blank   blk_006DB 16:40 
22 hydrocarbons   hyd_004DB 17:20 
23 001 - 0 dog_001DB 18:00 
24 149 - 0 dog_149DB 18:40 
25 016 - 0 dog_016DB 19:20 
26 147 - 0 dog_147DB 20:00 
27 hydrocarbons   hyd_005DB 21:20 
28 Blank   blk_007DB 22:00 
29 150 + 0.44 dog_150DB 22:40 
30 Blank   blk_008DB 23:20 
31 070 - 0 dog_070DB 24:00 
32 052 - 0 dog_052DB 0:40 
33 hydrocarbons   hyd_006DB 1:20 
34 Blank   blk_009DB 2:00 
35 164 + 0.73 dog_164DB 2:40 
36 Blank   blk_010DB 3:20 
37 157 - 0 dog_157DB 4:00 
38 blank   blk_011DB 4:40 
39 123 + 33.74 dog_123DB 5:20 
40 blank   blk_012DB 6:00 
41 hydrocarbons   hyd_007DB 6:40 
42 121 - 0 dog_121DB 7:20 





44 026 + 8.89 dog_026DB 8:40 
45 blank   blk_014DB 9:20 
46 035 + 12.82 dog_035DB 10:00 
47 blank   blk_015DB 10:40 
48 hydrocarbons   hyd_008DB 11:20 
49 021 - 0 dog_021DB 12:40 
50 082 - 0 dog_082DB 13:20 
51 094 - 0 dog_094DB 14:00 
52 099 - 0 dog_099DB 14:40 
53 hydrocarbons   hyd_009DB 15:20 
54 163 - 0 dog_163DB 16:00 
55 153 - 0 dog_153DB 16:40 
56 171 - 0 dog_171DB 18:00 
57 013 - 0 dog_013DB 18:40 
58 hydrocarbons   hyd_010DB 19:20 
59 106 - 0 dog_106DB 20:00 
60 036 - 0 dog_036DB 20:40 
61 blank   blk_016DB 21:20 
62 132 + 32.73 dog_132DB 22:00 
63 blank   blk_017DB 22:40 
64 hydrocarbons   hyd_011DB 23:20 
65 032 - 0 dog_032DB 0:40 
66 061 - 0 dog_061DB 1:20 
67 blank   blk_018DB 2:40 
68 146 + 0.41 dog_146DB 3:20 
69 blank   blk_019DB 4:00 
70 hydrocarbons   hyd_012DB 4:40 
71 142 - 0 dog_142DB 5:20 
72 blank   blk_020DB 6:40 
73 041 + 2.14 dog_041DB 7:20 
74 blank   blk_021DB 8:00 
75 hydrocarbons   hyd_013DB 8:40 
76 139 - 0 dog_139DB 9:20 
77 125 - 0 dog_125DB 10:00 
78 043 - 0 dog_043DB 10:40 
79 029 - 0 dog_029DB 11:20 
80 024 - 0 dog_024DB 12:00 
81 hydrocarbons   hyd_014DB 12:40 
82 Blank   blk_022DB 13:20 
Supplementary Table 9.2. DB Wax GC/MS run schedule for 2017 cohort of 
dogs. HP5-MS replicate A was repeated using the DB-wax column (replicate D) 
however these samples were manually injected. Hexane blanks were run before 
and after each positive dog samples, with hydrocarbon standards injected 









No. of parasites 
per ml of blood 
GC/MS file name 
     
1 hydrocarbons   hyd2018_001HP5 
2 Blank   blk2018_001HP5 
3  dog 017 + 28.10 dog2018_017HP5 
4 Blank   blk2018_002HP5 
5 dog 169 - 0 dog2018_169HP5 
6 Blank   blk2018_003HP5 
7  dog 082 + 128.00 dog2018_082HP5 
8 Blank   blk2018_004HP5 
9 hydrocarbons   hyd2018_002HP5 
10 dog 153 - 0 dog2018_153HP5 
11 Blank   blk2018_005HP5 
12  dog 007 + 38.70 dog2018_007HP5 
13 Blank   blk2018_006HP5 
14  dog 096 + 5.63 dog2018_096HP5 
15 Blank   blk2018_007HP5 
16 hydrocarbons   hyd2018_003HP5 
17 dog 124 - 0 dog2018_124HP5 
18 Blank   blk2018_008HP5 
19  dog 003 + 233.68 dog2018_003HP5 
20 Blank   blk2018_009HP5 
21 dog 009 - 0 dog2018_009HP5 
22 hydrocarbons   hyd2018_004HP5 
23 dog 028 - 0 dog2018_028HP5 
24 dog 110 - 0 dog2018_110HP5 
25 dog 070 - 0 dog2018_070HP5 
26 Blank   blk2018_010HP5 
27  dog 176 + 50.91 dog2018_176HP5 
28 Blank   blk2018_011HP5 
29  dog 112 + 49.38 dog2018_112HP5 
30 Blank   blk2018_012HP5 
31 hydrocarbons   hyd2018_005HP5 
32 dog 032 - 0 dog2018_032HP5 
33 Blank   blk2018_013HP5 
34  dog 105 + 8.50 dog2018_105HP5 
35 Blank   blk2018_014HP5 
36  dog 117 + 36.41 dog2018_117HP5 
37 Blank   blk2018_015HP5 
38  dog 062 + 24.50 dog2018_062HP5 
39 Blank   blk2018_016HP5 
40  dog 074 + 115.93 dog2018_074HP5 
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41 Blank   blk2018_017HP5 
42 dog 125 - 0 dog2018_125HP5 
43 hydrocarbons   hyd2018_006HP5 
44 Blank   blk2018_018HP5 
45  dog 114 + 27.68 dog2018_114HP5 
46 Blank   blk2018_019HP5 
47  dog 059 + 25.45 dog2018_059HP5 
48 Blank   blk2018_020HP5 
49  dog 019 + 61.59 dog2018_019HP5 
50 Blank   blk2018_021HP5 
51 dog 130 - 0 dog2018_130HP5 
52 Blank   blk2018_022HP5 
53  dog 054 + 27.68 dog2018_054HP5 
54 Blank   blk2018_023HP5 
55  dog 075 + 31.50 dog2018_075HP5 
56 Blank   blk2018_024HP5 
57  dog 068 + 27.47 dog2018_068HP5 
58 Blank   blk2018_025HP5 
59  dog 034 + 15.16 dog2018_034HP5 
60 Blank   blk2018_026HP5 
61 hydrocarbons   hyd2018_007HP5 
62 dog 004 - 0 dog2018_004HP5 
63 dog 043 - 0 dog2018_043HP5 
64 Blank   blk2018_027HP5 
65  dog 134 + 50.53 dog2018_134HP5 
66 Blank   blk2018_028HP5 
67  dog 127 + 36.41 dog2018_127HP5 
68 Blank   blk2018_029HP5 
69  dog 047 + 1.30 dog2018_047HP5 
70 Blank   blk2018_030HP5 
71  dog 140 + 40.51 dog2018_140HP5 
72 Blank   blk2018_031HP5 
73 dog 023 - 0 dog2018_023HP5 
74 dog 131 - 0 dog2018_131HP5 
75 hydrocarbons   hyd2018_008HP5 
76 Blank   blk2018_032HP5 
77  dog 102 + 6.92 dog2018_102HP5 
78 Blank   blk2018_033HP5 
79 dog 136 - 0 dog2018_136HP5 
80 Blank   blk2018_034HP5 
81  dog 178 + 28.32 dog2018_178HP5 
82 Blank   blk2018_035HP5 
83 hydrocarbons   hyd2018_009HP5 
84 dog 045 - 0 dog2018_045HP5 
85 Blank   blk2018_036HP5 




87 Blank   blk2018_037HP5 
88 dog 142 - 0 dog2018_142HP5 
89 dog 021 - 0 dog2018_021HP5 
90 Blank   blk2018_038HP5 
91  dog 080 + 21.69 dog2018_080HP5 
92 Blank   blk2018_039HP5 
93 dog 016 - 0 dog2018_016HP5 
94 dog 010 - 0 dog2018_010HP5 
95 hydrocarbons   hyd2018_010HP5 
96 dog 175 - 0 dog2018_175HP5 
97 blank   blk2018_040HP5 
98  dog 126 + 853.44 dog2018_126HP5 
99 blank   blk2018_041HP5 
100 dog 137 - 0 dog2018_137HP5 
101 blank   blk2018_042HP5 
102  dog 141 + 13.73 dog2018_141HP5 
103 blank   blk2018_043HP5 
104  dog 103 + 41.76 dog2018_103HP5 
105 blank   blk2018_044HP5 
106 dog 093 - 0 dog2018_093HP5 
107 hydrocarbons   hyd2018_011HP5 
108 dog 005 - 0 dog2018_005HP5 
109 dog 172 - 0 dog2018_172HP5 
110 dog 181 - 0 dog2018_181HP5 
111 dog 037 - 0 dog2018_037HP5 
112 hydrocarbons   hyd2018_012HP5 
113 blank   blk2018_045HP5 
114  dog 044 + 27.89 dog2018_044HP5 
115 blank   blk2018_046HP5 
116 dog 118 - 0 dog2018_118HP5 
117 dog 090 - 0 dog2018_090HP5 
118 dog 042 - 0 dog2018_042HP5 
Supplementary Table 9.3. HP5-MS GC/MS run schedule for 2018 cohort of 
dogs. For the HP5-MS analysis the samples were manually injected into the 
GC/MS following the schedule above. Hexane blanks were run before and after 
each positive dog samples, with hydrocarbon standards injected randomly 









No. of parasites 
per ml of blood 
GC/MS file name 
     
1 hydrocarbons   hyd2018_001 DB 
2 Blank   blk2018_001 DB 
3  dog 017 + 28.10 dog2018_017 DB 
4 Blank   blk2018_002 DB 
5 dog 169 - 0 dog2018_169 DB 
6 Blank   blk2018_003 DB 
7  dog 082 + 128.00 dog2018_082 DB 
8 Blank   blk2018_004DB 
9 hydrocarbons   hyd2018_002 DB 
10 dog 153 - 0 dog2018_153 DB 
11 Blank   blk2018_005 DB 
12  dog 007 + 38.70 dog2018_007 DB 
13 Blank   blk2018_006 DB 
14  dog 096 + 5.63 dog2018_096 DB 
15 Blank   blk2018_007 DB 
16 hydrocarbons   hyd2018_003 DB 
17 dog 124 - 0 dog2018_124 DB 
18 Blank   blk2018_008 DB 
19  dog 003 + 233.68 dog2018_003 DB 
20 Blank   blk2018_009 DB 
21 dog 009 - 0 dog2018_009 DB 
22 hydrocarbons   hyd2018_004 DB 
23 dog 028 - 0 dog2018_028 DB 
24 dog 110 - 0 dog2018_110 DB 
25 dog 070 - 0 dog2018_070 DB 
26 Blank   blk2018_010 DB 
27  dog 176 + 50.91 dog2018_176 DB 
28 Blank   blk2018_011 DB 
29  dog 112 + 49.38 dog2018_112 DB 
30 Blank   blk2018_012 DB 
31 hydrocarbons   hyd2018_005 DB 
32 dog 032 - 0 dog2018_032 DB 
33 Blank   blk2018_013 DB 
34  dog 105 + 8.50 dog2018_105 DB 
35 Blank   blk2018_014 DB 
36  dog 117 + 36.41 dog2018_117 DB 
37 Blank   blk2018_015 DB 
38  dog 062 + 24.50 dog2018_062 DB 
39 blank   blk2018_016 DB 
40  dog 074 + 115.93 dog2018_074 DB 
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41 blank   blk2018_017 DB 
42 dog 125 - 0 dog2018_125 DB 
43 hydrocarbons   hyd2018_006 DB 
44 blank   blk2018_018 DB 
45  dog 114 + 27.68 dog2018_114 DB 
46 blank   blk2018_019 DB 
47  dog 059 + 25.45 dog2018_059 DB 
48 blank   blk2018_020 DB 
49  dog 019 + 61.59 dog2018_019 DB 
50 blank   blk2018_021 DB 
51 dog 130 - 0 dog2018_130 DB 
52 blank   blk2018_022 DB 
53  dog 054 + 27.68 dog2018_054 DB 
54 blank   blk2018_023 DB 
55  dog 075 + 31.50 dog2018_075 DB 
56 Blank   blk2018_024 DB 
57  dog 068 + 27.47 dog2018_068 DB 
58 Blank   blk2018_025 DB 
59  dog 034 + 15.16 dog2018_034 DB 
60 blank   blk2018_026 DB 
61 hydrocarbons   hyd2018_007 DB 
62 dog 004 - 0 dog2018_004 DB 
63 dog 043 - 0 dog2018_043 DB 
64 blank   blk2018_027 DB 
65  dog 134 + 50.53 dog2018_134 DB 
66 blank   blk2018_028 DB 
67  dog 127 + 36.41 dog2018_127 DB 
68 blank   blk2018_029 DB 
69  dog 047 + 1.30 dog2018_047 DB 
70 blank   blk2018_030 DB 
71  dog 140 + 40.51 dog2018_140 DB 
72 blank   blk2018_031 DB 
73 dog 023 - 0 dog2018_023 DB 
74 dog 131 - 0 dog2018_131 DB 
75 hydrocarbons   hyd2018_008 DB 
76 blank   blk2018_032 DB 
77  dog 102 + 6.92 dog2018_102 DB 
78 blank   blk2018_033 DB 
79 dog 136 - 0 dog2018_136 DB 
80 blank   blk2018_034 DB 
81  dog 178 + 28.32 dog2018_178 DB 
82 blank   blk2018_035 DB 
83 hydrocarbons   hyd2018_009 DB 
84 dog 045 - 0 dog2018_045 DB 
85 blank   blk2018_036 DB 





87 blank   blk2018_037 DB 
88 dog 142 - 0 dog2018_142 DB 
89 dog 021 - 0 dog2018_021 DB 
90 blank   blk2018_038 DB 
91  dog 080 + 21.69 dog2018_080 DB 
92 blank   blk2018_039 DB 
93 dog 016 - 0 dog2018_016 DB 
94 dog 010 - 0 dog2018_010 DB 
95 hydrocarbons   hyd2018_010 DB 
96 175 - 0 dog2018_175 DB 
97 blank   blk2018_040 DB 
98  dog 126 + 853.44 dog2018_126 DB 
99 blank   blk2018_041 DB 
100 dog 137 - 0 dog2018_137 DB 
101 blank   blk2018_042 DB 
102  dog 141 + 13.73 dog2018_141 DB 
103 blank   blk2018_043 DB 
104  dog 103 + 41.76 dog2018_103 DB 
105 blank   blk2018_044 DB 
106 dog 093 - 0 dog2018_093 DB 
107 hydrocarbons   hyd2018_011 DB 
108 dog 005 - 0 dog2018_005 DB 
109 dog 172 - 0 dog2018_172 DB 
110 dog 181 - 0 dog2018_181 DB 
111 dog 037 - 0 dog2018_037 DB 
112 hydrocarbons   hyd2018_012 DB 
113 blank   blk2018_045 DB 
114  dog 044 + 27.89 dog2018_044 DB 
115 blank   blk2018_046 DB 
116 dog 118 - 0 dog2018_118 DB 
117 dog 090 - 0 dog2018_090 DB 
118 dog 042 - 0 dog2018_042 DB 
Supplementary Table 9.4. DB-Wax GC/MS run schedule for 2018 cohort of dogs. 
For the DB-Wax analysis the samples were manually injected into the GC/MS following 
the schedule above. Hexane blanks were run before and after each positive dog 















Supplementary Figure 9.5: DFA with multiple variables of the VOCs 
released from in vitro cultures of Leishmania and the growth media 
controls.  5ml of each sample was collected and stored in a 50mL glass vial 
prior to VOC Analyser analysis. Analysis was performed according to the 
methodology outlined in Chapter 4, with the headspace of the samples passed 
over the sensor head. C1: HOMEM medium; C2: Medium 199; T1: [10]6 Le. 
infantum/mL: T2: [10]6 Le. mexicana/mL; T3: [10]6 Le. tarantolae/mL; F1: 
discriminant function 1; F2: discriminant function 2.  The numbers in 
parentheses show the percentages of the data matrix as described by the 

































Appendix 1: Staniek, M.E., Sedda, L., Gibson, T.D., de Souza, C.F., Costa, E.M., Dillon, 
R.J., Hamilton, J.G.C. 2019. eNose analysis of volatile chemicals from dogs naturally 















Appendix 2: Field work documentation, licence and letters for research equipment UK 







28 de Março de 2018 
 
 
A QUEM POSSA INTERESSAR 
 
Esta carta confirma que os itens listados abaixo são equipamentos serem utilizados conforme 
descritos no o projeto financiado pelo Wellcome Trust (Reino Unido). Este projeto é uma 
colaboração entre a universidade de Lancaster (Reino Unido) e o Instituto Fiocruz (Rio de 
Janeiro, Brasil): 
 
• 200 tubos de EDTA 
• 1 Kit de DNA extracao  
• 400 sacos de papel aluminio  
• 200 almofadas de fibra de carbono 
 
 
A Srta. Monica Staniek está a transportar o equipamento a serem utilizados única e 
exclusivamente para fins de pesquisa. Estes equipamentos não possuem valor comercial e não 
representam qualquer risco químico ou biológico. 
 
Nossos agradecimentos, 
Dr. Gordon Hamilton 






28th March 2018 
 
 
To Whom It May Concern: 
 
This is to confirm that the items listed below are equipment to be used as described in a 
project funded by the Wellcome Trust (United Kingdom). This project is a collaboration 
between the University of Lancaster (United Kingdom) and the Fiocruz Institute (Rio de 
Janeiro, Brazil): 
 
• 200 EDTA tubes 
• 1 DNA extraction kit 
• 400 foil bags 
• 200 carbon fibre pads 
 
 
Miss Monica Staniek is transporting these to be used solely for research purposes. These items 
of equipment are of no commercial value and present no chemical or biological risk. 
 
Yours sincerely 
Dr. Gordon Hamilton 



















































ICROCHIP BARCODE/BIOPSY BARCODE 
     Sam
ple date:  
  
NAM
E OF DOG: 
  
ORIGIN OF DOG: 
1. Brought in from
 street       
2. Born in house 
3. Born in tow
n 






      
Leishm
ania treatm
ent? 1.Y           0.N  
Leishm
ania vaccination                  Date: 
Collars   Scalibor              Other 
Advantix 
Citronella 




 Confident?        1.Y            0.N    
SEX                     1.M




















































































































TERMO DE CONSENTIMENTO LIVRE E ESCLARECIDO 
 
Título do projeto: O Papel do odor de cães infectados por Leishmania infantum na atração de 
Lutzomyia longipalpis, e sua utilização como base para diagnóstico precoce da leishmaniose 
visceral.,  Governador Valadares, Minas Gerais, Brasil. 
Nome do pesquisador principal: Reginaldo Peçanha Brazil 
Razão Social da instituição da CEUA que aprovou: Instituto Oswaldo Cruz - CIAEP nº 
01.0234.2014  
Objetivos do estudo:  
O objetivo do presente trabalho é utilizar cães da cidade de Governador Valadares, Minas Gerais 
para determinar se o odor de cães infectados com Leishmania infantum é mais atraente para os 
flebotomíneos da espécie Lutzomyia longipalpis do que odor de cães não infectados pelo 
parasita, e determinar se as alterações no odor podem estar relacionadas com o grau de 
parasitemia do cão, em busca de um diagnóstico precoce da doença nos cães. 
Procedimentos a serem realizados com os animais:  
Após a contenção física do animal.,  será realizado a coleta de sangue periférico das 
veias radial.,  coleta de pelos e implante de um microchip para a identificação do cão. Os 
procedimento de coleta de sangue e pelos serão realizados por três vezes ao longo de dois 
anos.  
Os animais serão mantidos junto com o proprietário durante todo o período de coleta. 
As analises serão realizadas após todo o período de coleta e comparadas, o resultado será 
disponibilizado posteriormente para o proprietário e para a Centro de Controle de Zoonoses do 
Município de Governador Valadares-MG.  
Potenciais riscos para os animais:  
Os procedimentos adotados não apresentam riscos para os cães, além de todo o 




Composto de três momentos de coletas de sangue periférico e pelos, e no momento da primeira 
coleta será instalado um microchip para identificar o cão.  Serão coletados amostras de sangue 
até completar o número máximo de 300 cães. As coletas terão início apenas depois que for 
estabelecido a autorização da CEUA, e terminara quando completar coleta de sangue de 300 
cães.  
Benefícios:  
Em inúmeros focos de leishmanioses descritos no mundo, observa-se uma grande 
variedade de animais mamíferos incriminados como possíveis reservatórios ou hospedeiros 
acidentas. Entre os animais domésticos descritos envolvidos no ciclo de transmissão de 
diferentes espécies de Leishmania, o cão (Canis familiaris) apresenta papel de destaque, devido 
sua participação enquanto hospedeiro doméstico,  
Há evidências de que os parasitas são capazes de manipular seus hospedeiros de 
maneiras que melhoram suas perspectivas de transmissão para novos hospedeiros. Um 
exemplo são parasitas de insetos que modificam o habito alimentar do inseto para sangue para 
terem mais chances de o parasita ser transmitido. É de conhecimento na medicina que durante 
centenas de anos parasitas e outras formas de infecções podem modificar o odor dos 
acometidos, é tanto que para isso a medicina utiliza-se do cheiro (ou mesmo gosto) de urina 
para diagnosticar doenças. O estudo sugerido pretende detectar alterações no odor de cães ou 
identificar biomarcadores de odor específicos utilizando métodos analíticos modernos.  
O projeto aqui proposto é uma sequência de outros estudos que vem sendo 
desenvolvido em laboratório, onde foi observada uma mudança significativa na atratividade de 
Lutzomyia longipalpis por hamsters infectados com Leishmania infantum. Estas alterações 
observadas na atratividade foram resultados de alterações apenas no odor dos hospedeiros. 
Embora hamsters não são os hospedeiros naturais de Leishmania infantum é possível que o 
mesmo efeito possa ocorrer em hospedeiros naturais como os cães. De fato, é descrito que 
insetos vetores se alimentam mais frequentemente em cães com alta parasitemia de Leishmania 
infantum, quando comparados a cães não infectados e cães infectados têm um perfil de odor 
diferente em comparação com cães não infectados.  
Portanto, é provável que os cães infectados com Leishmania infantum são mais 
atraentes do que os cães não infectados, e é possível que a alteração no odor seja detectável 
antes que as alterações clinicas de leishmaniose visceral possam ser observadas.  
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O projeto proposto tem objetivo de investigar esse fenômeno, em uma combinação entre 
reservatório (cães) / vetor natural (Lutzomyia longipalpis), por meio de modernas metodologias 
de química analítica, bioquímica, comportamental e estatística.  
O projeto proposto irá investigar a possibilidade de que um equipamento eletrônico de 
mão que possa ser capaz de distinguir entre cães infectados (em um estágio em que os sintomas 
de infecção não são visíveis) e cães não infectados, analisando o odor dos cães. Uma 
ferramenta de diagnóstico confiável, preciso, rápido e não invasiva seria extremamente útil para 
reduzir a carga real e potencial dessa doença. 
 
Esclarecimentos ao proprietário sobre a participação do animal neste projeto:  
Sua autorização para a inclusão de seu animal neste estudo é voluntária.  
A confidencialidade dos seus dados pessoais serãó preservadas.  
Os membros da CEUA ou as autoridades regulatórias poderão solicitar suas informações e, 
nesse caso, elas serão dirigidas especificamente para fins de inspeções regulares.  
A médica veterinária responsável pelo(s) seu(s) animal(is) será a Dra. Erika Moutinho Costa, 
inscrito(a) no CRMV-RJ sob o no 7.996. Além dela, e a equipe do Pesquisador Principal.,  Dr. 
Reginaldo Peçanha Brazil, também se responsabilizara ́ pelo bem-estar do(s) seu(s) animal(is) 
durante a coleta do sangue periférico. Caso necessário, após a coleta, você̂ poderá ́ entrar em 
contato com a equipe pelo contato:  
Equipe: Dr. Reginaldo Brazil, Dra. Erika Moutinho Costa, Dr. Cristian Ferreira de Souza, Monica 
Staniek.  
Endereço: Av. Brasil 4365 - Manguinhos – Rio de Janeiro/RJ – CEP: 21040-900 
Telefone: (21) 25621468  
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DECLARAÇÃO DE CONSENTIMENTO 
 
Fui devidamente esclarecido(a) sobre todos os procedimentos deste estudo, seus riscos e 
benefícios ao(s) animal(is) pelo(s) qual(is) sou responsável. Fui também informado que posso 
retirar meu(s) animal(is) do estudo a qualquer momento. Ao assinar este Termo de 
Consentimento, declaro que autorizo a participação do(s) meu(s) animal(is), identificado(s) a 
seguir, neste projeto.  
Este documento será assinado em duas vias, sendo que uma via ficará comigo e a outra com o 
pesquisador.  
_________________________________________ 
(Cidade), dd/mm/aaaa  
 
 
________________________________                      ________________________________ 





Documento de Identidade:  




Identificação do(s) animal(is)  




Nome:      Número de identificação:  
















Record of a risk assessment 
 
Task:  
Field work in Brazil is to determine the Leishmania infection status of individual 
dogs and to monitor progression of the infection over time. The involves the 
collection of blood samples from domesticated dogs this work will be done by a 
qualified experienced Brazilian vet in accordance with local and UK ethical 
approvals. 
 
DNA will be extracted from the blood samples in a laboratory in FioCruz, Rio and 
returned to the UK. 
 
The odour analysis will be done by collecting hair samples from the dorsal region 





BLS Assessment ID   





 Review date  
 
Step 1  
List significant 
hazards 
Step 2  
who might be 
harmed 
Step 3  
determine appropriate 
controls 
Step 4  
make it happen 











I will be wearing PPE; 
Lab coats and gloves. 
Any skin 
abrasions/wounds to be 
covered with plaster 
before handling the 
EDTA tubes either in the 
field or in the lab.  
 
Correct procedures for 
the handling of 
biological samples will 
be implemented. 
 
EDTA tubes containing 
collected blood samples 
will be handled using 
Details of this 
risk assessment, 
scheme of work, 
correct handling 
of canines and 
safety 
procedures to be 
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team members 





gloves and sealed until 
DNA extraction occurs. 
 
DNA extraction from the 
blood samples will be 
done in a fully 
appropriately equipped 
lab in FioCruz, Rio. 
 
Risk of contamination 
will be reduced by 
restricting the DNA 
extraction to an 
extraction hood. 
 
I have received previous 
training and 
authorisation to work 
with L. infantum cultures 
inn LU and so is 
competent to work with 










All dogs will be muzzled 
and restrained by the 
vet and dog owner.  
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of canines and 
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team members 
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disposed of in a sharps 
bin 
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Visceral leishmaniasis (VL) in Brazil is a neglected, vector-borne, tropical parasitic disease
that is responsible for several thousand human deaths every year. The transmission route
involves sand flies becoming infected after feeding on infected reservoir host, mainly dogs,
and then transmitting the Leishmania infantum parasites while feeding on humans. A major
component of the VL control effort is the identification and euthanasia of infected dogs to
remove them as a source of infection. A rapid, non-invasive, point-of-care device able to dif-
ferentiate between the odours of infected and uninfected dogs may contribute towards the
accurate diagnosis of canine VL.
Methodology/Principal findings
We analysed the headspace volatile chemicals from the hair of two groups of dogs collected
in 2017 and 2018 using a bench-top eNose volatile organic chemical analyser. The dogs
were categorised as infected or uninfected by PCR analysis of blood samples taken by
venepuncture and the number of parasites per ml of blood was calculated for each dog by
qPCR analysis. We demonstrated using a robust clustering analysis that the eNose data
could be discriminated into infected and uninfected categories with specificity >94% and
sensitivity >97%. The eNose device and data analysis were sufficiently sensitive to be able
to identify infected dogs even when the Leishmania population in the circulating blood was
very low.
Conclusions/Significance
The study illustrates the potential of the eNose to rapidly and accurately identify dogs
infected with Le. infantum. Future improvements to eNose analyser sensor sensitivity, sam-
pling methodology and portability suggest that this approach could significantly improve the
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diagnosis of VL infected dogs in Brazil with additional potential for effective diagnosis of VL
in humans as well as for the diagnosis of other parasitic diseases.
Author summary
Visceral leishmaniasis (VL) is an insect transmitted, tropical parasitic disease and in Brazil
it causes thousands of human deaths every year. Domestic dogs can also be infected, and
they are a risk factor for people. The Brazilian Ministry of Health tries to control the dis-
ease in 3 ways; first by reducing the population of insects that can carry the disease, second
by using therapeutic drugs to treat the disease in humans, and third by identifying and
euthanising infected dogs. However, despite these efforts the burden of VL has doubled
since 2010 and a significant contributing factor is the lack of a rapid and accurate pathway
for diagnosing dogs. In this study we have shown that an eNose can differentiate between
the smell of VL infected and uninfected dogs. The analysis was highly sensitive i.e. if the
dog was infected, the eNose would detect it in> 97% of the cases and it was highly specific
i.e. if the dog was uninfected eNose detect it in >94% of the cases. The outcome was not
dependant on the numbers of parasites or the clinical status of the dog. The results suggest
that eNose analysis could be used to identify VL infected dogs with improved the speed
and accuracy compared to current methods.
Introduction
Visceral leishmaniasis (VL) is a neglected tropical disease caused by protist parasites belonging
to the genus Leishmania. Globally over 350 million people are at risk of infection with an esti-
mated 200–400 thousand cases annually and an estimated 10% fatality rate. Ninety percent of
all reported VL cases occur in only six countries including Brazil[1, 2].
In Brazil, transmission of Leishmania (Leishmania) infantum (Kinetoplastida: Trypanoso-
matidae) occurs between domestic dogs Canis familiaris (Carnivora: Canidae) (the reservoir
host) and from dogs to humans when an infected female sand fly vector Lutzomyia longipalpis
(Diptera: Psychodidae) takes a blood meal.
Despite substantial efforts by the Brazilian Ministry of Health (MoH) the burden of VL in
Brazil more than doubled between 1990 and 2016[3]. The increase is probably due to the
spread of the vector into urban areas as a result of human migration into cities[4] and the
expansion of the range of the vector into new areas because of environmental degradation[5–
7]. Given the spread of the disease and increase in cases it is also likely that current VL control
measures are inadequate[8].
The control of VL in Brazil has three main components. Insecticides are applied in houses
and animal sheds to lower the vector population density and reduce vector-human contact.
Secondly, diagnosis and treatment of human cases to prevent severe forms of the disease and
death. Finally, the identification and euthanasia of seropositive canine cases to decrease the
sources of infection for the vector[9, 10].
Modelling predicts that the dog-culling program in Brazil should be effective in areas
of low, medium but not high Leishmania transmission[11]. However, the practice is contro-
versial and despite the euthanasia of thousands of canines with suspected and confirmed infec-
tion each year the program has been unsuccessful[10, 12]. There are a number of possible
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explanations for this situation A). Shortage of qualified professionals caused by financial con-
straints leading to delays in collections, performance of routine diagnostic tests and subse-
quent removal of seropositive dogs. B). Failure to identify and remove the high proportion of
asymptomatic animals C). Refusal of dog owners to comply with surveillance measures. D).
The high rate of dog replacement with young immunologically naïve dogs. E). Lack of an accu-
rate point-of-care diagnostic test[13].
Identification of dogs infected with canine VL (CVL) follows a two stage serodiagnostic
protocol recommended by the Brazilian MoH. Initial screening using the Dual-Path Platform
(DPP CVL) immunochromatography diagnostic test is followed by a laboratory-based ELISA
(EIE CVL) confirmatory test. Overall the 2-step protocol was reported to have a 73% sensitivity
and 98% specificity however the relatively low sensitivity indicates the maintenance of false-
negative dogs in endemic areas which represents a public health concern[14].
The DPP CVL test has also been assessed several times since it was introduced and most
recently it has been shown that overall it has 86% sensitivity and 94% specificity[14] or 89%
sensitivity and 70% specificity[15].
The concept of volatile organic compounds (VOCs) as diagnostic aids to signal a disease is
well established and since antiquity, many physicians have used odours associated with disease
to help diagnose their patients[16]. Modern analytical techniques such as single ion flow tube
mass spectrometry (SIFT-MS) and chemi-resistive sensors have taken the concept to the point
of widespread clinical application. Volatile markers from human breath can be used to identify
a variety of disease states e.g. inflammatory bowel disease, chronic liver disease, diabetes, Pseu-
domonas aeruginosa infection and adenocarcinomas[17, 18]. A recent study has shown that
the use of VOCs is sufficiently robust to discriminate between 14 cancerous and other disease
states[19].
Parasite infections of humans and animals also alter the odour of the host animal. The
odours of golden hamsters infected with Le. infantum are more attractive to female sand flies
than the odours of uninfected hamsters[20, 21]. The odour obtained from the hair of dogs
infected with Le. infantum in Brazil was found to be significantly different to the odour of
uninfected dogs. These odour differences which were detected by coupled gas chromatogra-
phy-mass spectrometry (GC/MS) and multivariate statistical analysis indicated the increased
presence of a small number of primarily low molecular weight aldehydes (octanal, nonanal),
alkanes (undecane, heptadecane) and 2-ethylhexyl-salicylate[22, 23]. More recently, odours
were also implicated in children infected with the infectious gametocyte stage of the malaria
parasite Plasmodium falciparum were found to be more attractive to the mosquito vector
Anopheles gambiae[24]. This phenomenon occurred even when the gametocytemia was very
low and was associated with changes in aldehyde concentration of the foot odours of the
infected children[25, 26].
GC/MS analysis is a useful research tool but its use as a widely available diagnostic tool is
unrealistic because of significant costs associated with the infrastructure and personnel costs.
An alternative means of detecting the odour change associated with parasitaemia is required
that would fulfil the majority of the World Health Organisation ASSURED criteria; affordable,
sensitive, specific, user-friendly, rapid and robust, equipment free and deliverable to end-users
[27] for all new point-of-care diagnostics tools. VOC analysers (eNoses) may fulfil WHO crite-
ria, they can detect differences in the odours from sputum of tuberculosis (TB) infected and
TB uninfected patients with sensitivity, specificity and accuracy of around 70%[28]. The aim
of the present study was to determine if the odour of dogs naturally infected with Le. infantum
could be detected with high sensitivity and specificity using a commercially available VOC
analyser.
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Methods
Study site
Governador Valadares (18˚510S, 41˚560W) (Minas Gerais State, Brazil), located in the valley of
the Rio Doce 320 km northeast of Belo Horizonte is a city of approximately 280,000 people.
The climate is temperate, characterised by dry winters and hot, wet summers[29]. Studies in
Governador Valadares in 2013 found that an average of 30% of dogs from 16,529 samples
taken from 35 urban and rural districts were seropositive for canine visceral leishmaniasis
(CVL)[30]. From 2008 until 2017, 194 human VL cases were recorded in Governador Vala-
dares with a fatality rate of 15.5%[31].
Ethics
Dog blood and hair samples were taken from dogs that were also microchipped with the
informed consent of their owners. Ethical approval was obtained from the Comissão de E´tica
no Uso de Animais (CEUA), Instituto Oswaldo Cruz (licence L-027/2017) in Brazil and Lan-
caster University Animal Welfare and Ethics Review Board (AWERB) in the UK. The CEUA
approval complies with the provisions of Brazilian Law 11794/08, which provides for the scien-
tific use of animals, including the principles of Brazilian Society of Science in Laboratory Ani-
mals (SBCAL). The AWERB approval complies with the UK Home Office guidelines of the
Animals in Science Regulation Unit (ASRU) and in compliance with the Animals (Scientific
Procedures) Act (ASPA) 1986 (amended 2012) regulations and was consistent with UK Ani-
mal Welfare Act 2006.
Dog recruitment
A 2 year cohort study in the Altino´polos district of Governador Valadares was initiated in
August 2017 by initial recruitment and sampling of 185 dogs. The area was chosen because of
the high prevalence of CVL (average incidence 33.8%)[30] and the large population of house-
hold-owned dogs (ca. 2000) (Centro de Controle de Zoonoses (CCZ) survey) located there.
The dogs were microchipped to aid their identification. Inclusion criteria: dogs aged� 3
months, dogs without previous clinical assessment or laboratorial diagnosis for CVL. Exclu-
sion criteria: pregnant/lactating bitches; aggressive dogs; stray dogs. In April 2018 149 dogs
were sampled, this number included 133 dogs that were resampled from the 2017 cohort and
an additional 16 from CCZ which had been collected in the same area and at the same time as
our sample collections.
Between 5ml and 10ml of peripheral blood was collected in 10ml K2 EDTA-coated tubes
(BD Vacutainer, UK) via cephalic or jugular venepuncture by a qualified vet in 2017 and by a
CCZ qualified phlebotomist in 2018. Samples were placed in containers marked with the
microchip bar code to aid subsequent tracking and identification. Blood samples were stored
in a cool box with a freezer pack before being transferred to a fridge (4˚C) prior to processing.
Hair samples were obtained by cutting the dorsal hair close to the skin using surgical scis-
sors that had been washed with hexane prior to the collection of each sample by members of
the LU research team. A minimum of 2g of hair was collected from each dog. All hair samples
were placed in individual foil bags (110mm x 185mm; Polypouch UK Ltd, Watford, England)
heat sealed and stored at 4˚C prior to analysis.
All dogs were assessed for clinical signs of Leishmania infection by veterinarians and CVL
control specialists at CCZ. The animals were classified according to the presence of clinical
signs which were recorded for each dog. The main signs of CVL considered were onychogry-
phosis, ophthalmologic abnormalities, adenitis, cachexia, hepatosplenomegaly, alopecia,
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crusted ulcers and lesions; dogs were classified as asymptomatic (the absence of clinical signs),
oligosymptomatic (the presence of one to three clinical signs), or symptomatic (the presence
of more than three clinical signs[32].
Molecular diagnosis of dogs
DNA extraction. Collected blood samples were centrifuged at 2500 x g for 10 minutes at
room temperature and the top layer of buffy coat removed, placed in 1.5ml Eppendorf tubes
and stored at -20˚C until DNA extraction. The DNA was extracted from 200μl of buffy coat
samples using the QIAamp DNA Blood Mini Kit following the manufacturer’s instructions.
Cell lysis was mediated using protein kinase with a final elution volume of 50μl.
Qualitative detection of Leishmania DNA. Conventional PCR was initially used to ascer-
tain which blood samples were positive for Leishmania infantum. Although the sensitivity of
PCR is not 100% and is not considered to be as accurate as the direct parasitological assess-
ment of lymph node or bone marrow aspirates, it is highly sensitive, rapid, requires minimal
facilities, avoids potential dog-odour contamination issues and is less distressing for the dogs.
Following primer optimization, extracted DNA from canine blood obtained during August
2017 and April 2018 were tested using Primer pair MaryF (5’–CTT TTC TGG TCC TCC GGG
TAG G– 3’), and MaryR (5’- CCA CCC GGC CCT ATT TTA CAC CAA– 3’ [33]. The reac-
tions were performed in a final volume of 25μl containing 0.5μl DNA template (100ng μl-1),
12.5μl Mastermix (dH2O, Buffer 5x, MyTaq redmix polymerase, dNTP’s) and 10μM of each
primer. The PCR amplifications were performed in a TECHNE Prime Thermal Cycler (Cole-
Palmer Ltd., Staffordshire, UK) using the following conditions: 95˚C for 5mins and 30 cycles
of 95˚C for 30sec, 57˚C for 30sec and 72˚C for 60sec, followed by 72˚C for 10min.
The PCR products were analysed by gel electrophoresis using 2% agarose gels run at 90V
for 1hr 30 minutes and visualized under UV light following the addition of 6.5μl of 10,000x
SYBR Safe (Thermo Fisher Scientific, UK) to each gel. Samples were run 3 times and dogs
were considered to be infected if 2 or 3 out of the 3 replicates were positive.
Canine beta globin house-keeping gene was used to monitor the performance of the ampli-
fication and check for DNA degradation as the samples were transported from Brazil to the
UK. Amplification of the constitutive canine globin gene was performed using the primers:
‘5—CAA CTT CAT CCA CGT TCA CC– 3’ and ‘5—ACA CAA CTG TGT TCA CTA GC– 3’
[34]. Positive control was leishmania culture DNA at a 106 parasites ml-1 concentration. Nega-
tive control was obtained by performing DNA extraction on 200μl of water instead of buffy coat
in Brazil under the same conditions as the blood.
Quantitative detection of Leishmania DNA. A real-time quantitative PCR (qPCR) for
detection and quantification of Le. infantum DNA in positive dog samples from both sampling
occasions (August 2017 and April 2018) was performed using MaryF/R primers.
The qPCR amplifications were performed on a Bio-Rad C1000 Thermal Cycler with each
reaction consisting of a final volume of 13.0μl; 12.0μL of PCR mix plus 1μL of DNA (approxi-
mately 75–100 ng/μl per reaction). The qPCR mix was composed of 6.25 μL 2x QuantiNova
SYBR Green PCR Master Mix, 0.5 μL of each primer (MaryF/R, corresponding to 10 mmol)
and 4.75 μL of water[35].
The amplification was performed in triplicate[36] at 94˚C for 10 min, followed by 40 cycles
at 94˚C for 30 sec, 60˚C for 20 sec and 72˚C for 20 sec. At the end of each run, a melt curve
analysis was performed from 55˚C to 95˚C in order to identify the formation of non-specific
products as well as primer dimers. A standard curve was established using extracted Le. infan-
tum DNA; 1:10 serial dilutions, ranging from 10,000 to 0.01 parasites per ml and used to quan-
tify the number of parasites in the dog blood samples.
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VOC analysis
Initial VOC analysis was carried out on all (n = 11) of the infected dog hair samples and a sub-
set of the uninfected dog hair samples (n = 44) collected in 2017. The choice of 44 uninfected
dog hair samples (4 matched uninfected dog hair samples for each infected dog hair sample)
was obtained by a power analysis to optimise the control size. The uninfected dogs were
selected from groups of dogs matched by shared characteristics (age, sex and whether or not
treatment for ectoparasites was received) with infected dogs (Table 1). Subsequently the VOC
analysis was carried out on all the infected dog hair samples (n = 44, including 10 CCZ infected
dogs) and all of the uninfected dog hair samples (n = 105, including 6 CCZ uninfected dogs)
collected in 2018. The number of uninfected dog hair did not exceed the “4 uninfected for
each infected dog” rule set above, and for this reason all the dogs were used.
A VOC analyser (Model 307, RoboScientific Ltd, Leeds, UK) with 11 functioning semi-con-
ducting polymer sensors was used for the analysis. Each sensor has 2 outputs (positive and
negative) giving a total of 22 responses. Two calibration points were automatically set by the
sensor unit; the first was the baseline obtained when carbon-filtered air was passed over the
sensor at a flow rate of 200ml min-1 which was automatically adjusted to zero on the Y-axis
scale, and the second was a reference point obtained from sampling the head space of 5ml of a
liquid water control in a plastic vial.
The chemical sensors were thin films of semi-conducting polymers deposited onto interdig-
itated gold structures on a silicon substrate. We used 12 different sensor types chosen from a
group of polymers that included polyaniline, polythiophene and polypyrrole. Each sensor had
semi-selectivity to a different group of volatile chemicals; aldehydes, alcohols, amines, organic
acids and ketones etc. In this way a digital fingerprint of the VOC mixtures emanating from
the samples was generated. Two similar sensor arrays were used in the study, the second array
(used for the 2018 analysis) was a derivation of the first with 50% of the sensors being identical
to the first array.
The interaction of the mixtures of VOCs in the samples with the semi-conducting polymer
surfaces produced a change in electrical properties (e.g. voltage and resistance) over time. This
change was measured, recorded and simultaneously displayed on the VOC analyser data log-
ger screen for each sensor. Four parameters were used from each sensor response; the diver-
gence from the baseline (maximum response), the integrated area under each response curve,
absorbance and desorbance. Therefore, the total number of VOC measurements produced for
each sample were 88 (11 sensors x 4 parameters and 2 outputs–positive or negative). The sam-
pling profile was set at 2 seconds baseline, 7 seconds of absorption, a 1 second pause, 5 seconds
desorption and 12 seconds flush to bring the sensors back to baseline.
Water (DD;10μl) was injected into each foil bag containing the dog hair samples with a
Hamilton syringe and inflated with 140ml of laboratory air using a diaphragm pump. The
samples were then incubated at 50˚C for 15 minutes in an oven, then allowed to cool to room
temperature for 5 minutes prior to head space analysis.
Table 1. Leishmania infantum infection status of dogs sampled in Governador Valadares, Minas Gerais.
Month of sample collection Source of dogs Number of dogs sampled Leishmania positive dogs (PCR)
symptomatic oligosymptomatic asymptomatic
Aug-17 Altino´polis 185 0 3 8
Apr-18 Altino´polis 133 3 7 24
Apr-18 CCZ GV 16 6 2 2
Dogs from Altino´polis, Governador Valadares sampled in August 2017 (n = 185) and April 2018 (n = 133). An additional 16 dogs, considered positive by CCZ, were
sampled in April 2018. PCR experiments were performed in triplicate with both positive and negative dogs identified.
https://doi.org/10.1371/journal.pntd.0007599.t001
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For the analysis each foil bag (containing the dog hair + water) was sampled by insertion of
an 18-gauge needle connected to a PTFE tube through the sidewall of the bag with the tip
placed into the head space of each bag. This was connected to the sample port of the VOC ana-
lyser and the head space sample was therefore passed over the 12 sensor surfaces. The original
flow rate for the sampling was 200 ml min-1. The headspace of each foil bag was sampled 4
times. The first sample was disregarded as potentially it could contain volatile carryover from
the previous sample and thus, we retained the data from the next 3 samples for analysis. The
individual dog hair samples in each experiment were tested randomly with each sample used
once only.
Data analysis
To test the ability of the VOC analyser to differentiate between the odours of infected and
uninfected dogs, we employed mclust[37], a model-based clustering and classification algo-
rithm (R-CRAN statistical software[38]. This was applied to the known data classes (infected
or uninfected dogs). The initial analysis indicated that the model was overfitted, therefore we
identified the infected and uninfected dog sub-classes (unsupervised clustering) and the analy-
sis was repeated [39]. The robustness of the classification was evaluated by out-of-sample cross
validation (CV) while the within-group homogeneity of the overfitting models was evaluated
by a novel algorithm developed by the authors and termed confounder cross validation
(CCV). Finally, the importance of each variable produced by the VOC analyser in discriminat-
ing between the infected and uninfected sub-classes was assessed by variable permutation anal-
ysis. A more detailed explanation of the rationale for this analysis approach is provided in the
S1 Material and a more extensive description of the algorithms is provided in[40].
The VOC analysis dataset contained data from:
a. Infected and uninfected dog hair collected in 2017.
b. Infected and uninfected dog odour collected in 2018 including samples collected from CCZ
dogs.
Three replicate VOC analyser readings were obtained for each dog odour sample. These
replicates were considered to be independent, i.e. the three VOC replicates for each dog were
considered as coming from three different dogs (a common procedure for repeated data in
clustering analyses).
The analysis aimed to identify any significant differences in the VOC analyser variables
(used to obtain the means and covariances of the infected and uninfected classes and/or sub-
classes) of infected and uninfected dogs so as to be able to accurately predict the infection state
of newly sampled dogs. Initially, the data was evaluated to determine 1. if infected and unin-
fected dogs in both 2017 and 2018 could be statistically separated and 2. if the uninfected dogs
in 2017 were statistically separate from uninfected dogs in 2018.
As described above, to take account of overfitting [41], we reclassified the infected and
uninfected classes into sub-classes using the mclust function (mclust package). The optimal
inferential method and number of subclasses for infected and uninfected classes was obtained
by Bayesian information criterion (BIC) (S1 Material), bootstrapping and the likelihood ratio
test (function mclustBootstrapLRT (mclust package).
Importance of variables: Cross-validation (CV) and confounder cross-validation (CCV)
analyses. Once the best model (number of subclasses and model components) had been
found, we tested for the importance of the variables in clustering by permutation analysis;
while the predictive capacity of the model by using “leave-one-out” cross validation (CV); and
finally, the capacity of the model to recognise sample confounders by developing a technique
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named confounder cross-validation (CCV) (a test to evaluate the statistical homogeneity of the
class). For the latter 10% of the data from the infected class were placed in the uninfected class
and vice versa (leaving the remaining 90% in their correct class for training in both cases).
These analyses were done by compiling algorithms that included some of the MCLUST com-
ponents (Mclust, MclustDA, predict) and permutation functions. Additional information is
provided in the S1 Material.
Results
Molecular diagnosis of dogs
Qualitative detection of Leishmania DNA. PCR revealed that 11/185 (6%) dogs were
positive for Le. infantum infection in August 2017 and 34/133 (26%) in April 2018 (Table 1)
representing a 20 percent increase in infection rate over the 8-month period between sampling
points. The typical PCR results showed a band at 140bp of varying intensities representing a
semi-quantitative indication of parasite presence in individual samples (Fig 1).
In 2017, 3 out of the 11 positive dogs presented as oligosymptomatic and 8 were asymptomatic.
In 2018, 3 dogs were symptomatic, 7 were oligosymptomatic and 24 were asymptomatic
(Table 1). Of the 174 uninfected 2017 dogs 42 were lost to follow-up in 2018. There were 7 oligo-
symptomatic dogs and 3 had become symptomatic in the remaining 133 dogs. In the 2017 cohort
55% of the infected dogs had 3 out of 3 positive PCR results and 45% had 2 out of 3 positive PCR
results. In the 2018 field collected cohort 47% had 3/3 + PCR results and 53% had 2/3 + PCR
results. In the 2018 CCZ collected cohort 80% had 3/3 + PCR results and 20% had 2/3 + PCR
results. Of the 11 positive dogs found in 2017 only 1 (dog 105) was resampled in 2018. The fate of
all the loss to follow-up dogs (n = 52) was recorded by CCZ and in common with other surveys
[42] the dogs had mostly either; died (n = 20; 3 through non-illness related issues) or escaped,
became lost or stolen (n = 4), their owners moved (n = 13) or refused further testing (n = 7).
The evaluation indicated that the most frequently occurring clinical signs were skin lesions
including dermatitis (18% 2017; 27% 2018) and ulcerative lesions (0% 2017; 25% 2018), long
nails (9% 2017; 25% 2018) and signs of conjunctivitis (18% 2017; 14% 2018).
PCR diagnosis of the 16 CCZ dogs, sampled in April 2018, that were assumed to be VL
infected, indicated that 10 (63%) were positive and the remaining 6 cases were not infected.
Quantitative detection of Leishmania DNA. The kDNA qPCR assay showed that para-
site loads ranged from 0.4 to 103 parasites ml-1 in 2017 and from 1 to 850 parasite ml-1 in 2018
(both field and CCZ collected) (Fig 2).
This large variation in parasitic load over the study period can be observed through analysis
of the median values which ranged from 5.06 parasites/ml (dog #116) in 2017 to 28.32 para-
sites/ml (dog #178) in 2018. Comparisons of parasitic load among the samples revealed that
dog #126 in 2018 (853 parasites ml-1) exhibited the highest degree of parasitism with dog #146
in 2017 (0.4 parasites ml-1) exhibiting the lowest.
The average value of CT (ΔCT) obtained for dog #126 in 2018 (highest degree of parasitism)
and for dog #146 in 2017 (lowest degree of parasitism) were the following: dog #126; 20.43 and
dog #146; 30.45. A lower CT value correlates with a higher parasitic load per ml of blood.
Data analysis
The best model for the analysis of all infected and uninfected dog classes was EEE apart from
the uninfected 2017 dogs which was VVI [40]. The EEE model assumes ellipsoidal covariances
and equal shape, volume and orientation for all the classes. The VVI model assumes diagonal
covariances with orientation parallel to the coordinate axes with variable shape and volume for
all the classes [43]. Between 14 models x 1 to 9 classes were assessed (i.e. 126 mixture models)
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[44] (S1 Table (2017 data) and S2 Table (2018 data)). Clustering analysis of 2017 dogs identi-
fied 1 class for uninfected dogs and 3 classes for infected dogs and for the 2018 dogs 2 classes
for uninfected dogs and 6 classes for infected dogs were identified.
Confusion matrices of the separation obtained from the training set of uninfected vs
infected dogs in 2017 and uninfected vs infected dogs in 2018 without sub-classes are given in
Table 2A and 2C respectively and with sub-classes in Table 2B and 2D respectively below.
These data show that in both years the infected dog odours were significantly different
from the uninfected dog odours. In 2017 uninfected dogs were discriminated with 96% speci-
ficity and 97% sensitivity, that was improved to 100% for both metrics when the data was
divided in sub-classes. The overall training error was reduced (from 2.8% to 0%) when the
2017 data was divided in sub-classes.
In 2018 uninfected and infected dogs were discriminated with 89% specificity and 100%
sensitivity and that was improved to 94% specificity and 97% sensitivity when the data was
divided in sub-classes. The overall training error was reduced (from 7.6% to 4.2%) when the
2018 data was divided in sub-classes.
Cross-validation (CV) and confounder cross-validation (CCV) analysis. When consid-
ering only the infected and uninfected classes, the CV analysis returned a reduced sensitivity
of 50% and specificity of 84% for 2017 dogs, and 48% sensitivity and 96% specificity for 2018
dogs (Table 3A and 3B first line and first two columns) indicating a reduced capacity to esti-
mate true positives compared to the training set (as reported in Table 2) due to overfitting.
The CCV analysis suggested high heterogeneity of the infected and uninfected classes since the
model is unable to identify the false positive and false negatives in the training groups. How-
ever, when the analyses were repeated on the EDDA models with sub-classes, both cross vali-
dation (CV) and confounder cross validation (CCV) calculations of sensitivity and specificity
improved substantially (Table 3A and 3B second line). Thus, by identifying sub-classes for
infected and uninfected dogs it was possible to obtain a better delineation of the multivariate
space with improved predictivity capacity (CV analysis) and recognition of false positive and
false negative in the two main macro-classes (infected and uninfected) of the training sets
(increased homogeneity into sub-classes; CCV analysis).
The eNose variables important in the clustering are shown in S3 Table (2017 data) and S4
Table (2018 data). A 0.99 P-value indicates that in 99% of the permutations the number of
optimal clusters changed, indicating a strong influence of the variable in the final clustering.
Discussion
The results presented in this study show that by combining VOC (eNose) data with robust
clustering analysis we can identify dogs infected with Le. infantum by analysis of their odour
with very high sensitivity and specificity, regardless of parasite load or the presentation of clini-
cal symptoms. We observed this outcome in two data sets from dog hair samples collected in
2017 (99% [0.95,0.99] specificity and 90% [0.75,0.96] sensitivity) and in 2018 (89% [0.85,0.92]
specificity and 100% 0.97,1] sensitivity). When the small size of both data sets (2017, 55 dog
hair samples: 2018, 149 dog hair samples) and consequent potential for overfitting was
accounted for by improving the mixture of the models, both sensitivity and specificity
Fig 1. Preliminary detection of Leishmania infantum in dog blood samples. SYBR safe-stained 2% agarose gels
showing the results of electrophoresis of 24 random PCR products from A; August 2017 dogs and B; April 2018 dogs,
used to identify the presence of Leishmania in dog blood. Positive dogs are indicated by a 140bp band visible in line
with the PCR product for the Leishmania positive control. M, molecular weight marker (100bp DNA ladder); “+” =
positive control; “-” = negative control.
https://doi.org/10.1371/journal.pntd.0007599.g001
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Fig 2. Quantitative estimation of Leishmania infantum in blood samples from infected dogs. kDNA qPCR assay showing the quantification of
all positive samples from A; August 2017, B; CCZ (April 2018) and C; in the field (April 2018). All positive samples previously determined by
conventional PCR were qualitatively analysed by qPCR to determine parasite loads of each positive dog. Range of parasite load; 0.4 parasites mL1
to 853 parasites mL-1. White bars; asymptomatic dogs, grey bars; oligosymptomatic dogs and black bars; symptomatic dogs. Parasite load is per
mL of blood. For clarity parasite load is given for all dogs in 2A and 2B but is excluded from dogs with similar loads in 2C. Dog identification
number is given on the X-axis.
https://doi.org/10.1371/journal.pntd.0007599.g002
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increased (2017; 100% [0.96,1] specificity, 100% [0.88,1] sensitivity: 2018; 94% [0.91,0.96] spec-
ificity, 97% [0.93,0.99] sensitivity).
The robustness of the models was further tested by cross-validation and an novel approach
which we have termed confounder cross validation analyses. The model prediction was poor
when we used 2 classes (infected and uninfected). However, when we accounted for the
Table 2. Confusion matrices for Gaussian mixture model EDDA classification.
A. 2017: 1 uninfected and 1 infected dog class.
observed\predicted uninfected infected specificity sensitivity
uninfected 111 1 0.99 (0.95,0.99)
infected 3 28 0.90
(0.75,0.96)
training error: 0.028
B. 2017. VVI model: 1 uninfected and 3 infected dog classes.
uninfected 112 0 1
(0.96,1)
infected 0 31 1
(0.88,1)
training error: 0
C. 2018: 1 uninfected and 1 infected dog class.
uninfected 280 34 0.89
(0.85,0.92)
infected 0 132 1.00
(0.97,1)
training error 0.076
D. 2018. EEE model: 2 uninfected and 6 infected dog classes.
uninfected 298 16 0.94
(0.91,0.96)
infected 3 129 0.97
(0.93,0.99
training error 0.042
Training error is the average error, i.e. the ratio between correctly predicted class members and the total number of records e.g. in 1A above (111+28)/(111+28+1+3).
Specificity and sensitivity 95% confidence intervals (based on binomial probabilities) are reported in brackets.
https://doi.org/10.1371/journal.pntd.0007599.t002
Table 3. Comparison of sensitivity and specificity after CV and CCV analysis.
A 2017 dog samples

















2 classes = 1 uninfected + 1 infected class 4 classes = 1 uninfected + 3 infected classes

















2 classes = 1 uninfected + 1 infected 8 classes = 2 uninfected + 6 infected
Specificity and sensitivity 95% confidence intervals (based on binomial probabilities) are reported in brackets. CV-
cross validation; CCV- confounder cross validation.
https://doi.org/10.1371/journal.pntd.0007599.t003
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heterogeneity within each of these classes and subdivided them into either 4 subclasses (2017
data) or 8 subclasses (2018 data) the sensitivity and specificity and their confidence intervals
improved substantially. In both cases the models accurately placed dog odours in the correct
infected or uninfected class with a high degree of specificity and sensitivity (93% sensitivity
and 92% specificity).
The results suggested that the VOC analyser response was not related to the parasite load in
the dog peripheral blood. As the analysis gave sensitivity and specificity responses substantially
better than 90%, the effect of parasite load on the VOC analyser response is unlikely to have
been significant as the majority of infected animals, regardless of parasite load were detected.
However, determining the limits of detection will be important in the future.
Previous work has suggested that symptomatic dogs with a greater parasite load produced
greater quantities of volatiles than infected asymptomatic dogs[23]. However, asymptomatic
dogs can contribute to disease transmission and VL control strategies should target infectious
dogs rather than infected dogs per se and in particular the super-spreaders in the population
[21, 45]. In this study we identified Leishmania DNA in circulating blood obtained by cephalic
and jugular venepuncture, however the relationship between numbers of circulating parasites
in peripheral blood and the infection status of the dog is unclear. In future studies, the skin
parasite load, which appears to be more closely related to infectiousness[45] could be corre-
lated with the odour profile.
In our study we used molecular techniques, PCR and qPCR, to diagnose and quantify Le.
infantum infection in dogs. Although the gold standard diagnosis is considered to be the direct
parasitological assessment of lymph node or bone marrow aspirates, in this study we chose to
take blood and hair samples from the dogs at their homes. This methodology reduced the pos-
sibility of cross-contamination between infected and uninfected dog odour which might have
occurred if the dogs had been kept together e.g. at the CCZ facility. This less invasive sampling
protocol also reduced stress on the dogs, did not require large facilities (e.g. for sedation
required to obtain bone marrow aspirates), reduced the risk of infection to the animal and was
more likely to receive owner consent and compliance.
A recent study[46] evaluated the accuracy of serological tests, immunochromatographic
(Dual Path Platform: DPP) and enzyme-linked immunosorbent (ELISA EIE), for CVL in rela-
tion to the detection of Leishmania DNA through real-time PCR) in samples from symptom-
atic and asymptomatic dogs. The PCR analysis demonstrated greater homogeneity between
symptomatic and asymptomatic groups of infected dogs compared with DPP and ELISA.
Solcà et al. showed that The diagnosis of CVL through the amplification of kinetoplast DNA
presented the highest rates of sensitivity and specificity in comparison with parasitological and
serological methods[47]. These authors concluded that molecular methods are required to
confirm the infection. Even though serological tests are routinely employed for diagnosing
CVL, they have limitations in sensitivity, especially in asymptomatic dogs, and therefore may
underestimate Leishmania infection rates[48]. Despite the high specificity, the serological tests
present low capacity to detect Leishmania infection in relation to molecular tests [49]. The
authors of that study concluded that their study “demonstrated that real-time PCR identified
the presence of Leishmania DNA in asymptomatic dogs that had a negative result in serologi-
cal tests recommended by the official Brazilian protocol for CVL. In addition in a recent study
[50], 34 out of 36 (96%) Leishmania isolates from dogs sampled in GV were found to be Le.
infantum, the other 2 isolates were from the Leishmania mexicana complex, Le. (Le.) amazo-
nensis Le. (Le.) mexicana). Therefore, for the purposes of the current study our molecular diag-
nosis was likely to be representative of the true infection status of the dogs.
The prevalence of CVL recorded in our 2017 sample (6%) is low compared to the preva-
lence recorded in our 2018 sample (25.6%). It is possible that the extensive monitoring carried
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out by Governador Valadares health authorities in the Altino´polis district of GV, where the
study was carried out, immediately prior to our sample collection in 2017, had an impact on
CVL prevalence.
However, these values are within the range of prevalence seen previously in studies carried
out in the State of Minas Gerais generally e.g. a prevalence of 8.1% was observed in Belo Hori-
zonte in dogs surveyed between 2008–2010[42] and 13.6% in Divino´polis in 2011[51]. In GV
specifically, a study carried out in Altino´polis, between 2008–2011 found 33.8% of dogs sur-
veyed to be infected[30] whereas a survey of dogs carried out in 2014–2015 found 22% of dogs
to be positive by serology[52].
It has been suggested that change in odour of dogs infected with Le. infantum might be
related to the immune response[23]. Changes in odour profile have been observed in other dis-
ease states where changes in relatively low molecular weight compounds were expressed as dis-
tinct and immediate changes arising from pathophysiological processes occurring and altering
the body’s metabolism[19]. However, although the very low parasite loads in some dogs might
suggest recent infection, parasite load in the peripheral blood is not indicative[53] and as this
study did not determine if the dogs had seroconverted it therefore remains unclear if the
odour changes are related to the host immune response or not.
Our results also suggest that there was no relationship between clinical state of infection
(symptomatic, oligosymptomatic and asymptomatic) and detector response. The analyser
could accurately detect asymptomatic dogs with low parasite levels as well as symptomatic
dogs with high parasite loads.
It has been proposed that manipulation of the hosts chemical communication system could
enhance the transmission of the parasite to the insect vector and potentially have a significant
effect on the epidemiology of the disease[20, 54, 55]. Our study examined volatile odours pres-
ent on the dog hair only, it did not consider the effect of other volatiles, semi-volatiles and
non-volatiles from other sources e.g. breath compounds, specialized scent gland secretions,
sweat, urine or faeces[56]. The source of the odours that were detected by the VOC analyser is
not clear, they could have arisen from the skin, as a result of the metabolic activity of skin
microbiota[57], the immune response or potentially directly from the Le. infantum parasites.
Our study did not examine the effect of other infections and the ability of the VOC analyser
to differentiate between dogs infected with Le. infantum and other Leishmania spp. or other
infections was not determined. In Governador Valadares dogs infected with Le. amazonensis
have been found[50] and the sand fly vector Lu. longipalpis infected with multiple Leishmania
spp. have been also been found[58] indicating that the epidemiological features require further
work.
The application of VOC analyser technology is potentially a significant step towards the
application of volatile odour analysis in diagnosis of parasitic disease. It raises the possibility
that in the future a modified VOC device could provide a rapid, accurate, non-invasive point-
of-care diagnostic tool for the specific diagnosis of leishmaniasis in dogs and humans. In our
study we found that a small proportion of the sensor variables (2 out of 88 in 2017 and 3 out of
88 in 2018) contributed significantly to the outcome. Therefore, there is considerable scope for
enhancing the sensitivity and specificity of the device through modifications to the sensor
chemistry as well as incorporating further improvements to the field collection and analysis of
odour. As well as further developments in robustness, portability and simplicity of the device
all of which would improve the reliability and utility in the field.
A reliable, rapid, accurate, non-invasive additional point-of-care test that identifies Leish-
mania infection using a different set of disease markers in addition to the DPP CVL test could
potentially eliminate the need for the in-laboratory ELISA confirmatory test that currently fails
to rapidly diagnose and remove infected dogs from the population. The ability of a VOC
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analyser, that conforms to the WHO ASSURED criteria, to recognise infection in asymptom-
atic dogs and dogs with low levels of infection would be of great benefit to VL control
programs.
The possible integration of a rapid, non-invasive and point-of-care test would be much bet-
ter accepted by dog owners and could be an important epidemiological tool. In addition to
being useful for the selection of infected animals for euthanasia, it could also be useful in the
implementation, monitoring and evaluation of leishmania control activities such as insecticide
impregnated dog collars that are currently being implemented and sex pheromone-based Lu.
longipalpis control programs that are currently being evaluated[59, 60].
Further work to compare the sensitivity and specificity of a VOC test combined with DPP
CVL diagnostics against DPP CVL combined with ELISA is required. The development of a
non-invasive POC diagnostic tool based on host odour opens up a myriad range of opportuni-
ties to diagnose Leishmania infections in humans and other diseases such as malaria, trypano-
somiasis and Chaga’s disease.
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Rio de Janeiro, 23 de maio de 2017. 
Prezado Dr. Reginaldo Peçanha Brazil, 
 
No dia 23 de maio de 2017 representantes da CEUA-IOC se reuniram e deliberaram sobre o projeto intitulado “O papel do odor 
de cães infectados por Leishmania infantum na atração de Lutzomyia longipalpis, e sua utilização como base para 
diagnóstico precoce da leishmaniose visceral, Governador Valadares, Minas Gerais, Brasil”, proposto por V.S.a. Com base nos 
documentos apresentados, a comissão se posicionou favorável à aprovação da licença após as correções sugeridas abaixo. 
Favor executar as correções utilizando sempre o formulário atual disponível no site do IOC 
(http://www.fiocruz.br/ioc/cgi/cgilua.exe/sys/start.htm?sid=386) e a ferramenta “marcador de alterações” do seu processador de 
texto, enviando seu novo protocolo revisado para o email ceua.ioc@ioc.fiocruz.br.  
 
Favor verificar erros de digitação/português ao longo de todo o texto do formulário. 
Item 1. Título: Corrigir “Lutzomyia Longipalpis” para “Lutzomyia longipalpis”. 
Item 7. Resumo: (1) Mencionar que, em caso de detecção de animais infectados ou que se infectarem durante a pesquisa, as 
autoridades municipais de saúde serão notificadas; (2) Substituir “veia radial” por “veia cefálica”; (3) Respeitar o limite de 
caracteres do texto. 
Item 8. Justificativa: (1) Explicar a expressão “(...) a medicina utiliza-se do cheiro (ou mesmo gosto) de urina para diagnosticar 
doenças”; (2) Respeitar o limite de caracteres do texto. 
Item 9. Modelo animal: A idade mencionada “<3 meses” difere da mencionada no resumo “>3 meses”. 
Item 10.1. Detalhamento de cada procedimento:  
Procedimento 1: (1) No título deste procedimento, substituir o termo “assepsia” por “antissepsia”; (2) No texto, substituir “veia 
radial” por “veia cefálica”; (3) Como no resumo, mencionar “veia jugular” como alternativa para a coleta de sangue. 
Procedimento 2: (1) Substituir o termo “cabelo” por “pelo”; (2) Substituir “luvas de laboratório” por “luvas de procedimentos”. 
Procedimento 3: (1) Favor mencionar que os microchips serão implantados subcutaneamente. (2) Favor substituir “ISSO” por 
“ISO”. 
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Item 10.2. Desenho experimental: (1) O procedimento 3, “Implante de microchip nos cães”, ocorrerá somente uma vez. A 
leitura do microchip implantado é que ocorrerá três vezes. (2) Mencionar que a coleta será feita de animais de ambos os 
gêneros, conforme previamente mencionado na observação do item 9. 
TCLE: (1) Revisar o Português; (2) No título, corrigir “Longipalpis” para “longipalpis”; (3) Numerar as páginas (Pág. 1 de 4, Pág. 
2 de 4, etc.); (4) Substituir “veia radial” por “veia cefálica”; (5) Mencionar que, em caso de detecção de animais infectados ou que 
se infectarem durante a pesquisa, as autoridades municipais de saúde serão notificadas; (6) Explicar a expressão “(...) a 
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____________________________________________________________________________ 
                                      LICENÇA                             L-027/2017 
 
Certificamos que o protocolo (CEUA/IOC-018/2017), intitulado “O Papel do odor de cães 
infectados por Leishmania infantum na atração de Lutzomyia longipalpis, e sua utilização como base 
para diagnóstico precoce da leishmaniose visceral, Governador Valadares, Minas Gerais, Brasil.”, 
sob a responsabilidade de REGINALDO PEÇANHA BRAZIL atende ao disposto na Lei 
11794/08, que dispõe sobre o uso científico no uso de animais, inclusive, aos princípios da 
Sociedade Brasileira de Ciência em Animais de Laboratório (SBCAL). A referida licença não 
exime a observância das Leis e demais exigências legais na vasta legislação nacional. 
Esta licença tem validade até 30/06/2020 e inclui o uso total de: 
 




♂ ♀ Idade Peso Origem (*) 
( X ) Outros Canis 
familiaris 








Observação: Esta licença não substitui outras licenças necessárias, como Certificado de 
Qualidade em Biossegurança para animais geneticamente modificados, certificado do IBAMA 
para captura de animais silvestres ou outros. 




Flávio Alves Lara 
Coordenador da CEUA/Instituto Oswaldo Cruz 
Fundação Oswaldo Cruz 
